Science.gov

Sample records for submitting protocols sponsored

  1. 42 CFR 423.272 - Review and negotiation of bid and approval of plans submitted by potential Part D sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 3 2010-10-01 2010-10-01 false Review and negotiation of bid and approval of plans... and negotiation of bid and approval of plans submitted by potential Part D sponsors. (a) Review and negotiation regarding information, terms and conditions. CMS reviews the information filed under §...

  2. 42 CFR 423.272 - Review and negotiation of bid and approval of plans submitted by potential Part D sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... determinations. (1) Application of revenue requirements standard. CMS approves a bid submitted under § 423.265...) Limited risk plans. (1) Application of limited risk plans. There is no limit on the number of full risk... all MA-PD bid submission and approval requirements applicable to MA-PD plans with the...

  3. Inhibition of angiotensin-converting enzyme increases oestradiol production in ewes submitted to oestrous synchronization protocol.

    PubMed

    Costa, A s; Junior, A S; Viana, G E N; Muratori, M C S; Reis, A M; Costa, A P R

    2014-10-01

    This study aimed at evaluating the effects of angiotensin-converting enzyme inhibitor (enalapril) and angiotensin II antagonist (valsartan) on the oestradiol and progesterone production in ewes submitted to oestrous synchronization protocol. The animals were weighed and randomly divided into three groups (n = 7). A pre-experiment conducted to verify the effectiveness and toxicity of enalapril (0.5 mg/kg LW) and valsartan (2.2 mg/kg LW) showed that, in the doses used, these drugs were effective in reducing blood pressure without producing toxic effects. In the experiment, all animals were subjected to oestrous synchronization protocol during 12 days. On D10, D11 and D12, animals received saline, enalapril or valsartan (same doses of the pre-experiment), according to the group randomly divided. The hormonal analysis showed an increase in oestradiol on the last day of the protocol (D12) in animals that received enalapril (p < 0.05), but not in other groups, without changing the concentration of progesterone in any of the treatments. It is concluded that valsartan and enalapril are safe and effective subcutaneously for use in sheep and that the angiotensin-converting enzyme (ACE) inhibition with enalapril leads to an increase in oestradiol production near ovulation without changing the concentration of progesterone. This shows that ACE inhibition may be a useful tool in reproductive biotechnologies involving induction and synchronization of oestrus and ovulation in sheep.

  4. Utility of a Standardized Protocol for Submitting Clinically Suspected Endometrial Polyps to the Pathology Laboratory

    PubMed Central

    Safdar, Nida S.; Giannico, Giovanna; Desouki, Mohamed Mokhtar

    2016-01-01

    The purpose of the study is to assess whether a protocol for submitting clinically suspected endometrial polyps will improve the detection rate of polyps and evaluation of the background endometrium. A retrospective review from 1999– 2015 was performed. Cases were divided into: 1) polyps and curetting placed in 2 containers (separate, n=61) and 2) polyps and curettings placed in one container (combined, n=80). Polyps were identified in 100% of cases in the separate compared to 95% in the combined group (p=0.62). The background endometrium was evaluable in 79% in the combined compared to 90% in the separate group (p=0.07). The frequency of hyperplasia without atypia, atypical hyperplasia and carcinoma was 4.4%, 3.6% and 1.5%, respectively. In conclusion, the enhanced rate of polyp detection and evaluation of the background endometrium in the separate group is minimal. This supports the recommendation of submitting endometrial polyps and curetting combined in one container. PMID:27402220

  5. 21 CFR 312.83 - Treatment protocols.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 5 2010-04-01 2010-04-01 false Treatment protocols. 312.83 Section 312.83 Food...-debilitating Illnesses § 312.83 Treatment protocols. If the preliminary analysis of phase 2 test results appears promising, FDA may ask the sponsor to submit a treatment protocol to be reviewed under...

  6. 21 CFR 312.83 - Treatment protocols.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 5 2011-04-01 2011-04-01 false Treatment protocols. 312.83 Section 312.83 Food...-debilitating Illnesses § 312.83 Treatment protocols. If the preliminary analysis of phase 2 test results appears promising, FDA may ask the sponsor to submit a treatment protocol to be reviewed under the...

  7. 21 CFR 312.83 - Treatment protocols.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 5 2012-04-01 2012-04-01 false Treatment protocols. 312.83 Section 312.83 Food...-debilitating Illnesses § 312.83 Treatment protocols. If the preliminary analysis of phase 2 test results appears promising, FDA may ask the sponsor to submit a treatment protocol to be reviewed under the...

  8. 21 CFR 312.83 - Treatment protocols.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 5 2014-04-01 2014-04-01 false Treatment protocols. 312.83 Section 312.83 Food...-debilitating Illnesses § 312.83 Treatment protocols. If the preliminary analysis of phase 2 test results appears promising, FDA may ask the sponsor to submit a treatment protocol to be reviewed under the...

  9. Sponsored Programs.

    ERIC Educational Resources Information Center

    College and University Business Administration, 1980

    1980-01-01

    General administrative principles and procedures applicable to any type of program sponsored by external funds, including the federal government, are examined. Contracts, grants, and cooperative agreements are the devices for authorizing sponsored programs. Since the institutions assume full legal responsibility for the programs and for fulfilling…

  10. Sponsored Programs.

    ERIC Educational Resources Information Center

    College and University Business Administration, 1980

    1980-01-01

    General administrative principles and procedures applicable to any type of program sponsored by external funds, including the federal government, are examined. Contracts, grants, and cooperative agreements are the devices for authorizing sponsored programs. Since the institutions assume full legal responsibility for the programs and for fulfilling…

  11. Gallium Nitride (GaN) Monolithic Microwave Integrated Circuit (MMIC) Designs Submitted to Air Force Research Laboratory (AFRL) Sponsored Qorvo Fabrication

    DTIC Science & Technology

    2017-07-13

    ABSTRACT The US Army Research Laboratory (ARL) is exploring devices and circuits for radio frequency communications, networking, and sensor systems...stage driver amplifier were submitted for fabrication. There may not be die space for all 3 of these designs, likewise for some of the other...final fabrication due to space limitations. Passive power combiner circuits with isolation resistors that can handle the high powers of GaN

  12. Fate of protocols submitted to a French national funding scheme: a cohort study.

    PubMed

    Decullier, Evelyne; Huot, Laure; Chapuis, François R

    2014-01-01

    The fate of clinical research projects funded by a grant has been investigated, but there is no information on the projects which did not receive funding. The fate of these projects is not known: do they apply for and/or receive funding from other sources or are they carried out without specific funding? The aim of the study was to describe all clinical research projects submitted to a French national funding scheme (PHRC 2000) and to assess project initiation, completion and publication status taking into account whether or not they received funding. This study is a retrospective cohort. The initial project characteristics were retrieved from the submission files and follow-up information was collected from the primary investigator. The percentages of projects started, completed and published were studied. A total of 481 projects were studied. Follow-up information was obtained for 366. Overall, 185 projects were initiated (51%); 139 of them were funded by the PHRC 2000 or other sources. The most commonly cited reason for not initiating a project was a lack of funding. Subsequently, 121 of the projects initiated were completed (65%). Accrual difficulties were the main reason cited to explain why studies were stopped prematurely or were still ongoing. Finally, 88 of the completed projects were published (73%). Amongst the completed projects, the only factor explaining publication was the statistical significance of the results. Obtainment of funding was a determining factor for project initiation. However, once initiated, the funding did not influence completion or publication.

  13. Effects of eCG are more pronounced in primiparous than multiparous Bos indicus cows submitted to a timed artificial insemination protocol.

    PubMed

    Sales, J N S; Bottino, M P; Silva, L A C L; Girotto, R W; Massoneto, J P M; Souza, J C; Baruselli, P S

    2016-12-01

    The effects of eCG on follicular growth, ovulation, and pregnancy per artificial insemination (P/AI) in multiparous and primiparous Bos indicus beef cows submitted to timed artificial insemination (TAI) were evaluated in three experiments. In experiments 1 (follicular responses; n = 64), 2 (follicular growth and ovulation rate; n = 662), and 3 (P/AI; n = 2092), cows submitted to TAI were assigned to receive one of two treatments on Day 8 of the synchronization protocol: control (no additional treatment) or eCG (300-IU of eCG intramuscularly). In experiment 1, largest follicle (LF) diameter on Day 8 (P = 0.56) and the interval from progesterone (P4)-device removal to ovulation (P = 0.79) did not differ between treatments. However, the maximum diameter of the LF (P = 0.05) and ovulation rate (P = 0.03) were greater in cows that received eCG. In experiment 2, the diameter of the LF on Day 10, follicular growth, and ovulation rate were greater in eCG-treated cows (P < 0.01). However, CL diameter was similar between treatments (P = 0.11). In experiment 3, there was a treatment-by-parity interaction (P = 0.003) on P/AI, such that treatment with eCG was more effective in primiparous cows. In conclusion, eCG treatment resulted in increased final follicular growth, ovulation rate, and fertility in B indicus cows submitted to TAI protocols, especially in primiparous cows. Copyright © 2016 Elsevier Inc. All rights reserved.

  14. Biochemical and oxidative stress markers in the liver and kidneys of rats submitted to different protocols of anabolic steroids.

    PubMed

    Dornelles, Guilherme Lopes; Bueno, Andressa; de Oliveira, Juliana Sorraila; da Silva, Aleksandro Schafer; França, Raqueli Teresinha; da Silva, Cássia Bagolin; Machado, Márcia Silveira Netto; Petry, Letícia do Santos; Abdalla, Fátima Husein; Lhamas, Cibele Lima; de Andrade, Cinthia Melazzo

    2017-01-01

    The objective of this study was to evaluate the effects of different protocols (P1, P2, and P3) of boldenone undecylenate (BU) and stanozolol (ST) on markers of liver and kidney function and variables of oxidative stress in these organs. For this, 54 male Wistar rats were divided into nine groups of six animals each. Each animal received intramuscularly 5.0 mg kg(-1) of BU or ST once a week for 4 weeks (P1); 2.5 mg kg(-1) of BU or ST once a week for 8 weeks (P2); and 1.25 mg kg(-1) of BU or ST once a week for 12 weeks (P3). For each protocol, a control group was used, and they received 0.1 ml of olive oil intramuscularly. Blood and fragments of liver and kidney were collected for alanine aminotransferase activity (ALT), alkaline phosphatase, albumin, creatinine, cholesterol, total protein, triglycerides, urea, reactive oxygen species, thiobarbituric acid reactive substances, total thiols, and glutathione evaluation. The results show that the BU in doses of 5 (day 30) and 2.5 mg kg(-1) (day 60) changes the ALT seric activity, possibly showing a hepatotoxic effect. High doses of BU may lead to increased levels of cholesterol (protocol P1) possibly due to inhibition of the normal steroid biosynthesis process. All protocols used caused changes in the redox balance of the organs studied (except in the liver, protocol P2), which indicates that these drugs might be harmful even at low doses.

  15. ACKNOWLEDGEMENTS AND SPONSORS Acknowledgements and sponsors

    NASA Astrophysics Data System (ADS)

    2010-11-01

    6th International Conference on 3D Radiation Dosimetry www.IC3DDose.org Edited by Mark Oldham Assisted by Joseph R. Newton Academic Sponsors: American Association of Physicists in Medicine (AAPM) South Eastern Chapter of the AAPM (SEAAPM) The Duke Medical Physics Graduate Program The Department of Radiation Oncology, Duke University Medical Center Scientific Organizing Committee: Sven Back (Sweden), Clive Baldock (Australia), Cheng-Shie Wuu (USA), Yves De Deene (Belgium), Simon Doran (UK), Geoffrey Ibbott (USA), Andrew Jirasek (Canada - President), Kevin Jordan (Canada), Martin Lepage (Canada), Thomas Maris (Greece), Mark Oldham (USA - Chair), Evangelos Pappas (Greece), John Schreiner (Canada) Local Organizing Committee: Mark Oldham, Carolyn Crank, Joseph Newton, Andrew Thomas, Matthew DeLorenzo, Fang-Fang Yin, Duke University Medical Center, Durham, NC, USA Conference photograph Conference photograph. Sponsor's logos Sponsor's logos

  16. Static balance and function in children with cerebral palsy submitted to neuromuscular block and neuromuscular electrical stimulation: Study protocol for prospective, randomized, controlled trial

    PubMed Central

    2012-01-01

    Background The use of botulinum toxin A (BT-A) for the treatment of lower limb spasticity is common in children with cerebral palsy (CP). Following the administration of BT-A, physical therapy plays a fundamental role in potentiating the functionality of the child. The balance deficit found in children with CP is mainly caused by muscle imbalance (spastic agonist and weak antagonist). Neuromuscular electrical stimulation (NMES) is a promising therapeutic modality for muscle strengthening in this population. The aim of the present study is to describe a protocol for a study aimed at analyzing the effects of NMES on dorsiflexors combined with physical therapy on static and functional balance in children with CP submitted to BT- A. Methods/Design Protocol for a prospective, randomized, controlled trial with a blinded evaluator. Eligible participants will be children with cerebral palsy (Levels I, II and III of the Gross Motor Function Classification System) between five and 12 years of age, with independent gait with or without a gait-assistance device. All participants will receive BT-A in the lower limbs (triceps surae). The children will then be randomly allocated for either treatment with motor physical therapy combined with NMES on the tibialis anterior or motor physical therapy alone. The participants will be evaluated on three occasions: 1) one week prior to the administration of BT-A; 2) one week after the administration of BT-A; and 3) four months after the administration of BT-A (end of intervention). Spasticity will be assessed by the Modified Ashworth Scale and Modified Tardieu Scale. Static balance will be assessed using the Medicapteurs Fusyo pressure platform and functional balance will be assessed using the Berg Balance Scale. Discussion The aim of this protocol study is to describe the methodology of a randomized, controlled, clinical trial comparing the effect of motor physical therapy combined with NMES on the tibialis anterior muscle or motor

  17. Effects of two estradiol esters (benzoate and cypionate) on the induction of synchronized ovulations in Bos indicus cows submitted to a timed artificial insemination protocol.

    PubMed

    Sales, J N S; Carvalho, J B P; Crepaldi, G A; Cipriano, R S; Jacomini, J O; Maio, J R G; Souza, J C; Nogueira, G P; Baruselli, P S

    2012-08-01

    The effects of estradiol benzoate (EB) and estradiol cypionate (EC) on induction of ovulation after a synchronized LH surge and on fertility of Bos indicus females submitted to timed AI (TAI) were evaluated. In Experiment 1, ovariectomized Nelore heifers were used to evaluate the effect of EB (n = 5) and EC (n = 5) on the circulating LH profile. The LH surge timing (19.6 and 50.5 h; P = 0.001), magnitude (20.5 and 9.4 ng/mL; P = 0.005), duration (8.6 and 16.5 h; P = 0.001), and area under the LH curve (158.6 and 339.4 ng/mL; P = 0.01) differed between the EB and EC treatments, respectively. In Experiment 2 (follicular responses; n = 60) and 3 (pregnancy per AI; P/AI; n = 953) suckled Bos indicus beef cows submitted to an estradiol/progesterone-based synchronization protocol were assigned to receive one of two treatments to induce synchronized ovulation: 1 mg of EB im 24 h after progesterone (P4) device removal or 1 mg of EC im at P4 device removal. There was no difference (P > 0.05) between EB and EC treatments on follicular responses (maximum diameter of the ovulatory follicle, 13.1 vs. 13.9 mm; interval from progesterone device removal to ovulation, 70.2 vs. 68.5 h; and ovulation rate, 77.8 vs. 82.8%, respectively). In addition, P/AI was similar (P < 0.22) between the cows treated with EB (57.5%; 277/482) and EC (61.8%; 291/471). In conclusion, despite pharmacologic differences, both esters of estradiol administered either at P4 device removal (EC) or 24 h later (EB) were effective in inducing an LH surge which resulted in synchronized ovulations and similar P/AI in suckled Bos indicus beef cows submitted to TAI. Copyright © 2012 Elsevier Inc. All rights reserved.

  18. 7 CFR 654.11 - Sponsor(s)' responsibility.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) NATURAL RESOURCES CONSERVATION SERVICE... § 654.11 Sponsor(s)' responsibility. (a) On non-Federal land, sponsor(s) are responsible for financing...&M on land administered by that agency. If project measures benefit both Federal and non-Federal land...

  19. 7 CFR 654.11 - Sponsor(s)' responsibility.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) NATURAL RESOURCES CONSERVATION SERVICE... § 654.11 Sponsor(s)' responsibility. (a) On non-Federal land, sponsor(s) are responsible for financing...&M on land administered by that agency. If project measures benefit both Federal and non-Federal land...

  20. 7 CFR 654.11 - Sponsor(s)' responsibility.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) NATURAL RESOURCES CONSERVATION SERVICE... § 654.11 Sponsor(s)' responsibility. (a) On non-Federal land, sponsor(s) are responsible for financing...&M on land administered by that agency. If project measures benefit both Federal and non-Federal land...

  1. 7 CFR 654.11 - Sponsor(s)' responsibility.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) NATURAL RESOURCES CONSERVATION SERVICE... § 654.11 Sponsor(s)' responsibility. (a) On non-Federal land, sponsor(s) are responsible for financing...&M on land administered by that agency. If project measures benefit both Federal and non-Federal land...

  2. Institution-Sponsored Internships.

    ERIC Educational Resources Information Center

    Ard, Anne K.

    1994-01-01

    Colleges can use institutionally-sponsored internships, in-house opportunities to participate in the daily activities of leadership, to let employees learn the culture of leadership and interact with staff currently in such positions. Administrative internships at Pennsylvania State University, Eastern Illinois University, and Arizona State…

  3. 7 CFR 654.11 - Sponsor(s)' responsibility.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ..., DEPARTMENT OF AGRICULTURE SUPPORT ACTIVITIES OPERATION AND MAINTENANCE Federal Financially-Assisted Projects... agreed by the Federal agency, sponsor(s), and NRCS. If O&M of project measures is performed by mutual...

  4. Committees and sponsors

    NASA Astrophysics Data System (ADS)

    2011-10-01

    International Advisory Committee Richard F CastenYale, USA Luiz Carlos ChamonSão Paulo, Brazil Osvaldo CivitareseLa Plata, Argentina Jozsef CsehATOMKI, Hungary Jerry P DraayerLSU, USA Alfredo Galindo-UribarriORNL & UT, USA James J KolataNotre Dame, USA Jorge López UTEP, USA Joseph B NatowitzTexas A & M, USA Ma Esther Ortiz IF-UNAM Stuart PittelDelaware, USA Andrés SandovalIF-UNAM Adam SzczepaniakIndiana, USA Piet Van IsackerGANIL, France Michael WiescherNotre Dame, USA Organizing Committee Libertad Barrón-Palos (Chair)IF-UNAM Roelof BijkerICN-UNAM Ruben FossionICN-UNAM David LizcanoININ Sponsors Instituto de Ciencias Nucleares, UNAMInstituto de Física, UNAMInstituto Nacional de Investigaciones NuclearesDivisión de Física Nuclear de la SMFCentro Latinoamericano de Física

  5. 22 CFR 211.3 - Cooperating sponsor agreements; program procedure.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... programs. The other basic pattern of decision making results in a Transfer Authorization. The TA is used... submission to AID/W, a decision must be made on a proposal submitted by a private voluntary organization or... organization is eligible to be a cooperating sponsor for regular programs under paragraph (d)(2)(i) of this...

  6. 7 CFR 622.10 - Sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... AGRICULTURE WATER RESOURCES WATERSHED PROJECTS Qualifications § 622.10 Sponsors. (a) Watershed projects are sponsored by one or more local organizations qualifying as sponsors. All watershed plans shall be sponsored...

  7. 7 CFR 622.10 - Sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... AGRICULTURE WATER RESOURCES WATERSHED PROJECTS Qualifications § 622.10 Sponsors. (a) Watershed projects are sponsored by one or more local organizations qualifying as sponsors. All watershed plans shall be sponsored...

  8. 7 CFR 622.10 - Sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGRICULTURE WATER RESOURCES WATERSHED PROJECTS Qualifications § 622.10 Sponsors. (a) Watershed projects are sponsored by one or more local organizations qualifying as sponsors. All watershed plans shall be sponsored...

  9. 7 CFR 622.10 - Sponsors.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... AGRICULTURE WATER RESOURCES WATERSHED PROJECTS Qualifications § 622.10 Sponsors. (a) Watershed projects are sponsored by one or more local organizations qualifying as sponsors. All watershed plans shall be sponsored...

  10. 7 CFR 622.10 - Sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... AGRICULTURE WATER RESOURCES WATERSHED PROJECTS Qualifications § 622.10 Sponsors. (a) Watershed projects are sponsored by one or more local organizations qualifying as sponsors. All watershed plans shall be sponsored...

  11. Committees and Sponsors

    NASA Astrophysics Data System (ADS)

    2012-05-01

    Local Organizing Committee J Fernando Barbero González (IEM, CSIC) Laura Castelló Gomar (Univ. Complutense, Madrid) Mikel Fernández Méndez (IEM, CSIC) Iñaki Garay Elizondo (Univ. País Vasco) Luis J Garay Elizondo (Univ. Complutense, Madrid) Mercedes Martín-Benito (Perimeter Institute, Canada) Daniel Martín de Blas (IEM, CSIC) Guillermo A Mena Marugán (IEM, CSIC) Javier Olmedo Nieto (IEM, CSIC) Gonzalo Olmo Alba (IFIC, CSIC) Tomasz Pawlowski (Warsaw University, Poland) Eduardo J Sánchez Villaseñor (Univ. Carlos III, Madrid) Scientific International Committee Abhay Ashtekar (Penn State University, USA) J Fernando Barbero González (IEM, CSIC, Spain) John Barrett (University of Nottingham, UK) José Manuel Cidade Mourão (Instituto Superior Técnico de Lisboa, Portugal) Laurent Freidel (Perimeter Institute, Canada) Jerzy Lewandowski (Warsaw University, Poland) Guillermo A Mena Marugán (IEM, CSIC, Spain) Jorge Pullin (Louisiana State University, USA) Carlo Rovelli (Univ. Méditerranée, Marseille, France) Thomas Thiemann (Univ. Erlangen-Nürnberg, Germany) Sponsors MinisterioBBVA CSICESF UniCarlosCPAN

  12. Jointly Sponsored Research Program

    SciTech Connect

    Everett A. Sondreal; John G. Hendrikson; Thomas A. Erickson

    2009-03-31

    U.S. Department of Energy (DOE) Cooperative Agreement DE-FC26-98FT40321 funded through the Office of Fossil Energy and administered at the National Energy Technology Laboratory (NETL) supported the performance of a Jointly Sponsored Research Program (JSRP) at the Energy & Environmental Research Center (EERC) with a minimum 50% nonfederal cost share to assist industry in commercializing and effectively applying highly efficient, nonpolluting energy systems that meet the nation's requirements for clean fuels, chemicals, and electricity in the 21st century. The EERC in partnership with its nonfederal partners jointly performed 131 JSRP projects for which the total DOE cost share was $22,716,634 (38%) and the nonfederal share was $36,776,573 (62%). Summaries of these projects are presented in this report for six program areas: (1) resource characterization and waste management, (2) air quality assessment and control, (3) advanced power systems, (4) advanced fuel forms, (5) value-added coproducts, and (6) advanced materials. The work performed under this agreement addressed DOE goals for reductions in CO{sub 2} emissions through efficiency, capture, and sequestration; near-zero emissions from highly efficient coal-fired power plants; environmental control capabilities for SO{sub 2}, NO{sub x}, fine respirable particulate (PM{sub 2.5}), and mercury; alternative transportation fuels including liquid synfuels and hydrogen; and synergistic integration of fossil and renewable resources.

  13. Strategies to improve fertility in post partum Bos indicus cows submitted to a fixed-time insemination protocol with GnRH and PGF2a

    USDA-ARS?s Scientific Manuscript database

    In Experiment 1, we evaluated the effects of two lengths of progesterone exposure (CIDR; 7 vs. 14 d) prior to a modified CO-Synch protocol, with or without temporary weaning (TW) before GnRH treatments, on fertility of suckled Bos indicus Nelore cows (n = 283) and on calf performance. Timed AI (TAI)...

  14. 42 CFR 423.520 - Prompt payment by Part D sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... respect to all clean claims, as defined in paragraph (b) of this section, submitted by network pharmacies... after the postmark day of the claim or the date specified in the time stamp of the transmission, for any... Part D sponsor receiving the claim does not provide notice to the submitting network pharmacy of...

  15. 42 CFR 423.520 - Prompt payment by Part D sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... respect to all clean claims, as defined in paragraph (b) of this section, submitted by network pharmacies (other than mail-order and long-term care pharmacies) within— (i) 14 days after the date on which the... Part D sponsor receiving the claim does not provide notice to the submitting network pharmacy of...

  16. 42 CFR 423.520 - Prompt payment by Part D sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... respect to all clean claims, as defined in paragraph (b) of this section, submitted by network pharmacies (other than mail-order and long-term care pharmacies) within— (i) 14 days after the date on which the... Part D sponsor receiving the claim does not provide notice to the submitting network pharmacy of...

  17. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.

    PubMed

    Lundh, Andreas; Krogsbøll, Lasse T; Gøtzsche, Peter C

    2012-08-24

    Bias in industry-sponsored trials is common and the interpretation of the results can be particularly distorted in favour of the sponsor's product. We investigated sponsors' involvement in the conduct and reporting of industry-sponsored trials. We included all industry-sponsored trials published in The Lancet in 2008 and 2009 and corresponding trial protocols provided by The Lancet. For each protocol and publication, we extracted information on trial conduct and reporting. We identified 169 publications of randomised trials and included 69 (41%) that were industry-sponsored, and 12 (7%) industry-funded but seemingly independently conducted as a subsample. Entry of data into the study database was done independently by academic authors without the involvement of the sponsor or a contract research organisation in one of the 69 trials. Two trials had independent data analysis and one independent reporting of results. In 11 of the trials, there was a discrepancy between the information in the protocols and papers concerning who analysed the data. In four of the 12 seemingly independent trials, the protocol described sponsors' involvement in writing the report while the published paper explicitly stated that the sponsor was not involved. The sponsors are usually involved in the analysis and reporting of results in industry-sponsored trials, but their exact role is not always clear from the published papers. Journals should require more transparent reporting of the sponsors' role in crucial elements such as data processing, statistical analysis and writing of the manuscript and should consider requiring access to trial protocols, independent data analysis and submission of the raw data.

  18. 21 CFR 312.30 - Protocol amendments.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... clinical investigations are conducted according to protocols included in the application. This section sets... protocols may be made. Whenever a sponsor intends to conduct a clinical investigation with an exception from... separate IND for such investigation. (a) New protocol. Whenever a sponsor intends to conduct a study that...

  19. Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis.

    PubMed

    Suzumura, Erica Aranha; Ribeiro, Rodrigo Antonini; Kawano-Dourado, Leticia; de Barros E Silva, Pedro Gabriel; Oliveira, Claudia; Figueiró, Mabel Fernandes; Cavalcanti, Alexandre Biasi; Lopes, Renato D; Berwanger, Otavio

    2017-06-19

    Preliminary evidence suggests statins may reduce major perioperative vascular events. However, evidence is limited to observational studies, underpowered trials, and non-comprehensive systematic reviews. This review aims to assess the effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery. We will search MEDLINE/PubMed, EMBASE, LILACS, CENTRAL, Web of Science, and CINAHL for randomized controlled trials assessing the effects of perioperative statin use in adults undergoing non-cardiac surgery and reporting cardiovascular complications. For patients already using statins for hyperlipidemia, a preoperative loading dose of statin is required in the experimental group. We will place no language or publication restriction on our search. Teams of two reviewers will independently assess eligibility and risk of bias, and will extract data from the included trials. Our primary outcome is a combination of cardiovascular mortality or non-fatal myocardial infarction. We will also assess the following outcomes: individual components of the primary outcome, all-cause mortality, total myocardial infarction, elevated troponin in the first seven postoperative days, total stroke, total venous thromboembolism, postoperative atrial fibrillation, elevation of creatine phosphokinase or liver enzymes, and rates of myalgia or rhabdomyolysis. We will conduct meta-analyses using random-effects model and will use trial sequential analysis to establish monitoring boundaries to limit global type I error due to repetitive testing for our primary outcome. We will rate the quality of evidence using the GRADE system. The results of this systematic review may help to inform clinical practice and also the design of future large-scale randomized trials. PROSPERO CRD42016035987.

  20. 42 CFR 423.586 - Opportunity to submit evidence.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 3 2010-10-01 2010-10-01 false Opportunity to submit evidence. 423.586 Section 423..., Redeterminations, and Reconsiderations § 423.586 Opportunity to submit evidence. The Part D plan sponsor must... opportunity to present evidence and allegations of fact or law, related to the issue in dispute, in person as...

  1. 45 CFR 1222.6 - Sponsor's responsibilities.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 45 Public Welfare 4 2011-10-01 2011-10-01 false Sponsor's responsibilities. 1222.6 Section 1222.6... SERVICE PARTICIPATION OF PROJECT BENEFICIARIES § 1222.6 Sponsor's responsibilities. The sponsor or potential sponsor shall furnish the following evidence of the advisory group's participation in the planning...

  2. 45 CFR 1222.6 - Sponsor's responsibilities.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 45 Public Welfare 4 2014-10-01 2014-10-01 false Sponsor's responsibilities. 1222.6 Section 1222.6... SERVICE PARTICIPATION OF PROJECT BENEFICIARIES § 1222.6 Sponsor's responsibilities. The sponsor or potential sponsor shall furnish the following evidence of the advisory group's participation in the planning...

  3. Legal and ethical obligations to conduct a clinical drug trial in Australia as an investigator initiated and sponsored study for an overseas pharmaceutical company.

    PubMed

    Beran, Roy G

    2004-01-01

    Most multi-centre trials are both financed and sponsored by the pharmaceutical company involved. What follows will map the path adopted for an investigator initiated and sponsored study for a new indication of an established medication. The chief investigators of a company-sponsored, investigator-initiated, multi-centre, placebo-controlled study of an established medication, Pharmaceutical Benefit Scheme (PBS) listed for treatment of one condition but trialled in the management of another condition (trial of off-label use), were approached to submit a protocol to repeat the type of study with a different compound. The new study would test a different agent, also PBS listed, for the same condition as in the initial study and with the same off-licence application. The company would finance the study, provide the medication and matched placebo but only review the investigator-initiated protocol which would be sponsored by the principal investigator. This required the investigator to implement the trial, as would normally be done by the pharmaceutical company, yet also act as its principal investigator. The principal investigator, with colleagues and a Clinical Research Organisation (CRO), developed a protocol, adapted for the new agent, and submitted it for approval. Upon acceptance a contract was negotiated with the pharmaceutical company which had to overcome jurisdictional conflicts between common law and civil law legal systems. A CRO was contracted to undertake administrative functions which dictated special contractual agreements to overcome possible conflicts of interest for a sponsor/investigator to protect patient interests. There was need to find indemnification insurance with jurisdictional problems, co-investigators, ethics committee approvals and finance management as just some of the difficulties encountered. The paper will outline how these obstacles were overcome and how ethical and legal issues were respected through compromise. The ethical and legal

  4. Fertility of lactating Holstein cows submitted to a Double-Ovsynch protocol and timed artificial insemination versus artificial insemination after synchronization of estrus at a similar day in milk range.

    PubMed

    Santos, V G; Carvalho, P D; Maia, C; Carneiro, B; Valenza, A; Fricke, P M

    2017-10-01

    Our objective was to compare the AI submission rate and pregnancies per artificial insemination (P/AI) at first service of lactating Holstein cows submitted to a Double-Ovsynch protocol and timed artificial insemination (TAI) versus artificial insemination (AI) to a detected estrus after synchronization of estrus at a similar day in milk range. Lactating Holstein cows were randomly assigned to receive their first TAI after a Double-Ovsynch protocol (DO; n = 294) or to receive their first AI after a synchronized estrus (EST; n = 284). Pregnancy status was determined 33 ± 3 d after insemination and was reconfirmed 63 ± 3 d after insemination. Data were analyzed by ANOVA and logistic regression using the MIXED and GLIMMIX procedures of SAS (SAS Institute Inc., Cary, NC). By design, days in milk at first insemination did not differ between treatments (76.9 ± 0.2 vs. 76.7 ± 0.3 for DO vs. EST cows, respectively), but more DO cows were inseminated within 7 d after the end of the voluntary waiting period than EST cows (100.0 vs. 77.5%). Overall, DO cows had more P/AI than EST cows at both 33 d (49.0 vs. 38.6%) and 63 d (44.6 vs. 36.4%) after insemination, but pregnancy loss from 33 to 63 d after insemination did not differ between treatments. Primiparous cows had more P/AI than multiparous cows 33 and 63 d after insemination, but the treatment by parity interaction was not significant. Synchronization rate to the hormonal protocols was 85.3%, which did not differ between treatments; however, synchronized DO cows had more P/AI 33 d after insemination than synchronized EST cows (54.7 vs. 44.5%). In summary, submission of lactating Holstein cows to a Double-Ovsynch protocol and TAI for first insemination increased the percentage of cows inseminated within 7 d after the end of the voluntary waiting period and increased P/AI at 33 and 63 d after first insemination resulting in 64 and 58% more pregnant cows, respectively, than submission of cows for first AI after detection

  5. 22 CFR 62.3 - Sponsor eligibility.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Sponsor eligibility. 62.3 Section 62.3 Foreign Relations DEPARTMENT OF STATE PUBLIC DIPLOMACY AND EXCHANGES EXCHANGE VISITOR PROGRAM General Provisions § 62.3 Sponsor eligibility. (a) Entities eligible to apply for designation as a sponsor of an exchange...

  6. 22 CFR 62.3 - Sponsor eligibility.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 22 Foreign Relations 1 2011-04-01 2011-04-01 false Sponsor eligibility. 62.3 Section 62.3 Foreign Relations DEPARTMENT OF STATE PUBLIC DIPLOMACY AND EXCHANGES EXCHANGE VISITOR PROGRAM General Provisions § 62.3 Sponsor eligibility. (a) Entities eligible to apply for designation as a sponsor of an...

  7. 45 CFR 1226.12 - Sponsor employees.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 45 Public Welfare 4 2010-10-01 2010-10-01 false Sponsor employees. 1226.12 Section 1226.12 Public Welfare Regulations Relating to Public Welfare (Continued) CORPORATION FOR NATIONAL AND COMMUNITY SERVICE PROHIBITIONS ON ELECTORAL AND LOBBYING ACTIVITIES Sponsor Employee Activities § 1226.12 Sponsor...

  8. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.

    PubMed

    Tuech, Jean-Jacques; Moutel, Grégoire; Pessaux, Patrick; Thoma, Véronique; Schraub, Simon; Herve, Christian

    2005-10-01

    Financial relationships between industry, researchers and academic institutions are becoming increasingly complex, raising concern about sponsors' involvement in the conduct of biomedical research. A review of published randomised trials (RCTs) in cancer research was performed to assess adherence to the 1997 disclosure requirements and to document the nature of the disclosed interests. Source(s) of study support, author-sponsor relationships and the role of the study sponsor were assessed for all RCTs published between 1999 and 2003 in 12 international journals. A total of 655 cancer RCTs were identified. Of these, 516 (78.8%) disclosed the source of sponsorship. The nature of the relationship between the authors and the study sponsor was included in 219 of the 227 industry-sponsored studies. The most commonly cited relationships were (131 studies had multiple relations): grants (93.6%); employment (39.2%); consultant/honorarium (12.7%) and stock ownership and participation in a speaker's bureau (12, 5.5% each). Only 41 (18%) of the 227 industry-sponsored RCTs reported the role of the sponsor. Of these, 20 explicitly stated that the sponsor had no role in the study. Twenty-one papers described the sponsor's role, the degree of sponsor involvement was variable and usually described vaguely. Among these papers, four stated that researchers had full access to all data, one that the researchers had no limits on publication and one that 'the decision to submit the paper for publication was determined by the study sponsor'. In conclusion, no researcher should be expected to produce 'findings' without full access to the data, freedom from interference in analysis and interpretation and liberty to publish all results, however disappointing to the stakeholder they may be. In the meantime, researchers do well to arm themselves with the rules for research partnerships and editors to take on the role of watchdog.

  9. 77 FR 26697 - New Animal Drugs; Change of Sponsor; Change of Sponsor Address; Change of Sponsor Name and...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-05-07

    ...; a change of sponsor for fomepizole injectable solution from Synerx Pharma, LLC, to Mylan... Dr., Rockford, IL 61103. Synerx Pharma, LLC, 100 N. State St., Newton, PA 18940, has informed FDA... this change of sponsorship, Synerx Pharma, LLC, is no longer the sponsor of an approved...

  10. Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

    PubMed

    Kasenda, Benjamin; Schandelmaier, Stefan; Sun, Xin; von Elm, Erik; You, John; Blümle, Anette; Tomonaga, Yuki; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J; Stegert, Mihaela; Olu, Kelechi K; Tikkinen, Kari A O; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M; Mertz, Dominik; Akl, Elie A; Bassler, Dirk; Busse, Jason W; Ferreira-González, Ignacio; Lamontagne, Francois; Nordmann, Alain; Gloy, Viktoria; Raatz, Heike; Moja, Lorenzo; Rosenthal, Rachel; Ebrahim, Shanil; Vandvik, Per O; Johnston, Bradley C; Walter, Martin A; Burnand, Bernard; Schwenkglenks, Matthias; Hemkens, Lars G; Bucher, Heiner C; Guyatt, Gordon H; Briel, Matthias

    2014-07-16

    To investigate the planning of subgroup analyses in protocols of randomised controlled trials and the agreement with corresponding full journal publications. Cohort of protocols of randomised controlled trial and subsequent full journal publications. Six research ethics committees in Switzerland, Germany, and Canada. 894 protocols of randomised controlled trial involving patients approved by participating research ethics committees between 2000 and 2003 and 515 subsequent full journal publications. Of 894 protocols of randomised controlled trials, 252 (28.2%) included one or more planned subgroup analyses. Of those, 17 (6.7%) provided a clear hypothesis for at least one subgroup analysis, 10 (4.0%) anticipated the direction of a subgroup effect, and 87 (34.5%) planned a statistical test for interaction. Industry sponsored trials more often planned subgroup analyses compared with investigator sponsored trials (195/551 (35.4%) v 57/343 (16.6%), P<0.001). Of 515 identified journal publications, 246 (47.8%) reported at least one subgroup analysis. In 81 (32.9%) of the 246 publications reporting subgroup analyses, authors stated that subgroup analyses were prespecified, but this was not supported by 28 (34.6%) corresponding protocols. In 86 publications, authors claimed a subgroup effect, but only 36 (41.9%) corresponding protocols reported a planned subgroup analysis. Subgroup analyses are insufficiently described in the protocols of randomised controlled trials submitted to research ethics committees, and investigators rarely specify the anticipated direction of subgroup effects. More than one third of statements in publications of randomised controlled trials about subgroup prespecification had no documentation in the corresponding protocols. Definitive judgments regarding credibility of claimed subgroup effects are not possible without access to protocols and analysis plans of randomised controlled trials. © The DISCO study group 2014.

  11. 21 CFR 58.120 - Protocol.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... sponsor and the dated signature of the study director. (12) A statement of the proposed statistical... FOR NONCLINICAL LABORATORY STUDIES Protocol for and Conduct of a Nonclinical Laboratory Study § 58.120 Protocol. (a) Each study shall have an approved written protocol that clearly indicates the objectives...

  12. Observatory Sponsoring Astronomical Image Contest

    NASA Astrophysics Data System (ADS)

    2005-05-01

    Forget the headphones you saw in the Warner Brothers thriller Contact, as well as the guttural throbs emanating from loudspeakers at the Very Large Array in that 1997 movie. In real life, radio telescopes aren't used for "listening" to anything - just like visible-light telescopes, they are used primarily to make images of astronomical objects. Now, the National Radio Astronomy Observatory (NRAO) wants to encourage astronomers to use radio-telescope data to make truly compelling images, and is offering cash prizes to winners of a new image contest. Radio Galaxy Fornax A Radio Galaxy Fornax A Radio-optical composite image of giant elliptical galaxy NGC 1316, showing the galaxy (center), a smaller companion galaxy being cannibalized by NGC 1316, and the resulting "lobes" (orange) of radio emission caused by jets of particles spewed from the core of the giant galaxy Click on image for more detail and images CREDIT: Fomalont et al., NRAO/AUI/NSF "Astronomy is a very visual science, and our radio telescopes are capable of producing excellent images. We're sponsoring this contest to encourage astronomers to make the extra effort to turn good images into truly spectacular ones," said NRAO Director Fred K.Y. Lo. The contest, offering a grand prize of $1,000, was announced at the American Astronomical Society's meeting in Minneapolis, Minnesota. The image contest is part of a broader NRAO effort to make radio astronomical data and images easily accessible and widely available to scientists, students, teachers, the general public, news media and science-education professionals. That effort includes an expanded image gallery on the observatory's Web site. "We're not only adding new radio-astronomy images to our online gallery, but we're also improving the organization and accessibility of the images," said Mark Adams, head of education and public outreach (EPO) at NRAO. "Our long-term goal is to make the NRAO Image Gallery an international resource for radio astronomy imagery

  13. Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review.

    PubMed

    van Lent, Marlies; Rongen, Gerard A; Out, Henk J

    2014-12-10

    Submission of study protocols to research ethics committees (RECs) constitutes one of the earliest stages at which planned trials are documented in detail. Previous studies have investigated the amendments requested from researchers by RECs, but the type of issues raised during REC review have not been compared by sponsor type. The objective of this study was to identify recurring shortcomings in protocols of drug trials based on REC comments and to assess whether these were more common among industry-sponsored or non-industry trials. Retrospective analysis of 226 protocols of drug trials approved in 2010-2011 by three RECs affiliated to academic medical centres in The Netherlands. For each protocol, information on sponsorship, number of participating centres, participating countries, study phase, registration status of the study drug, and type and number of subjects was retrieved. REC comments were extracted from decision letters sent to investigators after review and were classified using a predefined checklist that was based on legislation and guidelines on clinical drug research and previous literature. Most protocols received comments regarding participant information and consent forms (n = 182, 80.5%), methodology and statistical analyses (n = 160, 70.8%), and supporting documentation, including trial agreements and certificates of insurance (n = 154, 68.1%). Of the submitted protocols, 122 (54.0%) were non-industry and 104 (46.0%) were industry-sponsored trials. Non-industry trials more often received comments on subject selection (n = 44, 36.1%) than industry-sponsored trials (n = 18, 17.3%; RR, 1.58; 95% CI, 1.01 to 2.47), and on methodology and statistical analyses (n = 95, 77.9% versus n = 65, 62.5%, respectively; RR, 1.18; 95% CI, 1.01 to 1.37). Non-industry trials less often received comments on supporting documentation (n = 72, 59.0%) than industry-sponsored trials (n = 82, 78.8%; RR, 0.83; 95% CI, 0.72 to 0.95). RECs identified important ethical and

  14. 15 CFR 782.6 - Where to submit reports.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 15 Commerce and Foreign Trade 2 2014-01-01 2014-01-01 false Where to submit reports. 782.6 Section... OF INDUSTRY AND SECURITY, DEPARTMENT OF COMMERCE ADDITIONAL PROTOCOL REGULATIONS GENERAL INFORMATION REGARDING REPORTING REQUIREMENTS AND PROCEDURES § 782.6 Where to submit reports. Reports required by the APR...

  15. Industry-sponsored research in developing countries.

    PubMed

    Abbas, E E

    2007-11-01

    Industry has become an important source of funding for clinical research; guidelines governing the relationship between industry and medical institutions are not clear in developing countries and hence we wanted to test attitudes and practices in those countries and compare them to developed countries. We conducted a survey amongst medical practitioners in developed and Arab countries representing developing countries, in order to document their views towards industry-sponsored research and their actual practice in this regard. A structured questionnaire was distributed by email, mail and through personal contacts. The questionnaire included information on characteristics of the practitioners involved, their attitudes towards industry-sponsored research and their actual practices. The questionnaire was distributed to 510 medical practitioners of countries in both groups. Practitioners representing developed countries were from the United States, United Kingdom, Australia and New Zealand. Those representing developing countries included Arab countries from Asia and Africa. We found that there were contrasting views and practices between the two groups although more than 80% in both groups agreed that industry-sponsored research is necessary. 69.7% of respondents in developed countries participated in industry-sponsored research while only 30.1% did so in developing countries. Guidelines governing such research were better adhered to in developed countries than in developing countries. Where there were no authors who were not part of investigators in developed countries, 16.3% of industry-sponsored research in developing countries included authors who were not part of the investigators. Research ethics committees were present in 94% and 58% of institutions in developed and developing countries respectively. Review bodies were available in 57% and 41% in developed and developing countries. Industry-sponsored research is necessary; it is much more common in developed

  16. 76 FR 39873 - Information Collections Being Submitted for Review and Approval to the Office of Management and...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-07-07

    ... sponsor a collection of information unless it displays a currently valid control number. No person shall.... The FCC may not conduct or sponsor a collection of information unless it displays a currently valid... you will be ] submitting comments, but find it difficult to do so within the period of time allowed...

  17. 76 FR 39871 - Information Collections Being Submitted for Review and Approval to the Office of Management and...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-07-07

    ... sponsor a collection of information unless it displays a currently valid control number. No person shall.... The FCC may not conduct or sponsor a collection of information unless it displays a currently valid... you will be submitting comments, but find it difficult to do so within the period of time allowed...

  18. 7 CFR 654.14 - Duration of sponsor(s)' responsibility.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 6 2013-01-01 2013-01-01 false Duration of sponsor(s)' responsibility. 654.14 Section 654.14 Agriculture Regulations of the Department of Agriculture (Continued) NATURAL RESOURCES... completed work located on Federal lands which are subject to special-use permits. The O&M agreement shall...

  19. 7 CFR 654.14 - Duration of sponsor(s)' responsibility.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 6 2010-01-01 2010-01-01 false Duration of sponsor(s)' responsibility. 654.14 Section 654.14 Agriculture Regulations of the Department of Agriculture (Continued) NATURAL RESOURCES... completed work located on Federal lands which are subject to special-use permits. The O&M agreement shall...

  20. 7 CFR 654.14 - Duration of sponsor(s)' responsibility.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 6 2014-01-01 2014-01-01 false Duration of sponsor(s)' responsibility. 654.14 Section 654.14 Agriculture Regulations of the Department of Agriculture (Continued) NATURAL RESOURCES... completed work located on Federal lands which are subject to special-use permits. The O&M agreement shall...

  1. 77 FR 56769 - New Animal Drugs; Change of Sponsor; Change of Sponsor Address; Lincomycin and Spectinomycin...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-09-14

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510 and 520 New Animal Drugs; Change of Sponsor...: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for three abbreviated new animal drug applications (ANADAs) from Teva Animal Health, Inc.,...

  2. Government-Sponsored Programs on Structures Technology

    NASA Technical Reports Server (NTRS)

    Noor, Ahmed K. (Compiler); Malone, John B. (Compiler)

    1997-01-01

    This document contains the presentations from the joint UVA/AIAA workshops on Government-Sponsored Programs on Structures Technology, held on April 6, 1997 in Kissimmee, Florida and on September 4, 1997 in Hampton, Virginia. Workshop attendees were the Members and Friends of the AIAA Structures Technical Committee. The objectives of the workshops were to: (a) provide a forum for discussion of current government-sponsored programs in the structures area; (b) identify high-potential research areas for future aerospace systems; and (c) initiate suitable interaction mechanisms with the managers of structures programs.

  3. 48 CFR 970.3501-1 - Sponsoring agreements.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 5 2011-10-01 2011-10-01 false Sponsoring agreements. 970... Sponsoring agreements. (a) The contract award document constitutes the sponsoring agreement between the... the purpose and mission of the FFRDC. (c) Other elements of the sponsoring agreement which shall be...

  4. Cheerleading. A Handbook for Teacher-Sponsors.

    ERIC Educational Resources Information Center

    Chicago Board of Education, IL.

    The high school cheerleader has the opportunity to set the stage for sportsmanship, school spirit, and the mood of the athletic program. A carefully planned program is essential to leading cheerleading sections into feelings of good fellowship and interschool rapport. This handbook is designed to assist teacher-sponsors and administrators in the…

  5. The State-Sponsored Student Entrepreneur

    ERIC Educational Resources Information Center

    Mars, Matthew M.; Slaughter, Sheila; Rhoades, Gary

    2008-01-01

    This paper introduces the emergent role of the state-sponsored student entrepreneur within the academic capitalist knowledge/learning regime. Drawing on two clarifying cases of such entrepreneurship, the study explores the shifting boundaries between public and private sectors, the creation of new circuits of knowledge, and the entrepreneurial…

  6. The State-Sponsored Student Entrepreneur

    ERIC Educational Resources Information Center

    Mars, Matthew M.; Slaughter, Sheila; Rhoades, Gary

    2008-01-01

    This paper introduces the emergent role of the state-sponsored student entrepreneur within the academic capitalist knowledge/learning regime. Drawing on two clarifying cases of such entrepreneurship, the study explores the shifting boundaries between public and private sectors, the creation of new circuits of knowledge, and the entrepreneurial…

  7. Use and Misuse of Industry Sponsored Materials.

    ERIC Educational Resources Information Center

    DuVall, Charles R.; Krepel, Wayne J.

    A review of educational research reveals that free and inexpensive materials are used today to a much greater extent than they had been in the past. Two studies, sponsored by the American Iron and Steel Institute, are evidence of the producer's interest in determining the strengths and weaknesses of the materials being sent into classrooms and…

  8. Parents Anonymous Chairperson-Sponsor Manual.

    ERIC Educational Resources Information Center

    Parents Anonymous, Inc., Redondo Beach, CA.

    Presented is a manual which focuses on the Chairperson-Sponsor relationship of Parents Anonymous (PA), an organization for helping parents with child abuse problems. Brief sections cover the following topics: Jolly and Leonard (the cases of two people, one an abusive mother and the other a psychiatric social worker, involved in PA); the basic…

  9. How to submit a nail specimen.

    PubMed

    Reinig, Erica; Rich, Phoebe; Thompson, Curtis T

    2015-04-01

    The scarcity of specific submission protocols for nail unit biopsies presents many challenges for appropriate specimen processing. Many nail biopsies are received fragmented or without orientation, often resulting in less-than-ideal tissue embedding and poor histologic sections, which are difficult to interpret. Methods are described for proper nail matrix/bed biopsy and plate submission that incorporate aspects of previous submission protocols and include inking the biopsy specimen along with submitting the tissue on a drawing of the nail. Also described is a technique for maintaining adherence of nail plate to glass slides, a chronic challenge in the laboratory.

  10. Effects of Disclosing Sponsored Content in Blogs

    PubMed Central

    van Reijmersdal, Eva A.; Fransen, Marieke L.; van Noort, Guda; Opree, Suzanna J.; Vandeberg, Lisa; Reusch, Sanne; van Lieshout, Floor; Boerman, Sophie C.

    2016-01-01

    This article presents two studies examining the effects of disclosing online native advertising (i.e., sponsored content in blogs) on people’s brand attitude and purchase intentions. To investigate the mechanisms underlying these effects, we integrated resistance theories with the persuasion knowledge model. We theorize that disclosures activate people’s persuasion knowledge, which in turn evokes resistance strategies that people use to cope with the persuasion attempt made in the blog. We tested our predications with two experiments (N = 118 and N = 134). We found that participants indeed activated persuasion knowledge in response to disclosures, after which they used both cognitive (counterarguing) and affective (negative affect) resistance strategies to decrease persuasion. The obtained insights do not only advance our theoretical understanding of how disclosures of sponsored blogs affect persuasion but also provide valuable insights for legislators, advertisers, and bloggers. PMID:27721511

  11. The health promotion internship: a sponsor's perspective.

    PubMed

    Smoczyk, C M

    1987-01-01

    Health promotion internships are an essential link between the university classroom and the corporate or public service environment. A well structured internship experience will provide the future health promotion professional with an opportunity to transfer learned theory into practical application within a controlled and supervised environment. The success of the internship experience is contingent upon the mutual effort of the student, academic institution, and sponsoring organization working together to develop a model that will reflect the goals and objectives of each group with primary long-term benefit accruing to the future health promotion professional. The purpose of this article is to explore the components of a successful health promotion internship model developed from the perspective of a sponsoring organization.

  12. Non-doe-sponsored Domestic Dish Activities

    NASA Technical Reports Server (NTRS)

    Fujita, T.

    1984-01-01

    The parabolic dish development activities being undertaken within the private sector of the United States were addressed. The primary emphasis of these non-DOE-sponsored activities is the development of commercial products that can penetrate the market in the near term. The exchange of information between these activities and the complementary DOE-sponsored work directed toward developing advancements in technology is considered to be of major importance. The experiences and problems encountered in the private sector serve as inputs that will help guide in the planning of the DOE program. In turn, a principal objective of the DOE program is the transfer findings of its technological development activities to the private sector. Activities in the private are characterized by their diversity in terms of both product design and marketing approach. The differences in the design concepts and the sizes of the dish concentrators under development are particularly noteworthy.

  13. [Sponsoring of physicians in private practice].

    PubMed

    Rieger, Hans-Jürgen

    2005-04-01

    The financing of advanced medical training for physicians by the pharmaceutical industry has been the subject of legal discussions for more than two decades. Recent legal changes have renewed the importance of industry sponsoring. At the 106th national convention of the German physicians, the model ordinance for the German medical profession ("Musterberufsordnung für die deutschen Arztinnen und Arzte-MBO-A") has been reformed, and for the first time individual physicians are now permitted, under certain circumstances, to receive financial support from sponsors to participate in medical-training events. A recent legal reform to modernize the healthcare system ("GKV-Modernisierungsgesetz"--GMG) obliges physicians to observe the law that regulates advertising of medicinal products ("Heilmittelwerbegesetz"--HWG); consequently, the physicians can commit a misdemeanor when accepting prohibited financial support. This essay discusses the implications of this legal reform for the most important types of commercially-sponsored medical training. The GMG reform has introduced an obligation for physicians to absolve continuous medical training, however the resulting legal situation has not changed the requirement that this training remain free of commercial interests.

  14. The Complex Dynamics of Sponsored Search Markets

    NASA Astrophysics Data System (ADS)

    Robu, Valentin; La Poutré, Han; Bohte, Sander

    This paper provides a comprehensive study of the structure and dynamics of online advertising markets, mostly based on techniques from the emergent discipline of complex systems analysis. First, we look at how the display rank of a URL link influences its click frequency, for both sponsored search and organic search. Second, we study the market structure that emerges from these queries, especially the market share distribution of different advertisers. We show that the sponsored search market is highly concentrated, with less than 5% of all advertisers receiving over 2/3 of the clicks in the market. Furthermore, we show that both the number of ad impressions and the number of clicks follow power law distributions of approximately the same coefficient. However, we find this result does not hold when studying the same distribution of clicks per rank position, which shows considerable variance, most likely due to the way advertisers divide their budget on different keywords. Finally, we turn our attention to how such sponsored search data could be used to provide decision support tools for bidding for combinations of keywords. We provide a method to visualize keywords of interest in graphical form, as well as a method to partition these graphs to obtain desirable subsets of search terms.

  15. Ovarian evaluation of Girolando (Holstein × Gir) heifers submitted to a GnRH-PGF2α-GnRH protocol in the dry or rainy seasons in the tropical savannah.

    PubMed

    Bilego, Ubirajara O; Santos, Fabricio C; Porto, Regiani N G; Pires, Bruno C; Oliveira Filho, Benedito D; Viu, Marco Antonio O; Gambarini, Maria Lúcia

    2013-10-01

    The Girolando breed is used in pasture-based dairy production systems in Brazil to associate the high production of Bos taurus to the rusticity and thermal adaptation of Bos indicus. This study was designed to evaluate the physiological response to a gonadotropin-releasing hormone (GnRH)-prostaglandin F2α (PGF2α)-GnRH protocol to synchronize the ovulation in 40 Girolando heifers of a pasture-based dairy production system and its relationships with the temperature and humidity index (THI) during the dry (DS) and rainy season (RS) in the tropical savannah-Brazil's cerrado biome. Responses were characterized by follicular and corpus luteum number and diameter, ovulation (D9), and pregnancy rates after first AI. Total follicle number (8.1 ± 0.3 × 8.8 ± 0.3), D9 ovulatory follicle diameter (11.9 ± 0.4 × 10.1 ± 0.4 mm), corpus luteum diameter (8.6 ± 1.3 × 3.9 ± 1.5 mm), corpus luteum score (3.7 ± 0.8 × 1.8 ± 1.0), corpus luteum diameter after AI (9.6 ± 1.6 × 3.9 ± 1.5 mm), and corpus luteum score after AI (3.2 ± 0.4 × 0.9 ± 0.6) in DS and RS differed (P < 0.01). D9 ovulation rate was 40 % (DS) and 20 % (RS), without differences (P > 0.05). Pregnancy rate was 45 % (DS) and 11 % (RS), with differences (P < 0.01). THI differed between DS and RS (P < 0.01). THI may interfere in the follicular and luteal dynamics and in the response of Girolando heifers to the GnRH-PGF2α protocol in the tropical savannah, thus reducing the chances of pregnancy at the first artificial insemination.

  16. 48 CFR 35.017-1 - Sponsoring agreements.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... of the FFRDC's relationship with its sponsor(s). (3) A provision for the identification of retained earnings (reserves) and the development of a plan for their use and disposition. (4) A prohibition against...

  17. 22 CFR 211.5 - Obligations of cooperating sponsor.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    .... (b) Program supervision. Cooperating sponsors shall provide adequate supervisory personnel for the efficient operation of the program, including personnel to: (1) Plan, organize, implement, control, and... provisions of this regulation. (c) Audits—(1) By nongovernmental cooperating sponsors. A nongovernmental...

  18. 22 CFR 211.5 - Obligations of cooperating sponsor.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    .... (b) Program supervision. Cooperating sponsors shall provide adequate supervisory personnel for the efficient operation of the program, including personnel to: (1) Plan, organize, implement, control, and... provisions of this regulation. (c) Audits—(1) By nongovernmental cooperating sponsors. A nongovernmental...

  19. DOE-EERC jointly sponsored research program

    SciTech Connect

    Hendrikson, J.G.; Sondreal, E.A.

    1999-09-01

    U.S. Department of Energy (DOE) Cooperative Agreement DE-FC21-93MC30098 funded through the Office of Fossil Energy and administered at the Federal Energy Technology Center (FETC) supported the performance of a Jointly Sponsored Research Program (JSRP) at the Energy and Environmental Research Center (EERC) with a minimum 50% nonfederal cost share to assist industry in commercializing and effectively applying efficient, nonpolluting energy technologies that can compete effectively in meeting market demands for clean fuels, chemical feedstocks, and electricity in the 21st century. The objective of the JSRP was to advance the deployment of advanced technologies for improving energy efficiency and environmental performance through jointly sponsored research on topics that would not be adequately addressed by the private sector alone. Examples of such topics include the barriers to hot-gas cleaning impeding the deployment of high-efficiency power systems and the search for practical means for sequestering CO{sub 2} generated by fossil fuel combustion. The selection of particular research projects was guided by a combination of DOE priorities and market needs, as provided by the requirement for joint venture funding approved both by DOE and the private sector sponsor. The research addressed many different energy resource and related environmental problems, with emphasis directed toward the EERC's historic lead mission in low-rank coals (LRCs), which represent approximately half of the U.S. coal resources in the conterminous states, much larger potential resources in Alaska, and a major part of the energy base in the former U.S.S.R., East Central Europe, and the Pacific Rim. The Base and JSRP agreements were tailored to the growing awareness of critical environmental issues, including water supply and quality, air toxics (e.g., mercury), fine respirable particulate matter (PM{sub 2.5}), and the goal of zero net CO{sub 2} emissions.

  20. 45 CFR 233.51 - Eligibility of sponsored aliens.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 45 Public Welfare 2 2012-10-01 2012-10-01 false Eligibility of sponsored aliens. 233.51 Section... CONDITIONS OF ELIGIBILITY IN FINANCIAL ASSISTANCE PROGRAMS § 233.51 Eligibility of sponsored aliens... affidavit(s) of support or similar agreement on behalf of an alien (who is not the child of the sponsor or...

  1. 45 CFR 233.51 - Eligibility of sponsored aliens.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 45 Public Welfare 2 2013-10-01 2012-10-01 true Eligibility of sponsored aliens. 233.51 Section 233... CONDITIONS OF ELIGIBILITY IN FINANCIAL ASSISTANCE PROGRAMS § 233.51 Eligibility of sponsored aliens... affidavit(s) of support or similar agreement on behalf of an alien (who is not the child of the sponsor or...

  2. 45 CFR 233.51 - Eligibility of sponsored aliens.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 45 Public Welfare 2 2014-10-01 2012-10-01 true Eligibility of sponsored aliens. 233.51 Section 233... CONDITIONS OF ELIGIBILITY IN FINANCIAL ASSISTANCE PROGRAMS § 233.51 Eligibility of sponsored aliens... affidavit(s) of support or similar agreement on behalf of an alien (who is not the child of the sponsor or...

  3. Ethos and Vision Realization in Sponsored Academy Schools

    ERIC Educational Resources Information Center

    Gibson, Mark T.

    2015-01-01

    This article investigates the realization of ethos and vision in the early stages of sponsored academy schools in England. It is a qualitative nested case study of ten academies. Nineteen key actors were interviewed, including principals and sponsor representatives. The nests were organized by sponsor type. Key themes are discussed within the…

  4. 42 CFR 423.401 - General requirements for PDP sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... financial solvency and other standards as the State may require for it to operate as a PDP sponsor. (2) Assumption of financial risk for unsubsidized coverage. The PDP sponsor assumes financial risk on a... sponsor is organized and licensed under State law as a risk bearing entity eligible to offer health...

  5. 42 CFR 423.401 - General requirements for PDP sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... financial solvency and other standards as the State may require for it to operate as a PDP sponsor. (2) Assumption of financial risk for unsubsidized coverage. The PDP sponsor assumes financial risk on a... sponsor is organized and licensed under State law as a risk bearing entity eligible to offer health...

  6. 45 CFR 233.51 - Eligibility of sponsored aliens.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 45 Public Welfare 2 2010-10-01 2010-10-01 false Eligibility of sponsored aliens. 233.51 Section... CONDITIONS OF ELIGIBILITY IN FINANCIAL ASSISTANCE PROGRAMS § 233.51 Eligibility of sponsored aliens... affidavit(s) of support or similar agreement on behalf of an alien (who is not the child of the sponsor...

  7. 45 CFR 233.51 - Eligibility of sponsored aliens.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 45 Public Welfare 2 2011-10-01 2011-10-01 false Eligibility of sponsored aliens. 233.51 Section... CONDITIONS OF ELIGIBILITY IN FINANCIAL ASSISTANCE PROGRAMS § 233.51 Eligibility of sponsored aliens... affidavit(s) of support or similar agreement on behalf of an alien (who is not the child of the sponsor...

  8. Ethos and Vision Realization in Sponsored Academy Schools

    ERIC Educational Resources Information Center

    Gibson, Mark T.

    2015-01-01

    This article investigates the realization of ethos and vision in the early stages of sponsored academy schools in England. It is a qualitative nested case study of ten academies. Nineteen key actors were interviewed, including principals and sponsor representatives. The nests were organized by sponsor type. Key themes are discussed within the…

  9. 22 CFR 42.31 - Family-sponsored immigrants.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 22 Foreign Relations 1 2011-04-01 2011-04-01 false Family-sponsored immigrants. 42.31 Section 42... IMMIGRATION AND NATIONALITY ACT, AS AMENDED Immigrants Subject to Numerical Limitations § 42.31 Family-sponsored immigrants. (a) Entitlement to status. An alien shall be classifiable as a family-sponsored...

  10. 48 CFR 235.017-1 - Sponsoring agreements.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 3 2011-10-01 2011-10-01 false Sponsoring agreements. 235.017-1 Section 235.017-1 Federal Acquisition Regulations System DEFENSE ACQUISITION REGULATIONS SYSTEM... Sponsoring agreements. (c)(4) DoD-sponsoring FFRDCs that function primarily as research laboratories (C3I...

  11. Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials.

    PubMed

    Perez, Raymond; Archdeacon, Patrick; Roach, Nancy; Goodwin, Robert; Jarow, Jonathan; Stuccio, Nina; Forrest, Annemarie

    2017-06-01

    The Food and Drug Administration's final rule on investigational new drug application safety reporting, effective from 28 March 2011, clarified the reporting requirements for serious and unexpected suspected adverse reactions occurring in clinical trials. The Clinical Trials Transformation Initiative released recommendations in 2013 to assist implementation of the final rule; however, anecdotal reports and data from a Food and Drug Administration audit indicated that a majority of reports being submitted were still uninformative and did not result in actionable changes. Clinical Trials Transformation Initiative investigated remaining barriers and potential solutions to full implementation of the final rule by polling and interviewing investigators, clinical research staff, and sponsors. In an opinion-gathering effort, two discrete online surveys designed to assess challenges and motivations related to management of expedited (7- to 15-day) investigational new drug safety reporting processes in oncology trials were developed and distributed to two populations: investigators/clinical research staff and sponsors. Data were collected for approximately 1 year. Twenty-hour-long interviews were also conducted with Clinical Trials Transformation Initiative-nominated interview participants who were considered as having extensive knowledge of and experience with the topic. Interviewees included 13 principal investigators/study managers/research team members and 7 directors/vice presidents of pharmacovigilance operations from 5 large global pharmaceutical companies. The investigative site's responses indicate that too many individual reports are still being submitted, which are time-consuming to process and provide little value for patient safety assessments or for informing actionable changes. Fewer but higher quality reports would be more useful, and the investigator and staff would benefit from sponsors'"filtering" of reports and increased sponsor communication. Sponsors

  12. Criteria for submitting photos.

    PubMed

    Vallarelli, Andrelou Fralete Ayres

    2011-01-01

    Dermatological photography is used as a supplement to dermatological examination with the function of providing additional knowledge and information. Its quality depends on the expertise of the photographer-dermatologist in recording the relevant elements present. Therefore, the dermatologist should know basic principles of photography and the journal editors should ensure that the articles have high-quality images. This article suggests criteria to improve the quality of photographs submitted to journals for publication.

  13. [Third-party funding and industrial sponsoring].

    PubMed

    Bock, R-W

    2003-11-01

    Due to sensational publications, media-effective proceedings and not least due to personal involvement in many cases the medical profession became aware of the potential criminal significance of third-party funding and industrial sponsoring in hospitals. It started with the so-called Heart-Valve-Affair ("Herzklappenskandal") in 1994. Since then, insecurity prevails which was further nourished by a new series of legal proceedings in spring 2002. Industrial sponsoring has been practised in hospitals for a long time. Research work at universities and colleges would hardly be possible without third-party funding, which is accepted de lege lata according to section sign 25 of the German Hochschulrahmengesetz (framework law on universities and colleges). In view of the course of action of the criminal prosecution authorities the question came up which precautions must be taken with regard to grants by the medical-pharmaceutical industry to avoid consequences from the point of view of criminal law.[nl]There are various facts and circumstances in relation with these benefits, such as providing financing of educational training, payments related to the participation in congresses, speaker's fees, consultancy agreements, clinical tests and application evaluation, provision of equipment and staff as well as providing financing thereof, donations to medical facilities and so-called Fördervereine (supporting associations), benefits for research projects, etc.

  14. Protocol Development | Division of Cancer Prevention

    Cancer.gov

    The chemoprevention Phase I and II consortia must submit Letters of Intent for review and approval prior to the submission and review of the protocol. Letter of Intent (LOI) Process The chemoprevention Phase I and II consortia must submit Letters of Intent for review and approval prior to the submission and review of the protocol. DCP will solicit Letters of Intent from investigators who want to conduct clinical trials with specific agents. |

  15. Fallout from government-sponsored radiation research.

    PubMed

    Spicer, Carol Mason

    1994-06-01

    On December 28, 1993, Energy Secretary Hazel R. O'Leary publicly appealed to both the executive and legislative branches of the United States Government to consider compensation for individuals who were harmed by their exposure to ionizing radiation while enrolled in government-sponsored studies conducted between 1940 and the early 1970s. The call for compensation was issued three weeks after Secretary O'Leary disclosed that radiation experiments involving humans, sometimes without their consent, had occurred under the auspices of the Atomic Energy Commission (AEC), a forerunner of the Department of Energy (DOE). Secretary O'Leary directed her department to investigate the nature and extent of the experiments, report on their medical and ethical acceptability, and locate the research subjects or their families.

  16. Jointly Sponsored Research Program Energy Related Research

    SciTech Connect

    Western Research Institute

    2009-03-31

    Cooperative Agreement, DE-FC26-98FT40323, Jointly Sponsored Research (JSR) Program at Western Research Institute (WRI) began in 1998. Over the course of the Program, a total of seventy-seven tasks were proposed utilizing a total of $23,202,579 in USDOE funds. Against this funding, cosponsors committed $26,557,649 in private funds to produce a program valued at $49,760,228. The goal of the Jointly Sponsored Research Program was to develop or assist in the development of innovative technology solutions that will: (1) Increase the production of United States energy resources - coal, natural gas, oil, and renewable energy resources; (2) Enhance the competitiveness of United States energy technologies in international markets and assist in technology transfer; (3) Reduce the nation's dependence on foreign energy supplies and strengthen both the United States and regional economies; and (4) Minimize environmental impacts of energy production and utilization. Under the JSR Program, energy-related tasks emphasized enhanced oil recovery, heavy oil upgrading and characterization, coal beneficiation and upgrading, coal combustion systems development including oxy-combustion, emissions monitoring and abatement, coal gasification technologies including gas clean-up and conditioning, hydrogen and liquid fuels production, coal-bed methane recovery, and the development of technologies for the utilization of renewable energy resources. Environmental-related activities emphasized cleaning contaminated soils and waters, processing of oily wastes, mitigating acid mine drainage, and demonstrating uses for solid waste from clean coal technologies, and other advanced coal-based systems. Technology enhancement activities included resource characterization studies, development of improved methods, monitors and sensors. In general the goals of the tasks proposed were to enhance competitiveness of U.S. technology, increase production of domestic resources, and reduce environmental impacts

  17. Immigrants and Employer-Sponsored Health Insurance

    PubMed Central

    Buchmueller, Thomas C; Lo Sasso, Anthony T; Lurie, Ithai; Dolfin, Sarah

    2007-01-01

    Objective To investigate the factors underlying the lower rate of employer-sponsored health insurance coverage for foreign-born workers. Data Sources 2001 Survey of Income and Program Participation. Study Design We estimate probit regressions to determine the effect of immigrant status on employer-sponsored health insurance coverage, including the probabilities of working for a firm that offers coverage, being eligible for coverage, and taking up coverage. Data Extraction Methods We identified native born citizens, naturalized citizens, and noncitizen residents between the ages of 18 and 65, in the year 2002. Principal Findings First, we find that the large difference in coverage rates for immigrants and native-born Americans is driven by the very low rates of coverage for noncitizen immigrants. Differences between native-born and naturalized citizens are quite small and for some outcomes are statistically insignificant when we control for observable characteristics. Second, our results indicate that the gap between natives and noncitizens is explained mainly by differences in the probability of working for a firm that offers insurance. Conditional on working for such a firm, noncitizens are only slightly less likely to be eligible for coverage and, when eligible, are only slightly less likely to take up coverage. Third, roughly two-thirds of the native/noncitizen gap in coverage overall and in the probability of working for an insurance-providing employer is explained by characteristics of the individual and differences in the types of jobs they hold. Conclusions The substantially higher rate of uninsurance among immigrants is driven by the lower rate of health insurance offers by the employers of immigrants. PMID:17355593

  18. List of Organizing Committees and Sponsors

    NASA Astrophysics Data System (ADS)

    2012-03-01

    Organizers DIRECTORS Maria L CalvoPresident of International Commission for Optics, Spain Aram V PapoyanDirector of Institute for Physical Research of NAS, Armenia HEADS OF PROJECT Tigran Dadalyan YSU, Armenia Artsrun MartirosyanIPR, Armenia COORDINATOR Narine GevorgyanIPR, Armenia / ICTP, Italy MANAGERS Paytsar MantashyanIPR, Armenia Karen VardanyanIPR, Armenia INTERNATIONAL ADVISORY COMMITTEE Marcis AuzinshLatvia Roland AvagyanArmenia Tapash ChakrabortyCanada Yuri ChilingaryanArmenia Eduard KazaryanArmenia Albert KirakosyanArmenia Radik KostanyanArmenia Avinash PandeyIndia Marat SoskinUkraine INTERNATIONAL PROGRAM COMMITTEE David Sarkisyan (Chair)Armenia Roman AlaverdyanArmenia Dan ApostolRomania Levon AslanyanArmenia Aranya BhattacherjeeIndia Gagik BuniatyanArmenia Vigen ChaltykyanArmenia Roldao Da RochaBrazil Miltcho DanailovItaly Vladimir GerdtRussia Samvel GevorgyanArmenia Gayane GrigoryanArmenia Rafik HakobyanArmenia Takayuki MiyaderaJapan Levon MouradianArmenia Atom MuradyanArmenia Simon RochesterUSA Hayk SarkisyanArmenia Aleksandr VardanyanArmenia LOCAL ORGANIZING COMMITTEE Narek AghekyanArmenia Anahit GogyanArmenia Melanya GrigoryanArmenia Armen HovhannisyanArmenia Lilit HovhannisyanArmenia Tatevik KhachatryanArmenia Astghik KuzanyanArmenia Satenik KuzanyanArmenia Vladimir LazarevRussia Lilit MantashyanArmenia Hripsime MkrtchyanArmenia Pavel MuzhikyanArmenia Wahi NarsisianArmenia Sahak OrdukhanyanArmenia Anna ReymersArmenia Narine TorosyanArmenia The Symposium was organized by YSU & NAS SPIE Armenian Student Chapter Institute for Physical Research (IPR) of National Academy of Sciences (NAS) Russian-Armenian (Slavonic) University (RAU) LT-PYRKAL cjsc Yerevan State University (YSU) Official Sponsors of the Symposium LT-PYRKAlRussian ArmenianSPIE LT-PYRKAL cjscRussian-Armenian UniversityYSU & NAS SPIE Student Chapter Further sponsors NFSATICTPSCSADevout Generation National Foundation of Science and Advanced TechnologiesThe Abdus Salam International Centre

  19. Sponsoring Organization | Division of Cancer Prevention

    Cancer.gov

    The National Cancer Institute (NCI) project officers are responsible for the design and oversight of all aspects of the PLCO trial. These NCI components work directly with the Coordinating Center which provides support for development and implementation of the study protocol; and with the Principal Investigators from each of the Screening Centers to ensure that the technical aspects of the trial are carried out under rigorous scientific standards. |

  20. Jointly Sponsored Research Program. Final report

    SciTech Connect

    1997-07-01

    The Jointly Sponsored Research Program (JSRP) is a US Department of Energy (DOE) program funded through the Office of Fossil Energy and administered at the Morgantown Energy Technology Center. Under this program, which has been in place since Fiscal Year 1990, DOE makes approximately $2.5 million available each year to the Energy and Environmental Research Center (EERC) to fund projects that are of current interest to industry but which still involve significant risk, thus requiring some government contribution to offset the risk if the research is to move forward. The program guidelines require that at least 50% of the project funds originate from nonfederal sources. Projects funded under the JSRP often originate under a complementary base program, which funds higher-risk projects. The projects funded in Fiscal Year 1996 addressed a wide range of Fossil Energy interests, including hot-gas filters for advanced power systems; development of cleaner, more efficient processing technologies; development of environmental control technologies; development of environmental remediation and reuse technologies; development of improved analytical techniques; and development of a beneficiation technique to broaden the use of high-sulfur coal. Descriptions and status for each of the projects funded during the past fiscal year are included in Section A of this document, Statement of Technical Progress.

  1. Recent DOE-sponsored hydropower engineering research

    SciTech Connect

    Chappell, J.R.

    1983-01-01

    Purpose of this paper is to provide an overview of DOE Engineering Development research activity since Waterpower 1981. General results of about 11 projects that have been completed since Waterpower 1981 are presented and compared. Continuing efforts are also described briefly. DOE has sponsored four projects dealing with the use of pumps as turbines. This approach results in capital cost savings, shorter time for completing a hydropower plant, wider variety of off-the-shelf equipment available, and better maintenance services. Results are summarized for feasibility studies, laboratory tests, and in-the-field experience surveys of the use of pumps as turbines. Other projects discussed include microhydropower plants (less than 100 kW in capacity), head augmentation devices, Schneider engines, the use of marine thrusters as turbines, low cost cross-flow turbines made of plastic, variable speed constant frequency generators, hydraulic air compressors, scroll motor turbines and modular float-in powerhouses. The paper also discusses some of the technologies where future research may prove fruitful.

  2. Team sponsors in community-based health leadership programs.

    PubMed

    Patterson, Tracy Enright; Dinkin, Donna R; Champion, Heather

    2017-05-02

    Purpose The purpose of this article is to share the lessons learned about the role of team sponsors in action-learning teams as part of community-based health leadership development programs. Design/methodology/approach This case study uses program survey results from fellow participants, action learning coaches and team sponsors to understand the value of sponsors to the teams, the roles they most often filled and the challenges they faced as team sponsors. Findings The extent to which the sponsors were perceived as having contributed to the work of the action learning teams varied greatly from team to team. Most sponsors agreed that they were well informed about their role. The roles sponsors most frequently played were to provide the teams with input and support, serve as a liaison to the community and serve as a sounding board, motivator and cheerleader. The most common challenges or barriers team sponsors faced in this role were keeping engaged in the process, adjusting to the role and feeling disconnected from the program. Practical implications This work provides insights for program developers and community foundations who are interested in building the capacity for health leadership by linking community sponsors with emerging leaders engaged in an action learning experience. Originality/value This work begins to fill a gap in the literature. The role of team sponsors has been studied for single organization work teams but there is a void of understanding about the role of sponsors with multi-organizational teams working to improve health while also learning about leadership.

  3. Diffusion-Weighted Imaging Outside the Brain: Consensus Statement From an ISMRM-Sponsored Workshop

    PubMed Central

    Taouli, Bachir; Beer, Ambros J.; Chenevert, Thomas; Collins, David; Lehman, Constance; Matos, Celso; Padhani, Anwar R.; Rosenkrantz, Andrew B.; Shukla-Dave, Amita; Sigmund, Eric; Tanenbaum, Lawrence; Thoeny, Harriet; Thomassin-Naggara, Isabelle; Barbieri, Sebastiano; Corcuera-Solano, Idoia; Orton, Matthew; Partridge, Savannah C.; Koh, Dow-Mu

    2016-01-01

    The significant advances in magnetic resonance imaging (MRI) hardware and software, sequence design, and postprocessing methods have made diffusion-weighted imaging (DWI) an important part of body MRI protocols and have fueled extensive research on quantitative diffusion outside the brain, particularly in the oncologic setting. In this review, we summarize the most up-to-date information on DWI acquisition and clinical applications outside the brain, as discussed in an ISMRM-sponsored symposium held in April 2015. We first introduce recent advances in acquisition, processing, and quality control; then review scientific evidence in major organ systems; and finally describe future directions. PMID:26892827

  4. 22 CFR 62.9 - General obligations of sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 1 2010-04-01 2010-04-01 false General obligations of sponsors. 62.9 Section 62.9 Foreign Relations DEPARTMENT OF STATE PUBLIC DIPLOMACY AND EXCHANGES EXCHANGE VISITOR PROGRAM General Provisions § 62.9 General obligations of sponsors. (a) Adherence to Department of State...

  5. 22 CFR 62.9 - General obligations of sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 22 Foreign Relations 1 2011-04-01 2011-04-01 false General obligations of sponsors. 62.9 Section 62.9 Foreign Relations DEPARTMENT OF STATE PUBLIC DIPLOMACY AND EXCHANGES EXCHANGE VISITOR PROGRAM General Provisions § 62.9 General obligations of sponsors. (a) Adherence to Department of...

  6. 7 CFR 225.14 - Requirements for sponsor participation.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 225.14 Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM Sponsor and Site Provisions... sponsor the Program include: (1) Public or nonprofit private school food authorities; (2) Public...

  7. 22 CFR 42.31 - Family-sponsored immigrants.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Family-sponsored immigrants. 42.31 Section 42... IMMIGRATION AND NATIONALITY ACT, AS AMENDED Immigrants Subject to Numerical Limitations § 42.31 Family-sponsored immigrants. (a) Entitlement to status. An alien shall be classifiable as a...

  8. 17 CFR 229.1104 - (Item 1104) Sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... discussion of the sponsor's experience in securitizing assets of any type as well as a more detailed discussion of the sponsor's experience in and overall procedures for originating or acquiring and securitizing assets of the type included in the current transaction. Include to the extent material...

  9. 7 CFR 225.15 - Management responsibilities of sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... any time of the year in an area with a continuous school calendar). Training of site personnel shall... company for year-round service, and sponsors whose total contracts with food service management companies... accruing to the Program” at § 225.2 and with the regulations at § 225.9(d). Sponsors which are school food...

  10. 7 CFR 225.15 - Management responsibilities of sponsors.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... any time of the year in an area with a continuous school calendar). Training of site personnel shall... management company for year-round service, and sponsors whose total contracts with food service management... accruing to the Program” at § 225.2 and with the regulations at § 225.9(d). Sponsors which are school food...

  11. 7 CFR 225.15 - Management responsibilities of sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... any time of the year in an area with a continuous school calendar). Training of site personnel shall... management company for year-round service, and sponsors whose total contracts with food service management... accruing to the Program” at § 225.2 and with the regulations at § 225.9(d). Sponsors which are school food...

  12. 7 CFR 225.15 - Management responsibilities of sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... any time of the year in an area with a continuous school calendar). Training of site personnel shall... management company for year-round service, and sponsors whose total contracts with food service management... accruing to the Program” at § 225.2 and with the regulations at § 225.9(d). Sponsors which are school food...

  13. Employer-Sponsored Child Care: A Movement or a Mirage?

    ERIC Educational Resources Information Center

    Washington, Valora; Oyemade, Ura Jean

    1984-01-01

    Reviews trends in family life-styles that affect the workplace. Identifies employer trends affecting employee expectations. Examines the prevalence, success, and limitations of employer-sponsored child care and government-sponsored initiatives. Finally, discusses the permanence of the trend. (SK)

  14. Employer-Sponsored Child Care Models and Related Issues.

    ERIC Educational Resources Information Center

    Renfroe, Martha Lou

    This study was designed to describe the different models of Employer-Sponsored Child Care (ESCC) available to employers and child care professionals. Examples of specific child care programs sponsored by employers are described, and five ESCC models are identified: on-site and off-site centers for a single employer, off-site centers for multiple…

  15. 42 CFR 423.401 - General requirements for PDP sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 3 2013-10-01 2013-10-01 false General requirements for PDP sponsors. 423.401 Section 423.401 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN... sponsor is organized and licensed under State law as a risk bearing entity eligible to offer...

  16. 42 CFR 423.401 - General requirements for PDP sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 3 2014-10-01 2014-10-01 false General requirements for PDP sponsors. 423.401 Section 423.401 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN... sponsor is organized and licensed under State law as a risk bearing entity eligible to offer...

  17. 42 CFR 423.401 - General requirements for PDP sponsors.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 3 2012-10-01 2012-10-01 false General requirements for PDP sponsors. 423.401 Section 423.401 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN... sponsor is organized and licensed under State law as a risk bearing entity eligible to offer...

  18. 77 FR 32897 - New Animal Drugs; Change of Sponsor's Name

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-04

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Part 510 New Animal Drugs; Change of Sponsor's Name... (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Novopharm Ltd..., Animal drugs, Labeling, Reporting and recordkeeping requirements. Therefore, under the Federal Food, Drug...

  19. 77 FR 4224 - New Animal Drugs; Change of Sponsor's Name

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-01-27

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Part 510 New Animal Drugs; Change of Sponsor's Name... (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Nycomed US... practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. Therefore, under...

  20. 48 CFR 235.017-1 - Sponsoring agreements.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ..., DEPARTMENT OF DEFENSE SPECIAL CATEGORIES OF CONTRACTING RESEARCH AND DEVELOPMENT CONTRACTING 235.017-1 Sponsoring agreements. (c)(4) DoD-sponsoring FFRDCs that function primarily as research laboratories (C3I... solicitations and announcements for programs which promote research, development, demonstration, or transfer of...

  1. 21 CFR 312.50 - General responsibilities of sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 5 2010-04-01 2010-04-01 false General responsibilities of sponsors. 312.50 Section 312.50 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) DRUGS FOR HUMAN USE INVESTIGATIONAL NEW DRUG APPLICATION Responsibilities of Sponsors...

  2. 48 CFR 235.017-1 - Sponsoring agreements.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ..., DEPARTMENT OF DEFENSE SPECIAL CATEGORIES OF CONTRACTING RESEARCH AND DEVELOPMENT CONTRACTING 235.017-1 Sponsoring agreements. (c)(4) DoD-sponsoring FFRDCs that function primarily as research laboratories (C3I... Institute of Technology, and Software Engineering Institute operated by Carnegie Mellon) may respond...

  3. 76 FR 2807 - New Animal Drugs; Change of Sponsor

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-01-18

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Part 510 New Animal Drugs; Change of Sponsor AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for hemoglobin glutamer-200...

  4. 76 FR 48714 - New Animal Drugs; Change of Sponsor; Moxidectin

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-09

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Parts 520, 522, and 524 New Animal Drugs; Change of Sponsor; Moxidectin AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for...

  5. 22 CFR 211.5 - Obligations of cooperating sponsor.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... been provided through the friendship of the American people as food for peace. At distribution and... through the friendship of the American people as food for peace; (iii) Not to be sold or exchanged (where... cooperating sponsor, the direct and indirect costs of an office maintained by the cooperating sponsor in...

  6. 22 CFR 211.5 - Obligations of cooperating sponsor.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... been provided through the friendship of the American people as food for peace. At distribution and... through the friendship of the American people as food for peace; (iii) Not to be sold or exchanged (where... cooperating sponsor, the direct and indirect costs of an office maintained by the cooperating sponsor in...

  7. 22 CFR 211.5 - Obligations of cooperating sponsor.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... been provided through the friendship of the American people as food for peace. At distribution and... through the friendship of the American people as food for peace; (iii) Not to be sold or exchanged (where... cooperating sponsor, the direct and indirect costs of an office maintained by the cooperating sponsor in...

  8. Employer-Sponsored Child Care: A Movement or a Mirage?

    ERIC Educational Resources Information Center

    Washington, Valora; Oyemade, Ura Jean

    1984-01-01

    Reviews trends in family life-styles that affect the workplace. Identifies employer trends affecting employee expectations. Examines the prevalence, success, and limitations of employer-sponsored child care and government-sponsored initiatives. Finally, discusses the permanence of the trend. (SK)

  9. 45 CFR 1226.13 - Obligations of sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 45 Public Welfare 4 2010-10-01 2010-10-01 false Obligations of sponsors. 1226.13 Section 1226.13 Public Welfare Regulations Relating to Public Welfare (Continued) CORPORATION FOR NATIONAL AND COMMUNITY SERVICE PROHIBITIONS ON ELECTORAL AND LOBBYING ACTIVITIES Sponsor Employee Activities §...

  10. 7 CFR 226.16 - Sponsoring organization provisions.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... activities related to the annual updating of children's enrollment forms. Sponsoring organizations that were... participation, or renewal materials, for each child care and adult day care facility accompanied by all... 7 Agriculture 4 2014-01-01 2014-01-01 false Sponsoring organization provisions. 226.16 Section...

  11. 14 CFR 152.103 - Sponsors: Airport development.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 14 Aeronautics and Space 3 2010-01-01 2010-01-01 false Sponsors: Airport development. 152.103 Section 152.103 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION... Sponsors: Airport development. (a) To be eligible to apply for a project for airport development with...

  12. 14 CFR 152.103 - Sponsors: Airport development.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 14 Aeronautics and Space 3 2014-01-01 2014-01-01 false Sponsors: Airport development. 152.103 Section 152.103 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION... Sponsors: Airport development. (a) To be eligible to apply for a project for airport development with...

  13. 14 CFR 152.103 - Sponsors: Airport development.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 3 2011-01-01 2011-01-01 false Sponsors: Airport development. 152.103 Section 152.103 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION... Sponsors: Airport development. (a) To be eligible to apply for a project for airport development with...

  14. 14 CFR 152.103 - Sponsors: Airport development.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 14 Aeronautics and Space 3 2012-01-01 2012-01-01 false Sponsors: Airport development. 152.103 Section 152.103 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION... Sponsors: Airport development. (a) To be eligible to apply for a project for airport development with...

  15. 14 CFR 152.103 - Sponsors: Airport development.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 14 Aeronautics and Space 3 2013-01-01 2013-01-01 false Sponsors: Airport development. 152.103 Section 152.103 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION... Sponsors: Airport development. (a) To be eligible to apply for a project for airport development with...

  16. Evaluating alcoholics anonymous sponsor attributes using conjoint analysis.

    PubMed

    Stevens, Edward B; Jason, Leonard A

    2015-12-01

    Alcoholics Anonymous (AA) considers sponsorship an important element of the AA program, especially in early recovery. 225 adult individuals who had experience as either a sponsor, sponsee, or both, participated in a hypothetical sponsor ranking exercise where five attributes were varied across three levels. Conjoint analysis was used to compute part-worth utility of the attributes and their levels for experience, knowledge, availability, confidentiality, and goal-setting. Differences in utilities by attribute were found where confidentiality had the greatest overall possible impact on utility and sponsor knowledge had the least. These findings suggest qualitative differences in sponsors may impact their effectiveness. Future research on AA should continue to investigate sponsor influence on an individual's overall recovery trajectory.

  17. Should Sponsors and DSMBs Share Interim Results Across Trials?

    PubMed Central

    Shah, Seema K.; Dawson, Liza; Dixon, Dennis O.; Lie, Reidar K.

    2011-01-01

    Increasing numbers of multinational clinical trials have generated new ethical obligations of research sponsors and their DSMBs. Although sponsors and DSMBs clearly have ethical obligations to protect subjects in their trials, future patients, and the integrity of their trial, the obligations they have to protect subjects in other trials have been overlooked. When interim results from clinical trials can significantly affect the conduct of other trials and the welfare of the subjects in those trials, sponsors and DSMBs may have obligations to disclose results to the relevant parties. We propose that sponsors and DSMBs routinely work together in advance to develop a plan for disclosing relevant information in cases where it is necessary to protect the welfare of subjects in other trials. Channels of communication between sponsors, DSMBs, IRBs, and others involved in similar and concurrent trials will better protect both research participants and the integrity of the research enterprise. PMID:21937922

  18. 78 FR 17866 - New Animal Drug Approvals; Change of Sponsor; Change of Sponsor's Drug Labeler Code; Gonadorelin...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-25

    ... Approvals; Change of Sponsor; Change of Sponsor's Drug Labeler Code; Gonadorelin Acetate; Isoflurane... Technologies GONABREED (gonadorelin 1. Original approval 522.1073 yes 1. CE \\2\\ Pty. Ltd., unit 4, 476 acetate... South 2. Supplemental Wales 2015, Australia. approval for use with cloprostenol sodium to synchronize...

  19. Canadian Association for Immunization Research and Evaluation (CAIRE) guidelines for industry-sponsored clinical trial and epidemiology contract research.

    PubMed

    Halperin, Scott A; Scheifele, David; Duval, Bernard; Law, Barbara; Ward, Brian; Bjornson, Gordean; Halperin, Beth; Skowronski, Danuta; King, Arlene; Hammond, Greg; Dobson, Simon; Tamblyn, Susan; Wang, Elaine; Lavigne, Pierre; Danzig, Lisa; Elrick, Donald; Carnan, Elspeth; Mansi, James; Bertrand, Francoise; Palkonyay, Laszlo; Clements, Gail; Maresky, Neil; Wortzman, David

    2005-01-01

    In response to concerns about interactions of academic and public health investigators with industry, the Canadian Association for Immunization Research and Evaluation (CAIRE), in collaboration with six major vaccine manufacturers, developed guidelines for participation in industry-sponsored clinical trial and epidemiology contract research within Canada. Topics addressed include definition of investigators, data ownership, protocol development, data management, data analysis, producing a study report and publication of the results of the study.

  20. Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations.

    PubMed

    Hartmann, M; Knoth, H; Schulz, D; Knoth, S

    2003-10-20

    The purpose of this analysis of health economic studies in the field of oncology was to investigate among sponsored studies whether any relationship could be established between the type of sponsorship and (1) type of economic analysis, (2) health technology assessed, (3) sensitivity analysis performed, (4) publication status, and (5) qualitative conclusions about costs. The Health Economic Evaluations Database (HEED, version 1995-2000) was searched on the basis of oncological ICD-9 codes, sponsorship, and comparative studies. This search yielded a total of 150 eligible articles. Their evaluations were prepared independently by two investigators, on the basis of specific criteria. When evaluators disagreed, a third investigator provided a deciding evaluation. There was no statistically significant relationship between the type of sponsorship and sensitivity analysis performed (P=0.29) or publication status (P=0.08). However, we found a significant relationship between the types of sponsorship and of economic analysis (P=0.004), the health technology assessed (P<0.0001), and qualitative cost assessment (P=0.002). Studies with industrial sponsorship were 2.56 (99% lower confidence interval (CI)=1.28) times more likely to involve cost-minimisation analyses, were 0.04 (99% higher CI=0.39) times less likely to investigate diagnostic screening methods, and were 1.86 (99% lower CI=1.21) times more likely to reach positive qualitative conclusions about costs than studies supported by nonprofit organisations. In conclusion, our results suggest that there is a greater probability that industry-sponsored economic studies in the field of oncology tend to be cost-minimisation analyses, to investigate less likely diagnostic screening methods, and to draw positive qualitative conclusions about costs, as compared to studies supported by nonprofit organisations.

  1. 41. March 18, 1939 Oakland, California Launching party with sponsor ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    41. March 18, 1939 Oakland, California Launching party with sponsor Miss Harriet Biota Mason (holding flowers) at the Moore Dry Dock Company. - U.S. Coast Guard Cutter FIR, Puget Sound Area, Seattle, King County, WA

  2. 76 FR 28777 - Information Collections Being Submitted for Review and Approval to the Office of Management and...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-18

    ... employees. The FCC may not conduct or sponsor a collection of information unless it displays a currently... before June 17, 2011. If you anticipate that you will be submitting PRA comments, but find it difficult...) click on the downward-pointing arrow in the ``Select Agency'' box below the ``Currently Under...

  3. 75 FR 9897 - Notice of Public Information Collection Being Submitted to the Office of Management and Budget...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-04

    ... COMMISSION Notice of Public Information Collection Being Submitted to the Office of Management and Budget for... information unless it displays a currently valid control number. No person shall be subject to any penalty for... sponsor a collection of information unless it displays a currently valid control number. No person...

  4. Communications protocol

    NASA Technical Reports Server (NTRS)

    Zhou, Xiaoming (Inventor); Baras, John S. (Inventor)

    2010-01-01

    The present invention relates to an improved communications protocol which increases the efficiency of transmission in return channels on a multi-channel slotted Alohas system by incorporating advanced error correction algorithms, selective retransmission protocols and the use of reserved channels to satisfy the retransmission requests.

  5. 76 FR 16532 - New Animal Drugs; Change of Sponsor's Name and Address; Corrections

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-03-24

    ... labeler code (DLC). Cross-references to the sponsor's DLC are amended in two sections of the Code of... change to the sponsor's drug labeler code (DLC). Cross-references to the sponsor's DLC are amended in...

  6. Benefits of Addressing HFCs under the Montreal Protocol 2014

    EPA Pesticide Factsheets

    The United States, Canada, and Mexico together submitted a proposal in April 2015 to phase-down production and consumption of hydrofluorocarbons (HFCs) under the Montreal Protocol. This paper presents an analysis of the potential benefits of such action.

  7. 42 CFR 423.272 - Review and negotiation of bid and approval of plans submitted by potential Part D sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICARE PROGRAM (CONTINUED... applicable requirements of § 423.104(h). (3) Modification of pharmacy access standard and disclosure requirement. If the plan provides coverage for drugs purchased from all pharmacies, without charging...

  8. 42 CFR 423.272 - Review and negotiation of bid and approval of plans submitted by potential Part D sponsors.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICARE PROGRAM (CONTINUED... applicable requirements of § 423.104(h). (3) Modification of pharmacy access standard and disclosure requirement. If the plan provides coverage for drugs purchased from all pharmacies, without charging...

  9. 42 CFR 423.272 - Review and negotiation of bid and approval of plans submitted by potential Part D sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ...) VOLUNTARY MEDICARE PRESCRIPTION DRUG BENEFIT Submission of Bids and Monthly Beneficiary Premiums; Plan... prescription drug coverage and actuarial determinations. (1) Application of revenue requirements standard. CMS... basic and supplemental prescription drug coverage are supported by the actuarial bases provided and...

  10. SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

    PubMed

    Chan, An-Wen; Tetzlaff, Jennifer M; Altman, Douglas G; Laupacis, Andreas; Gøtzsche, Peter C; Krle A-Jerić, Karmela; Hrobjartsson, Asbjørn; Mann, Howard; Dickersin, Kay; Berlin, Jesse A; Dore, Caroline J; Parulekar, Wendy R; Summerskill, William S M; Groves, Trish; Schulz, Kenneth F; Sox, Harold C; Rockhold, Frank W; Rennie, Drummond; Moher, David

    2015-12-01

    The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol. The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

  11. SPIRIT 2013 statement: defining standard protocol items for clinical trials.

    PubMed

    Chan, An-Wen; Tetzlaff, Jennifer M; Altman, Douglas G; Laupacis, Andreas; Gøtzsche, Peter C; Krleža-Jerić, Karmela; Hróbjartsson, Asbjørn; Mann, Howard; Dickersin, Kay; Berlin, Jesse A; Doré, Caroline J; Parulekar, Wendy R; Summerskill, William S M; Groves, Trish; Schulz, Kenneth F; Sox, Harold C; Rockhold, Frank W; Rennie, Drummond; Moher, David

    2013-02-05

    The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol.The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

  12. 37 CFR 4.3 - Submitting complaints.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Submitting complaints. 4.3... COMMERCE GENERAL COMPLAINTS REGARDING INVENTION PROMOTERS § 4.3 Submitting complaints. (a) A person may submit a complaint concerning an invention promoter with the Office. A person submitting a...

  13. [Criminal implication of sponsoring in medicine: legal ramifactions and recommendations].

    PubMed

    Mahnken, A H; Theilmann, M; Bolenz, M; Günther, R W

    2005-08-01

    As a consequence of the so-called "Heart-Valve-Affair" in 1994, the German public became aware of the potential criminal significance of industrial sponsoring and third-party financial support in medicine. Since 1997, when the German Anti-Corruption Law came into effect, the penal regulations regarding bribery and benefits for public officers were tightened. Due to the lack of explicit and generally accepted guidelines in combination with regional differences of jurisdiction, there is a lingering uncertainty regarding the criminal aspects of third-party funding and industrial sponsoring. The aim of this review is to summarize the penal and professional implications of third-party funding and sponsoring in medicine including recent aspects of jurisdiction. The currently available recommendations on this issue are introduced.

  14. Protocol Coordinator II | Center for Cancer Research

    Cancer.gov

    Provides programmatic and logistical support for the operations of clinical research for Phase I and Phase II clinical trials Provides deployment of clinical support services for clinical research  Streamlines protocol development timeline Provides data and document collection and compilation for regulatory filing with the FDA and other regulatory authorities Provides technical review and report preparation Provides administrative coordination and general logistical support for regulatory activities Ensures the provision of training for investigators and associate staff to reinforce and enhance a GCP culture Provides quality assurance and quality control oversight Performs regulatory review of clinical protocols, informed consent and other clinical documents  Tracks and facilitates a portfolio of protocols through each process step (IRB, RAC, DSMB, Office of Protocol Services) Assists clinical investigators in preparing clinical research protocols, including writing and formatting protocol documents and consent forms Prepares protocol packages for review and ensures that protocol packages include all the required material and comply with CCR, NCI and NIH policies Collaborates with investigators to resolve any protocol/data issues Coordinates submission of protocols for scientific and ethical review by the Branch scientific review committees, the NCI Institutional Review Board (IRB) and the clinical trial sponsor or the FDA Monitors the review process and maintains detailed, complete and accurate records for each protocol of the approvals at the various stages of the review process, including new protocol submissions, amendments to protocols, and continuing reviews, as well as other submissions such as adverse events Attends and prepares minutes for the Branch Protocol Review Committees For protocols that are performed with other research centers: contacts coordinators at other centers to obtain review committee approvals at these centers,  maintains records of

  15. The publication of sponsored symposiums in medical journals.

    PubMed

    Bero, L A; Galbraith, A; Rennie, D

    1992-10-15

    An increasing proportion of spending by the pharmaceutical industry has gone to funding symposiums that are published by peer-reviewed medical journals. This study tests the hypothesis that such sponsorship, particularly by a single pharmaceutical company, is associated with a promotional orientation of the symposium and a distortion of the peer-review process. We counted the symposiums published in 58 journals of clinical medicine and surveyed the journal editors regarding their policies for symposium issues. We analyzed the symposium issues that appeared in the 11 journals that published the most symposiums in order to determine the sponsor or sponsors, the topics, whether the titles were misleading, whether brand names were used, and whether the featured drugs were classified by the Food and Drug Administration as innovative or approved. The number of symposiums published per year increased steadily from 1966 through 1989. Forty-two percent of those analyzed (262 of 625) had a single pharmaceutical company as the sponsor. These symposiums were more likely than those with other sponsors to have misleading titles (P less than 0.001) and to use brand names (P less than 0.001), and less likely to be peer-reviewed in the same manner as other articles in the parent journal (P less than 0.001). Of the 161 symposiums that focused on a single drug, 51 percent concerned unapproved therapies; 14 percent concerned drugs classified as bringing important therapeutic gains. Symposiums sponsored by drug companies often have promotional attributes and are not peer-reviewed. Financial relations among symposium participants, sponsors, and journals should be completely disclosed, symposiums should be clearly identified, and journal editors should maintain editorial control over contributions from symposiums.

  16. Dosimetry of patients submitted to cerebral PET/CT for the diagnosis of mild cognitive impairment.

    PubMed

    Santana, Priscila do Carmo; Mourão, Arnaldo Prata; de Oliveira, Paulo Márcio Campos; Bernardes, Felipe Dias; Mamede, Marcelo; da Silva, Teógenes Augusto

    2014-01-01

    The present study was aimed at evaluating the effective radiation dose in patients submitted to PET/CT for the diagnosis of mild cognitive impairment. TLD-100 detectors inserted into an Alderson Rando® anthropomorphic phantom were utilized to measure the absorbed dose coming from the CT imaging modality. The anthropomorphic phantoms (male and female adult versions) were submitted to the same technical protocols for patients' images acquisition. The absorbed dose resulting from the radiopharmaceutical injection was estimated by means of the model proposed by the ICRP publication 106. The effective dose in patients submitted to this diagnostic technique was approximately (5.34 ± 1.99) mSv. Optimized protocols for calculation of radioactive activity injected into patients submitted to this diagnostic technique might contribute to reduce the effective radiation dose resulting from PET/CT in the diagnosis of mild cognitive impairment.

  17. Dosimetry of patients submitted to cerebral PET/CT for the diagnosis of mild cognitive impairment

    PubMed Central

    Santana, Priscila do Carmo; Mourão, Arnaldo Prata; de Oliveira, Paulo Márcio Campos; Bernardes, Felipe Dias; Mamede, Marcelo; da Silva, Teógenes Augusto

    2014-01-01

    Objective The present study was aimed at evaluating the effective radiation dose in patients submitted to PET/CT for the diagnosis of mild cognitive impairment. Materials and Methods TLD-100 detectors inserted into an Alderson Rando® anthropomorphic phantom were utilized to measure the absorbed dose coming from the CT imaging modality. The anthropomorphic phantoms (male and female adult versions) were submitted to the same technical protocols for patients’ images acquisition. The absorbed dose resulting from the radiopharmaceutical injection was estimated by means of the model proposed by the ICRP publication 106. Results The effective dose in patients submitted to this diagnostic technique was approximately (5.34 ± 1.99) mSv. Conclusion Optimized protocols for calculation of radioactive activity injected into patients submitted to this diagnostic technique might contribute to reduce the effective radiation dose resulting from PET/CT in the diagnosis of mild cognitive impairment. PMID:25741117

  18. [A possible protocol for postoperative management in laparoscopic cholecystectomy].

    PubMed

    Ionescu, D; Vlad, L; Iancu, C; Puia, C; Al Hajjar, N; Munteanu, D; Bălă, O; Pop, F

    2005-01-01

    The goal of the "Prospect" programme (sponsored by Pfizer) is to create possible evidence-based protocols related to the management of postoperative pain after certain type of surgical intervention (e.g. hernia repairs, hysterectomies, etc.). This article is introducing the protocol for laparoscopic cholecystectomy for both day-case and longer hospital admission cases. The protocol is designed for preoperative, intra and postoperative period, choosing only those measures which were effective for postoperative pain, published in the literature. We are also presenting an analyze of our 13,000 laparoscopic cholecystectomies, from "Prospect" protocol point of view, and what we should do to improve the management of postoperative pain.

  19. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.

    PubMed

    Flacco, Maria Elena; Manzoli, Lamberto; Boccia, Stefania; Capasso, Lorenzo; Aleksovska, Katina; Rosso, Annalisa; Scaioli, Giacomo; De Vito, Corrado; Siliquini, Roberta; Villari, Paolo; Ioannidis, John P A

    2015-07-01

    To map the current status of head-to-head comparative randomized evidence and to assess whether funding may impact on trial design and results. From a 50% random sample of the randomized controlled trials (RCTs) published in journals indexed in PubMed during 2011, we selected the trials with ≥ 100 participants, evaluating the efficacy and safety of drugs, biologics, and medical devices through a head-to-head comparison. We analyzed 319 trials. Overall, 238,386 of the 289,718 randomized subjects (82.3%) were included in the 182 trials funded by companies. Of the 182 industry-sponsored trials, only 23 had two industry sponsors and only three involved truly antagonistic comparisons. Industry-sponsored trials were larger, more commonly registered, used more frequently noninferiority/equivalence designs, had higher citation impact, and were more likely to have "favorable" results (superiority or noninferiority/equivalence for the experimental treatment) than nonindustry-sponsored trials. Industry funding [odds ratio (OR) 2.8; 95% confidence interval (CI): 1.6, 4.7] and noninferiority/equivalence designs (OR 3.2; 95% CI: 1.5, 6.6), but not sample size, were strongly associated with "favorable" findings. Fifty-five of the 57 (96.5%) industry-funded noninferiority/equivalence trials got desirable "favorable" results. The literature of head-to-head RCTs is dominated by the industry. Industry-sponsored comparative assessments systematically yield favorable results for the sponsors, even more so when noninferiority designs are involved. Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

  20. 48 CFR 970.5235-1 - Federally funded research and development center sponsoring agreement.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... and development center sponsoring agreement. 970.5235-1 Section 970.5235-1 Federal Acquisition... Federally funded research and development center sponsoring agreement. As prescribed in 970.3501-4, the... Sponsoring Agreement (DEC 2010) (a) Pursuant to 48 CFR 35.017-1, this contract constitutes the sponsoring...

  1. Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees.

    PubMed

    Li, Rebecca H; Wacholtz, Mary C; Barnes, Mark; Boggs, Liam; Callery-D'Amico, Susan; Davis, Amy; Digilova, Alla; Forster, David; Heffernan, Kate; Luthin, Maeve; Lynch, Holly Fernandez; McNair, Lindsay; Miller, Jennifer E; Murphy, Jacquelyn; Van Campen, Luann; Wilenzick, Mark; Wolf, Delia; Woolston, Cris; Aldinger, Carmen; Bierer, Barbara E

    2016-04-01

    A novel Protocol Ethics Tool Kit ('Ethics Tool Kit') has been developed by a multi-stakeholder group of the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard. The purpose of the Ethics Tool Kit is to facilitate effective recognition, consideration and deliberation of critical ethical issues in clinical trial protocols. The Ethics Tool Kit may be used by investigators and sponsors to develop a dedicated Ethics Section within a protocol to improve the consistency and transparency between clinical trial protocols and research ethics committee reviews. It may also streamline ethics review and may facilitate and expedite the review process by anticipating the concerns of ethics committee reviewers. Specific attention was given to issues arising in multinational settings. With the use of this Tool Kit, researchers have the opportunity to address critical research ethics issues proactively, potentially speeding the time and easing the process to final protocol approval.

  2. Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees

    PubMed Central

    Li, Rebecca H; Wacholtz, Mary C; Barnes, Mark; Boggs, Liam; Callery-D'Amico, Susan; Davis, Amy; Digilova, Alla; Forster, David; Heffernan, Kate; Luthin, Maeve; Lynch, Holly Fernandez; McNair, Lindsay; Miller, Jennifer E; Murphy, Jacquelyn; Van Campen, Luann; Wilenzick, Mark; Wolf, Delia; Woolston, Cris; Aldinger, Carmen; Bierer, Barbara E

    2016-01-01

    A novel Protocol Ethics Tool Kit (‘Ethics Tool Kit’) has been developed by a multi-stakeholder group of the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard. The purpose of the Ethics Tool Kit is to facilitate effective recognition, consideration and deliberation of critical ethical issues in clinical trial protocols. The Ethics Tool Kit may be used by investigators and sponsors to develop a dedicated Ethics Section within a protocol to improve the consistency and transparency between clinical trial protocols and research ethics committee reviews. It may also streamline ethics review and may facilitate and expedite the review process by anticipating the concerns of ethics committee reviewers. Specific attention was given to issues arising in multinational settings. With the use of this Tool Kit, researchers have the opportunity to address critical research ethics issues proactively, potentially speeding the time and easing the process to final protocol approval. PMID:26811365

  3. Undergraduates with Employer-Sponsored Aid: Comparing Group Differences

    ERIC Educational Resources Information Center

    Faulk, Dagney G.; Wang, Zhenlei

    2014-01-01

    Tuition assistance offered by employers is an understudied area of financial aid research. The purpose of this study is to compare the demographic, socioeconomic, academic and financial aid characteristics of college students who receive employer-sponsored financial aid with students who receive traditional financial aid (institutional, state, or…

  4. 7 CFR 225.15 - Management responsibilities of sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... the conduct of these reviews. (e) Media Release. Each sponsor shall annually announce in the media... media releases issued by camps and other programs not eligible under § 225.2 (paragraph (a) of “areas in... members; (iii) The social security number of the adult household member who signs the application or...

  5. The American Sponsored Overseas School: A Research Matrix.

    ERIC Educational Resources Information Center

    Orr, Paul Glenn

    This publication provides a source of information and research to the people interested in and responsible for American Sponsored Overseas Schools (ASOS). The first section includes an overview of six major categories of research, namely: school setting, school institutionalization; school organization and administration, school program,…

  6. College-Sponsored Experiential Learning--A CAEL Student Guide.

    ERIC Educational Resources Information Center

    Nesbitt, Hadley

    This guide is designed for college students who are involved in college-sponsored, off campus work experience programs, to help them meaningfully integrate these experiences into their ongoing educational programs. It would also be useful to anyone entering their first working situation. Basic steps which are outlined include selecting and…

  7. 17 CFR 229.1104 - (Item 1104) Sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... the securitization of assets. The description must include, to the extent material, a general... securitizing assets of the type included in the current transaction. Include to the extent material information... securitized and information or factors related to the sponsor that may be material to an analysis of...

  8. 17 CFR 229.1104 - (Item 1104) Sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... the securitization of assets. The description must include, to the extent material, a general... securitizing assets of the type included in the current transaction. Include to the extent material information... securitized and information or factors related to the sponsor that may be material to an analysis of...

  9. 14 CFR 60.9 - Additional responsibilities of the sponsor.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 14 Aeronautics and Space 2 2010-01-01 2010-01-01 false Additional responsibilities of the sponsor. 60.9 Section 60.9 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION (CONTINUED) AIRMEN FLIGHT SIMULATION TRAINING DEVICE INITIAL AND CONTINUING QUALIFICATION AND USE §...

  10. 14 CFR 60.9 - Additional responsibilities of the sponsor.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 2 2011-01-01 2011-01-01 false Additional responsibilities of the sponsor. 60.9 Section 60.9 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION (CONTINUED) AIRMEN FLIGHT SIMULATION TRAINING DEVICE INITIAL AND CONTINUING QUALIFICATION AND USE §...

  11. A Commentary on Literacy Narratives as Sponsors of Literacy

    ERIC Educational Resources Information Center

    Brandt, Deborah

    2015-01-01

    This brief commentary first clarifies Brandt's concept of sponsors of literacy in light of the way the concept has been taken up in writing studies. Then it treats Brandt's methods for handling accounts of literacy learning in comparison with other ways of analyzing biographical material. Finally it takes up Lawrence's argument about literacy…

  12. A Commentary on Literacy Narratives as Sponsors of Literacy

    ERIC Educational Resources Information Center

    Brandt, Deborah

    2015-01-01

    This brief commentary first clarifies Brandt's concept of sponsors of literacy in light of the way the concept has been taken up in writing studies. Then it treats Brandt's methods for handling accounts of literacy learning in comparison with other ways of analyzing biographical material. Finally it takes up Lawrence's argument about literacy…

  13. Budget negotiation for industry-sponsored clinical trials.

    PubMed

    Beal, Kristy; Dean, Juliette; Chen, James; Dragaon, Elena; Saulino, Ann; Collard, Charles D

    2004-07-01

    The specialty of anesthesia is well suited to attract industry-sponsored clinical trials and research revenues because of its fundamental contributions to surgery, critical care, and pain medicine. However, the performance and budgeting of industry-sponsored clinical research over the past decade has been significantly altered by the rapid growth of commercially oriented networks of contract-research organizations and site-management organizations. Further, the competitive nature of today's clinical research climate can make the planning and negotiating of study budgets and contracts stressful, time consuming, frustrating, and full of pitfalls. Because a clinical trial contract is a fixed-price agreement, investigators are obligated to perform the work described in the contract, even if the actual costs exceed the study contract. Successful budgeting for the performance of an industry-sponsored clinical trial thus requires a thorough understanding of the direct and indirect costs associated with performing clinical research. We reviewed budget and contractual considerations for the successful negotiation and performance of industry-sponsored clinical research.

  14. 17 CFR 229.1104 - (Item 1104) Sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 17 Commodity and Securities Exchanges 2 2011-04-01 2011-04-01 false (Item 1104) Sponsors. 229.1104 Section 229.1104 Commodity and Securities Exchanges SECURITIES AND EXCHANGE COMMISSION STANDARD... pursuant to § 230.424 of this chapter on or after February 14, 2013 but prior to February 14, 2014...

  15. 17 CFR 229.1104 - (Item 1104) Sponsors.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 17 Commodity and Securities Exchanges 2 2012-04-01 2012-04-01 false (Item 1104) Sponsors. 229.1104 Section 229.1104 Commodity and Securities Exchanges SECURITIES AND EXCHANGE COMMISSION STANDARD... pursuant to § 230.424 of this chapter on or after February 14, 2013 but prior to February 14, 2014...

  16. A Reform Strategy for Education: Employer-Sponsored Teacher Internships.

    ERIC Educational Resources Information Center

    Gold, Gerard G.

    1987-01-01

    Summer teacher internships that are employer-sponsored benefit the teachers, the employers, and the students. Most of the programs have concentrated on improving science and mathematics teaching. Educating employers and school districts about the benefits of participating in these programs is a complex and difficult task. (MD)

  17. 7 CFR 226.16 - Sponsoring organization provisions.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... the meal reimbursements estimated or actually earned during the budget year, unless the State agency... centers. If at any point a sponsoring organization determines that the meal reimbursements estimated to be... experience and duties, on the Program's meal patterns, meal counts, claims submission and review procedures...

  18. Undergraduates with Employer-Sponsored Aid: Comparing Group Differences

    ERIC Educational Resources Information Center

    Faulk, Dagney G.; Wang, Zhenlei

    2014-01-01

    Tuition assistance offered by employers is an understudied area of financial aid research. The purpose of this study is to compare the demographic, socioeconomic, academic and financial aid characteristics of college students who receive employer-sponsored financial aid with students who receive traditional financial aid (institutional, state, or…

  19. Recycling: Establishing a Citizen-Sponsored Reclamation Center.

    ERIC Educational Resources Information Center

    Keep America Beautiful, Inc., New York, NY.

    This booklet applies the Clean Community System (CCS) of Keep America Beautiful, Inc. to the development of citizen-sponsored recycling projects. Six initial steps in establishing a reclamation center are given and include information gathering, market analysis, legal requirements, and site location. Suggestions are included for recruiting staff…

  20. Current guidelines regarding industry-sponsored continuing medical education.

    PubMed

    DelSignore, Jeanne L

    2003-07-01

    The importance of continuing medical education has been long recognized by the orthopaedic profession as vital in maintaining a current knowledge and skills base. There has been increasing concern over the expanding involvement of industry in sponsoring continuing medical education. Concomitant with rising costs of medical education is a decreasing source of funds from government and other sources; therefore industry has taken an active role in sponsoring continuing medical education, leading to a potential for serious conflict of interest. National and federal guidelines have been created to allow commercial sponsorship, yet leave the responsibility for the design, faculty, and content to the accredited provider. The guidelines are intended to prevent bias, keep commercial displays separate from educational presentations, and clearly state that industry-sponsored events should be primarily educational in nature and directly benefit the patient. Because of the potential conflict inherent within industry-sponsored continuing medical education, a cooperative relationship between educators, industry, and attendees of educational activities must be achieved to prevent bias and to keep the patient's best interest as paramount. Each orthopaedic surgeon has an ethical obligation to resolve any conflicts of interest in the best interest of the patient.

  1. 32 CFR 855.21 - Procedures for sponsor.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... National Defense Department of Defense (Continued) DEPARTMENT OF THE AIR FORCE AIRCRAFT CIVIL AIRCRAFT USE OF UNITED STATES AIR FORCE AIRFIELDS Agreements for Civil Aircraft Use of Air Force Airfields § 855.21 Procedures for sponsor. To initiate consideration for joint use of an Air Force airfield, a...

  2. 32 CFR 855.21 - Procedures for sponsor.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... National Defense Department of Defense (Continued) DEPARTMENT OF THE AIR FORCE AIRCRAFT CIVIL AIRCRAFT USE OF UNITED STATES AIR FORCE AIRFIELDS Agreements for Civil Aircraft Use of Air Force Airfields § 855.21 Procedures for sponsor. To initiate consideration for joint use of an Air Force airfield, a...

  3. 32 CFR 855.21 - Procedures for sponsor.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... National Defense Department of Defense (Continued) DEPARTMENT OF THE AIR FORCE AIRCRAFT CIVIL AIRCRAFT USE OF UNITED STATES AIR FORCE AIRFIELDS Agreements for Civil Aircraft Use of Air Force Airfields § 855.21 Procedures for sponsor. To initiate consideration for joint use of an Air Force airfield, a...

  4. 32 CFR 855.21 - Procedures for sponsor.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... National Defense Department of Defense (Continued) DEPARTMENT OF THE AIR FORCE AIRCRAFT CIVIL AIRCRAFT USE OF UNITED STATES AIR FORCE AIRFIELDS Agreements for Civil Aircraft Use of Air Force Airfields § 855.21 Procedures for sponsor. To initiate consideration for joint use of an Air Force airfield, a...

  5. 32 CFR 855.21 - Procedures for sponsor.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... National Defense Department of Defense (Continued) DEPARTMENT OF THE AIR FORCE AIRCRAFT CIVIL AIRCRAFT USE OF UNITED STATES AIR FORCE AIRFIELDS Agreements for Civil Aircraft Use of Air Force Airfields § 855.21 Procedures for sponsor. To initiate consideration for joint use of an Air Force airfield, a...

  6. Disability Awareness Night[TM]: 2006 Honorees, Sponsors, Teams

    ERIC Educational Resources Information Center

    Exceptional Parent, 2006

    2006-01-01

    This article presents the 2006 honorees, sponsors, and teams for the Disability Awareness Night[TM]. Disability Awareness Night[TM] is a unique and powerful community outreach program. Its vision is to continue to raise awareness outside of the community of individuals with disabilities to continue the goal that this program will open doors to…

  7. Financial Management Requirements for Bureau of Work Programs Sponsors.

    ERIC Educational Resources Information Center

    Manpower Administration (DOL), Washington, DC.

    This handbook was developed for use by sponsors of Bureau of Work Programs such as Operation Mainstream, New Careers, Special Impact Programs, Work Experience Programs, Concentrated Employment Programs and Community Action Programs. Included are the audit requirements of the Manpower Administration, an accounting manual designed for effective…

  8. Union-Sponsored Workplace ESL Instruction. ERIC Digest.

    ERIC Educational Resources Information Center

    Rosenblum, Susan

    Labor unions have provided English-as-a-Second-Language (ESL) instruction in the workplace since the early 1900s, to serve a growing immigrant workforce. In the late 1970s and early 1980s, an increase in immigrant population, decline in manufacturing jobs, new technology, and work restructuring brought a new urgency to union-sponsored worker…

  9. Consumer Perceptions of Sponsors of Disease Awareness Advertising

    ERIC Educational Resources Information Center

    Hall, Danika V.; Jones, Sandra C.; Iverson, Donald C.

    2011-01-01

    Purpose: In many countries there is emerging concern regarding alliances between the pharmaceutical industry and health non-profit organizations (NPOs), and the increase of co-sponsored marketing activities such as disease awareness advertising. The current study aims to explore Australian women's perceptions of disease awareness advertising with…

  10. 48 CFR 970.3501-1 - Sponsoring agreements.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... SUPPLEMENTARY REGULATIONS DOE MANAGEMENT AND OPERATING CONTRACTS Research and Development Contracting 970.3501-1... Research and Development Center Sponsoring Agreement,” which, in part, prescribes limitations on the FFRDC... Department of Energy and the contractor operating an FFRDC. (b) The contract statement of work shall define...

  11. 21 CFR 312.50 - General responsibilities of sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... promptly informed of significant new adverse effects or risks with respect to the drug. Additional specific... 21 Food and Drugs 5 2013-04-01 2013-04-01 false General responsibilities of sponsors. 312.50 Section 312.50 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN...

  12. 78 FR 17595 - New Animal Drugs; Changes of Sponsor

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-22

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510, 520, 522, 524, 529, and 558 New Animal Drugs; Changes of Sponsor AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of...

  13. 78 FR 21058 - New Animal Drugs; Change of Sponsor

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-09

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510, 520, 522, 524, 526, 529, and 558 New Animal Drugs; Change of Sponsor AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of...

  14. The Benefits and Challenges of Registered Apprenticeship: The Sponsors' Perspective

    ERIC Educational Resources Information Center

    Lerman, Robert; Eyster, Lauren; Chambers, Kate

    2009-01-01

    The Employment and Training Administration (ETA) of the U.S. Department of Labor oversees the registered apprenticeship system by issuing standards, monitoring state agencies, and promoting registered apprenticeship. Registered apprenticeship program "sponsors" are individual employers or groups of employers (sometimes in collaboration with…

  15. School-Sponsored Health Insurance: Planning for a New Reality

    ERIC Educational Resources Information Center

    Liang, Bryan A.

    2010-01-01

    Health care reform efforts in both the Clinton and Obama administrations have attempted to address college and university health. Yet, although the world of health care delivery has almost universally evolved to managed care, school health programs have not. In general, school-sponsored health plans do little to improve access and have adopted…

  16. Management of Federally Sponsored Libraries: Case Studies and Analysis.

    ERIC Educational Resources Information Center

    Missar, Charles D., Ed.

    This book provides insight into how managers of federally sponsored libraries view their roles and carry out their duties. Seven federally supported libraries were selected to serve as case studies. These libraries represent a cross-section of various types, and the nine chapters are written by librarians from these facilities. The discussion…

  17. Management of Federally Sponsored Libraries: Case Studies and Analysis.

    ERIC Educational Resources Information Center

    Missar, Charles D., Ed.

    This book provides insight into how managers of federally sponsored libraries view their roles and carry out their duties. Seven federally supported libraries were selected to serve as case studies. These libraries represent a cross-section of various types, and the nine chapters are written by librarians from these facilities. The discussion…

  18. 14 CFR 60.9 - Additional responsibilities of the sponsor.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 14 Aeronautics and Space 2 2012-01-01 2012-01-01 false Additional responsibilities of the sponsor. 60.9 Section 60.9 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION (CONTINUED) AIRMEN FLIGHT SIMULATION TRAINING DEVICE INITIAL AND CONTINUING QUALIFICATION AND USE § 60.9...

  19. 14 CFR 60.9 - Additional responsibilities of the sponsor.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 14 Aeronautics and Space 2 2014-01-01 2014-01-01 false Additional responsibilities of the sponsor. 60.9 Section 60.9 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION (CONTINUED) AIRMEN FLIGHT SIMULATION TRAINING DEVICE INITIAL AND CONTINUING QUALIFICATION AND USE § 60.9...

  20. 14 CFR 60.9 - Additional responsibilities of the sponsor.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 14 Aeronautics and Space 2 2013-01-01 2013-01-01 false Additional responsibilities of the sponsor. 60.9 Section 60.9 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION (CONTINUED) AIRMEN FLIGHT SIMULATION TRAINING DEVICE INITIAL AND CONTINUING QUALIFICATION AND USE § 60.9...

  1. 7 CFR 225.9 - Program assistance to sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... management company from which they competitively procured meals for the National School Lunch Program during..., sponsors must conduct training sessions before receiving the second advance payment. Training sessions must... changes in the series for food away from home of the Consumer Price Index(CPI) for all urban consumers...

  2. An Experiment in Employer-Sponsored Day Care. Final Report.

    ERIC Educational Resources Information Center

    Nellum (A.L.) and Associates, Washington, DC.

    The report describes the need of working mothers for day care, the meaning of day care for employers in Government, business, and industry, the importance of employer-sponsored child day-care to the Department of Labor, and objectives of the Department's child day care center. The evaluation design provides for an analysis of the project as it…

  3. Exclusion of pregnant women from industry-sponsored clinical trials.

    PubMed

    Shields, Kristine E; Lyerly, Anne Drapkin

    2013-11-01

    The lack of human data available to inform evidence-based treatment for illness during pregnancy has led to calls for greater inclusion of pregnant women in research, but the extent of their current representation is poorly characterized. Our objective was to measure the current exclusion of pregnant women from industry-sponsored clinical trials as a baseline for future comparison. We compiled data from studies enrolling women of childbearing potential posted on www.ClinicalTrials.gov between 1 October 2011 and 31 January 2012. The review was limited to open United States-based phase IV interventional studies sponsored by the pharmaceutical industry evaluating treatment of conditions that may be experienced by but are not limited to pregnant women and did not involve a medication classified as potentially teratogenic. If there was no mention of pregnancy in the inclusion or exclusion criteria, we contacted a study representative to confirm that pregnant women could be enrolled. Of 558 qualifying industry-sponsored studies, five (1%) were designed specifically for pregnant women. Of 367 phase IV clinical trials with verified inclusion and exclusion criteria, 348 (95%) excluded pregnant women and 19 (5%) did not. We found the exclusion of pregnant women from industry-sponsored clinical trials to be common practice. Moving beyond reflexive exclusion and developing thoughtful criteria for inclusion of pregnant women in clinical research would likely advance the evidence base to inform treatment decisions during pregnancy and lead to better health outcomes for women and children.

  4. 7 CFR 225.12 - Claims against sponsors.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 4 2010-01-01 2010-01-01 false Claims against sponsors. 225.12 Section 225.12 Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.12 Claims...

  5. Corporate Sponsors: Is There a Price to Pay?

    ERIC Educational Resources Information Center

    Hahn, Laurel Markey

    1986-01-01

    Funding of college union and student activities programs by local and national companies is discussed. While a great many colleges use corporate sponsorship to some extent, an issue is which corporate sponsors should be used and how. Colleges rely on four major types of corporate sponsorship: companies may offer (1) a specific amount for a…

  6. Employer-Sponsored Training: Current Status, Future Possibilities.

    ERIC Educational Resources Information Center

    Vaughan, Roger J.; Berryman, Sue E.

    This document summarizes the conclusions of research papers and participant discussions at a conference on employer-sponsored training in 1988. Following an introduction, the first section offers support for the statement that employers invest heavily in training their best-educated and trained employees. The following are among the conclusions…

  7. Employer-Sponsored Training. Overview: ERIC Fact Sheet No. 17.

    ERIC Educational Resources Information Center

    Beaudin, Bart

    This fact sheet identifies some of the basic premises of employer-sponsored training and reviews two studies that surveyed the quantity of occupational training in industry. Highlights and statistics from a 1977 study by Seymour Lusterman entitled "Education in Industry," and a 1975 study by the Bureau of Labor Statistics entitled…

  8. 7 CFR 226.16 - Sponsoring organization provisions.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... activities related to the annual updating of children's enrollment forms. Sponsoring organizations that were... participation, or renewal materials, for each child care and adult day care facility accompanied by all... school food authority provides child care and is applying to participate in the Program, the State...

  9. 7 CFR 226.16 - Sponsoring organization provisions.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... activities related to the annual updating of children's enrollment forms. Sponsoring organizations that were... participation, or renewal materials, for each child care and adult day care facility accompanied by all... school food authority provides child care and is applying to participate in the Program, the State...

  10. 7 CFR 226.16 - Sponsoring organization provisions.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... activities related to the annual updating of children's enrollment forms. Sponsoring organizations that were... participation, or renewal materials, for each child care and adult day care facility accompanied by all... school food authority provides child care and is applying to participate in the Program, the State...

  11. 7 CFR 225.12 - Claims against sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 4 2013-01-01 2013-01-01 false Claims against sponsors. 225.12 Section 225.12 Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.12 Claims...

  12. 7 CFR 225.9 - Program assistance to sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.9 Program... months before the sponsor is scheduled to begin food service operations and shall not exceed 20 percent...

  13. 7 CFR 225.9 - Program assistance to sponsors.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.9 Program... months before the sponsor is scheduled to begin food service operations and shall not exceed 20 percent...

  14. 7 CFR 225.12 - Claims against sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 4 2014-01-01 2014-01-01 false Claims against sponsors. 225.12 Section 225.12 Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.12 Claims...

  15. 7 CFR 225.9 - Program assistance to sponsors.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.9 Program... months before the sponsor is scheduled to begin food service operations and shall not exceed 20 percent...

  16. 7 CFR 225.12 - Claims against sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 4 2011-01-01 2011-01-01 false Claims against sponsors. 225.12 Section 225.12 Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.12 Claims...

  17. 7 CFR 225.9 - Program assistance to sponsors.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.9 Program... months before the sponsor is scheduled to begin food service operations and shall not exceed 20 percent...

  18. 7 CFR 225.12 - Claims against sponsors.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 4 2012-01-01 2012-01-01 false Claims against sponsors. 225.12 Section 225.12 Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SUMMER FOOD SERVICE PROGRAM State Agency Provisions § 225.12 Claims...

  19. Employer-Sponsored Career Development Programs. Information Series No. 231.

    ERIC Educational Resources Information Center

    Lancaster, Anita Sklare; Berne, Richard R.

    This monograph presents an overview of employer-sponsored career development programs. It is divided into four sections. The "Adult Development" and "Adult Career Development" sections review pertinent theories and research (basic concepts, task model, transition model, theme model, adult career stages, career anchors approach, career development…

  20. Sponsoring congregations' answer to McGrath Thesis: corporate control.

    PubMed

    Maida, A J

    1980-04-01

    Fr. Maida refutes McGrath's Thesis and posits that Catholic health care facilities face special corporate, financial, and theological administrative issues. By maintaining corporate control of the institutions they sponsor, religious congregations can determine institutional policies consistent with church teachings.

  1. Consumer Perceptions of Sponsors of Disease Awareness Advertising

    ERIC Educational Resources Information Center

    Hall, Danika V.; Jones, Sandra C.; Iverson, Donald C.

    2011-01-01

    Purpose: In many countries there is emerging concern regarding alliances between the pharmaceutical industry and health non-profit organizations (NPOs), and the increase of co-sponsored marketing activities such as disease awareness advertising. The current study aims to explore Australian women's perceptions of disease awareness advertising with…

  2. 22 CFR 42.31 - Family-sponsored immigrants.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 22 Foreign Relations 1 2013-04-01 2013-04-01 false Family-sponsored immigrants. 42.31 Section 42.31 Foreign Relations DEPARTMENT OF STATE VISAS VISAS: DOCUMENTATION OF IMMIGRANTS UNDER THE IMMIGRATION AND NATIONALITY ACT, AS AMENDED Immigrants Subject to Numerical Limitations § 42.31...

  3. 22 CFR 42.31 - Family-sponsored immigrants.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 22 Foreign Relations 1 2014-04-01 2014-04-01 false Family-sponsored immigrants. 42.31 Section 42.31 Foreign Relations DEPARTMENT OF STATE VISAS VISAS: DOCUMENTATION OF IMMIGRANTS UNDER THE IMMIGRATION AND NATIONALITY ACT, AS AMENDED Immigrants Subject to Numerical Limitations § 42.31...

  4. 22 CFR 42.31 - Family-sponsored immigrants.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 22 Foreign Relations 1 2012-04-01 2012-04-01 false Family-sponsored immigrants. 42.31 Section 42.31 Foreign Relations DEPARTMENT OF STATE VISAS VISAS: DOCUMENTATION OF IMMIGRANTS UNDER THE IMMIGRATION AND NATIONALITY ACT, AS AMENDED Immigrants Subject to Numerical Limitations § 42.31...

  5. School-Sponsored Health Insurance: Planning for a New Reality

    ERIC Educational Resources Information Center

    Liang, Bryan A.

    2010-01-01

    Health care reform efforts in both the Clinton and Obama administrations have attempted to address college and university health. Yet, although the world of health care delivery has almost universally evolved to managed care, school health programs have not. In general, school-sponsored health plans do little to improve access and have adopted…

  6. Unfulfilled translation opportunities in industry sponsored clinical trials.

    PubMed

    Smed, Marie; Getz, Kenneth A

    2013-05-01

    Knowledge generated by site representatives through their participation in clinical trials is valuable for testing new products in use and obtaining final market approval. The leverage of this important knowledge is however challenged as the former direct relationships between in-house staff in the industry and site representatives are changing. The process of clinical trials has increased in complexity over the years, resulting in additional management layers. Besides an increase in internal management layers, sponsors often also outsource various tasks related to clinical trials to a CRO (Contract Research Organization) and thereby adding another link in the relationships between site and sponsor. These changes are intended to optimize the time-consuming and costly trial phases; however, there is a need to study whether valuable knowledge and experience is compromised in the process. Limited research exists on the full range of clinical practice insights obtained by investigators during and after clinical trials and how well these insights are transferred to study sponsors. This study explores the important knowledge-transfer processes between sites and sponsors and to what extent sites' knowledge gained in clinical trials is utilized by the industry. Responses from 451 global investigative site representatives are included in the study. The analysis of the extensive dataset reveals that the current processes of collaboration between sites and the industry restrict the leverage of valuable knowledge gained by physicians in the process of clinical trials. These restrictions to knowledge-transfer between site and sponsor are further challenged if CRO partners are integrated in the trial process.

  7. Protocol Coordinator III | Center for Cancer Research

    Cancer.gov

    Provides programmatic and logistical support for the operations of clinical research Provides deployment of clinical support services for clinical research Streamlines the protocol development timeline Provides data and documents collection and compilation for regulatory filing with the Food and Drug Administration (FDA) and other regulatory authorities Provides technical review and report preparation Provides administrative coordination and general logistical support for regulatory activities Ensures the provision of training for investigators and associate staff to reinforce and enhance a Good Clinical Practices (GCP) culture Oversees quality assurance and quality control, performs regulatory review of clinical protocols, informed consent and other clinical documents Tracks and facilitates a portfolio of protocols through each process step (Institutional Review Board [IRB], Regulatory Affairs Compliance [RAC], Data Safety Monitoring Board [DSMB], Office of Protocol Services) Assists clinical investigators in preparing clinical research protocols, including writing and formatting consent forms Prepares protocol packages for review and ensures that protocol packages include all required material and complies with CCR, NCI and NIH policies Collaborates with investigators to resolve any protocol/data issues Coordinates submission of protocols for scientific and ethical review by the Branch scientific review committees, the NCI IRB, and the clinical trial sponsor or the FDA Monitors the review process and maintains detailed, complete and accurate approval records for each protocol at the various stages of the review process, including new protocol submissions, amendments to protocols, and continuing reviews, as well as other submissions such as adverse events Attends and prepares minutes for the Branch Protocol Review Committees Contacts coordinators at other centers for protocols that are performed there to obtain review committee approvals at those centers

  8. Protocol Coordinator II | Center for Cancer Research

    Cancer.gov

    Provides programmatic and logistical support for the operations of clinical research for Phase I and Phase II clinical trials Provides deployment of clinical support services for clinical research Streamlines protocol development timeline Provides data and document collection and compilation for regulatory filing with the FDA and other regulatory authorities Provides technical review and report preparation Provides administrative coordination and general logistical support for regulatory activities Ensures the provision of training for investigators and associate staff to reinforce and enhance a GCP culture Provides quality assurance and quality control oversight Performs regulatory review of clinical protocols, informed consent and other clinical documents Tracks and facilitates a portfolio of protocols through each process step (IRB, RAC, DSMB, Office of Protocol Services) Assists clinical investigators in preparing clinical research protocols, including writing and formatting protocol documents and consent forms Prepares protocol packages for review and ensures that protocol packages include all of the required material and comply with CCR, NCI and NIH policies Collaborates with investigators to resolve any protocol/data issues Coordinates submission of protocols for scientific and ethical review by the Branch scientific review committees, the NCI Institutional Review Board (IRB) and the clinical trial sponsor or the FDA Monitors the review process and maintains detailed, complete and accurate records for each protocol of the approvals at the various stages of the review process, including new protocol submissions, amendments to protocols, and continuing reviews, as well as other submissions such as adverse events Attends and prepares minutes for the Branch Protocol Review Committees For protocols that are performed with other research centers: 1) contacts coordinators at other centers to obtain review committee approvals at these centers, 2) maintains records

  9. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis.

    PubMed

    Krauth, David; Anglemyer, Andrew; Philipps, Rose; Bero, Lisa

    2014-01-01

    Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the sponsor, even when controlling for potential bias in the methods used. However, the influence of sponsorship bias has not been examined in preclinical animal studies. We performed a meta-analysis of preclinical statin studies to determine whether industry sponsorship is associated with either increased effect sizes of efficacy outcomes and/or risks of bias in a cohort of published preclinical statin studies. We searched Medline (January 1966-April 2012) and identified 63 studies evaluating the effects of statins on atherosclerosis outcomes in animals. Two coders independently extracted study design criteria aimed at reducing bias, results for all relevant outcomes, sponsorship source, and investigator financial ties. The I(2) statistic was used to examine heterogeneity. We calculated the standardized mean difference (SMD) for each outcome and pooled data across studies to estimate the pooled average SMD using random effects models. In a priori subgroup analyses, we assessed statin efficacy by outcome measured, sponsorship source, presence or absence of financial conflict information, use of an optimal time window for outcome assessment, accounting for all animals, inclusion criteria, blinding, and randomization. The effect of statins was significantly larger for studies sponsored by nonindustry sources (-1.99; 95% CI -2.68, -1.31) versus studies sponsored by industry (-0.73; 95% CI -1.00, -0.47) (p value<0.001). Statin efficacy did not differ by disclosure of financial conflict information, use of an optimal time window for outcome assessment, accounting for all animals, inclusion criteria, blinding, and randomization. Possible reasons for the differences between nonindustry- and industry-sponsored studies, such as selective reporting of outcomes, require further study.

  10. Nonindustry-Sponsored Preclinical Studies on Statins Yield Greater Efficacy Estimates Than Industry-Sponsored Studies: A Meta-Analysis

    PubMed Central

    Krauth, David; Anglemyer, Andrew; Philipps, Rose; Bero, Lisa

    2014-01-01

    Industry-sponsored clinical drug studies are associated with publication of outcomes that favor the sponsor, even when controlling for potential bias in the methods used. However, the influence of sponsorship bias has not been examined in preclinical animal studies. We performed a meta-analysis of preclinical statin studies to determine whether industry sponsorship is associated with either increased effect sizes of efficacy outcomes and/or risks of bias in a cohort of published preclinical statin studies. We searched Medline (January 1966–April 2012) and identified 63 studies evaluating the effects of statins on atherosclerosis outcomes in animals. Two coders independently extracted study design criteria aimed at reducing bias, results for all relevant outcomes, sponsorship source, and investigator financial ties. The I2 statistic was used to examine heterogeneity. We calculated the standardized mean difference (SMD) for each outcome and pooled data across studies to estimate the pooled average SMD using random effects models. In a priori subgroup analyses, we assessed statin efficacy by outcome measured, sponsorship source, presence or absence of financial conflict information, use of an optimal time window for outcome assessment, accounting for all animals, inclusion criteria, blinding, and randomization. The effect of statins was significantly larger for studies sponsored by nonindustry sources (−1.99; 95% CI −2.68, −1.31) versus studies sponsored by industry (−0.73; 95% CI −1.00, −0.47) (p value<0.001). Statin efficacy did not differ by disclosure of financial conflict information, use of an optimal time window for outcome assessment, accounting for all animals, inclusion criteria, blinding, and randomization. Possible reasons for the differences between nonindustry- and industry-sponsored studies, such as selective reporting of outcomes, require further study. PMID:24465178

  11. The evolution of Japanese employer-sponsored retirement plans.

    PubMed

    Rajnes, David

    2007-01-01

    This article examines the development of Japanese voluntary employer-sponsored retirement plans with an emphasis on recent trends. Until 2001, companies in Japan offered retirement benefits as lump-sum severance payments and/or benefits from one of two types of defined benefit (DB) pension plans. One type of DB plan was based on the occupational pension model used in the United States before the adoption of the Employee Retirement Income Security Act of 1974 (ERISA), but lacked the funding, vesting, and other protective features contained in ERISA. The other type of DB plan allowed companies to opt out of the earnings-related portion of social security, commonly referred to as "contracting out." Landmark laws passed in 2001 introduced a new generation of occupational retirement plans to employers and employees. One law increased funding requirements and enhanced employee protections for employer-sponsored DB plans, while a second law introduced defined contribution (DC) plans for several reasons, chiefly to increase retirement savings and help boost Japanese financial markets. These laws complemented earlier changes in the tax code and financial accounting standards already affecting employer-sponsored retirement plans. As a result, new retirement plan designs will replace most prereform era company retirement plans by 2012. In 2001, the experience of 401(k) plans in the United States, where 42 million participants had accumulated more than $1.8 trillion in assets over 20 years, attracted considerable attention among Japanese lawmakers finalizing provisions of the DC pension law. Even with government support and encouragement from the financial services industry, Japanese companies have not adopted these new DC plans in large numbers. As a result, occupational retirement plans in Japan have remained predominantly DB-a surprising development in light of the shift in a number of countries from DB to DC plans observed in recent decades. However, recent proposals to

  12. [Buccal manifestations in patients submitted to chemotherapy].

    PubMed

    Hespanhol, Fernando Luiz; Tinoco, Eduardo Muniz Barretto; Teixeira, Henrique Guilherme de Castro; Falabella, Márcio Eduardo Vieira; Assis, Neuza Maria de Souza Picorelli

    2010-06-01

    Several changes in the oral cavity due to chemotherapy can be observed and can lead to important systemic complications, increasing the time of the patient in hospital and the costs of the treatment as well as affect the quality of life of the patients. The aim of this study was to assess the oral manifestation in patients treated with chemotherapy according to sex, age and tumor type. Data was collected in an oncology hospital in Juiz de Fora, Minas Gerais State, from patients' records that were submitted to oncologic treatment. It was possible to verify that mucositis, associated or not to other type of lesions, was the most common lesion in both sex of all ages (15.5%). Xerostomia and other lesions, such as Candida infection and aphthous lesions, were also present. It is possible to improve the quality of life of the patient during and after anti-neoplastic therapies through a protocol of odontological assistance that includes changes of the oral environment previous to chemotherapy such as profilaxis, caries removal, treatment of periodontal and periapical lesions, oral hygiene instructions, diet orientation and laser therapy. It is very important the insertion of the dentist in the oncologic medical team for the early diagnosis of the oral manifestation and follow-up during treatment time.

  13. Protocol Programmability

    DTIC Science & Technology

    2013-12-01

    Michael Maass, Ligia Nistor, Larry Maccherone, Cyrus Omar, Ivan Ruchkin, Jason Tsay, and YoungSeok Yoon. Thank you to former students and post-docs... Baumgartner , and Michal Young. Compiler and tool support for debugging object protocols. In Proceedings of the 8th ACM SIGSOFT International Symposium...ACM. 2.1 Michael Hoppe and Stefan Hanenberg. Do developers benefit from generic types?: An empirical comparison of generic and raw types in java. In

  14. A review of NASA-sponsored technology assessment projects

    NASA Technical Reports Server (NTRS)

    Mascy, A. C.; Alexander, A. D., III; Wood, R. D.

    1978-01-01

    Recent technology assessment studies sponsored by NASA are reviewed, and a summary of the technical results as well as a critique of the methodologies are presented. The reviews include Assessment of Lighter-Than-Air Technology, Technology Assessment of Portable Energy RDT&P, Technology Assessment of Future Intercity Passenger Transportation Systems, and Technology Assessment of Space Disposal of Radioactive Nuclear Waste. The use of workshops has been introduced as a unique element of some of these assessments. Also included in this report is a brief synopsis of a method of quantifying opinions obtained through such group interactions. Representative of the current technology assessments, these studies cover a broad range of socio-political factors and issues in greater depth than previously considered in NASA sponsored studies. In addition to the lessons learned through the conduct of these studies, a few suggestions for improving the effectiveness of future technology assessments are provided.

  15. Biopharmaceutical industry-sponsored global clinical trials in emerging countries.

    PubMed

    Alvarenga, Lenio Souza; Martins, Elisabeth Nogueira

    2010-01-01

    To evaluate biopharmaceutical industry-sponsored clinical trials placed in countries previously described as emerging regions for clinical research, and potential differences for those placed in Brazil. Data regarding recruitment of subjects for clinical trials were retrieved from www.clinicaltrials.gov on February 2nd 2009. Proportions of sites in each country were compared among emerging countries. Multiple logistic regressions were performed to evaluate whether trial placement in Brazil could be predicted by trial location in other countries and/or by trial features. A total of 8,501 trials were then active and 1,170 (13.8%) included sites in emerging countries (i.e., Argentina, Brazil, China, Czech Republic, Hungary, India, Mexico, Poland, Russia, South Korea, and South Africa). South Korea and China presented a significantly higher proportion of sites when compared to other countries (p<0.05). Multiple logistic regressions detected no negative correlation between placement in other countries when compared to Brazil. Trials involving subjects with less than 15 years of age, those with targeted recruitment of at least 1,000 subjects, and seven sponsors were identified as significant predictors of trial placement in Brazil. No clear direct competition between Brazil and other emerging countries was detected. South Korea showed the higher proportion of sites and ranked third in total number of trials, appearing as a major player in attractiveness for biopharmaceutical industry-sponsored clinical trials.

  16. Characteristics of current hospital-sponsored and nonhospital birth centers.

    PubMed

    Khoury, A J; Summers, L; Weisman, C S

    1997-06-01

    (1) To describe contemporary birth centers in terms of the population served, organizational and financial characteristics, services provided, mission and philosophy, and planning and marketing techniques. (2) To compare hospital-sponsored and nonhospital models with regard to the above characteristics. Data from the National Survey of Women's Health Centers conducted in 1994 are analyzed using t-tests and chi-square tests. Contemporary birth centers serve a diverse population of women and provide a range of clinical and nonclinical services. Birth centers are both hospital-sponsored and nonhospital, with the former growing at a faster rate. Compared to hospital-sponsored centers, nonhospital centers serve a larger proportion of uninsured women, provide a broader range of clinical services, and are more committed to women-centered care. Centers utilize different marketing methods and are involved in a number of organizational changes to better position themselves in the changing health care environment. Birth centers offer an attractive option to consumers and are a viable model for delivering women-centered care. Given that all "birth center" facilities do not share the same philosophy and service mix, women need to have some assurance of what a "birth center" will, and will not, provide.

  17. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial

    PubMed Central

    Cortés, J; Ribera, J M; Cardellach, F; Selva-O’Callaghan, A; Kostov, B; García, L; Cirugeda, L; Altman, D G; González, J A; Sànchez, J A; Miras, F; Urrutia, A; Fonollosa, V; Rey-Joly, C; Vilardell, M

    2011-01-01

    hypothesised and not definitively demonstrated. Authors adhere more to suggestions from conventional reviews than to those from additional reviews, showing difficulties in adhering to high methodological standards at the latest research phases. To boost paper quality and impact, authors should be aware of future requirements of reporting guidelines at the very beginning of their study. Trial registration and protocol Although registries do not include trials of peer review, the protocol design was submitted to sponsored research projects (Instituto de Salud Carlos III, PI081903). PMID:22108262

  18. Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies

    PubMed Central

    Prugger, Christof; Doshi, Peter; Ostrowski, Kerstin; Witte, Thomas; Hüsgen, Dieter; Keil, Ulrich

    2017-01-01

    Objectives To investigate the practice of post-marketing studies in Germany during a three year period and to evaluate whether these trials meet the aims specified in the German Medicinal Products Act. Design Survey of notifications submitted to German regulatory agencies before post-marketing studies were carried out, 2008-10. Setting Notifications obtained through freedom of information requests to the three authorities responsible for registering post-marketing studies in Germany. Main outcome measures Descriptive statistics of post-marketing studies, including the products under study, intended number of patients, intended number of participating physicians, proposed remunerations, study plan and protocol, and availability of associated scientific publications and reports on adverse drug reactions. Results Information was obtained from 558 studies, with a median of 600 (mean 2331, range 2-75 000) patients and 63 (270, 0-7000) participating physicians per study. The median remuneration to physicians per patient was €200 (€441, €0-€7280) (£170, £0-£6200; $215, $0-$7820), with a total remuneration cost of more than €217m for 558 studies registered over the three year period. The median remuneration per participating physician per study was €2000 (mean €19 424), ranging from €0 to €2 080 000. There was a broad range of drugs and non-drug products, of which only a third represented recently approved drugs. In many notifications, data, information, and results were, by contract, strictly confidential and the sole property of the respective sponsor. No single adverse drug reaction report could be identified from any of the 558 post-marketing studies. Less than 1% of studies could be verified as published in scientific journals. Conclusions Post-marketing studies are not improving drug safety surveillance. Sample sizes are generally too small to allow the detection of rare adverse drug reactions, and many participating physicians are

  19. Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.

    PubMed

    Spelsberg, Angela; Prugger, Christof; Doshi, Peter; Ostrowski, Kerstin; Witte, Thomas; Hüsgen, Dieter; Keil, Ulrich

    2017-02-07

     To investigate the practice of post-marketing studies in Germany during a three year period and to evaluate whether these trials meet the aims specified in the German Medicinal Products Act.  Survey of notifications submitted to German regulatory agencies before post-marketing studies were carried out, 2008-10.  Notifications obtained through freedom of information requests to the three authorities responsible for registering post-marketing studies in Germany.  Descriptive statistics of post-marketing studies, including the products under study, intended number of patients, intended number of participating physicians, proposed remunerations, study plan and protocol, and availability of associated scientific publications and reports on adverse drug reactions.  Information was obtained from 558 studies, with a median of 600 (mean 2331, range 2-75 000) patients and 63 (270, 0-7000) participating physicians per study. The median remuneration to physicians per patient was €200 (€441, €0-€7280) (£170, £0-£6200; $215, $0-$7820), with a total remuneration cost of more than €217m for 558 studies registered over the three year period. The median remuneration per participating physician per study was €2000 (mean €19 424), ranging from €0 to €2 080 000. There was a broad range of drugs and non-drug products, of which only a third represented recently approved drugs. In many notifications, data, information, and results were, by contract, strictly confidential and the sole property of the respective sponsor. No single adverse drug reaction report could be identified from any of the 558 post-marketing studies. Less than 1% of studies could be verified as published in scientific journals.  Post-marketing studies are not improving drug safety surveillance. Sample sizes are generally too small to allow the detection of rare adverse drug reactions, and many participating physicians are strictly obliged to maintain confidentiality towards the

  20. Asthma: NIH-Sponsored Research and Clinical Trials | NIH MedlinePlus the Magazine

    MedlinePlus

    ... of this page please turn Javascript on. Feature: Asthma Asthma: NIH-Sponsored Research and Clinical Trials Past Issues / Fall 2011 Table of Contents NIH-Sponsored Research Asthma in the Inner City: Recognizing that asthma severity ...

  1. 45 CFR 2551.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... § 2551.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Senior Companion Program as specified...

  2. 45 CFR 2551.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... § 2551.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Senior Companion Program as specified...

  3. 45 CFR 2552.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... § 2552.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Foster Grandparent Program as...

  4. 45 CFR 2551.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... § 2551.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Senior Companion Program as specified...

  5. 45 CFR 2552.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... § 2552.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Foster Grandparent Program as...

  6. 45 CFR 2552.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... § 2552.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Foster Grandparent Program as...

  7. 45 CFR 2552.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... § 2552.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Foster Grandparent Program as...

  8. 45 CFR 2551.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... § 2551.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Senior Companion Program as specified...

  9. New Product Development. Engineering and Commerce Students Join Forces with a Corporate Sponsor.

    ERIC Educational Resources Information Center

    Audet, Josee; Pegna, Joseph

    2001-01-01

    Mechanical engineering and business student teams developed new products using a corporate sponsor's technology in a simulated business setting. Students learned about product development and venture start-up, and the sponsor gained new applications for its patented technology. (SK)

  10. 77 FR 69631 - Draft Guidance for IRBs, Clinical Investigators, and Sponsors: IRB Responsibilities for Reviewing...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-11-20

    ... HUMAN SERVICES Food and Drug Administration Draft Guidance for IRBs, Clinical Investigators, and Sponsors: IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research... availability of a draft guidance entitled ``Guidance for IRBs, Clinical Investigators, and Sponsors: IRB...

  11. New Product Development. Engineering and Commerce Students Join Forces with a Corporate Sponsor.

    ERIC Educational Resources Information Center

    Audet, Josee; Pegna, Joseph

    2001-01-01

    Mechanical engineering and business student teams developed new products using a corporate sponsor's technology in a simulated business setting. Students learned about product development and venture start-up, and the sponsor gained new applications for its patented technology. (SK)

  12. 45 CFR 2552.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... § 2552.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Foster Grandparent Program as specified...

  13. 45 CFR 2551.22 - What are the responsibilities of a sponsor?

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... § 2551.22 What are the responsibilities of a sponsor? A sponsor is responsible for fulfilling all project management requirements necessary to accomplish the purposes of the Senior Companion Program as specified in...

  14. Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis.

    PubMed

    Schroll, Jeppe Bennekou; Penninga, Elisabeth I; Gøtzsche, Peter C

    2016-08-01

    Little is known about how adverse events are summarised and reported in trials, as detailed information is usually considered confidential. We have acquired clinical study reports (CSRs) from the European Medicines Agency through the Freedom of Information Act. The CSRs describe the results of studies conducted as part of the application for marketing authorisation for the slimming pill orlistat. The purpose of this study was to study how adverse events were summarised and reported in study protocols, CSRs, and published papers of orlistat trials. We received the CSRs from seven randomised placebo controlled orlistat trials (4,225 participants) submitted by Roche. The CSRs consisted of 8,716 pages and included protocols. Two researchers independently extracted data on adverse events from protocols and CSRs. Corresponding published papers were identified on PubMed and adverse event data were extracted from this source as well. All three sources were compared. Individual adverse events from one trial were summed and compared to the totals in the summary report. None of the protocols or CSRs contained instructions for investigators on how to question participants about adverse events. In CSRs, gastrointestinal adverse events were only coded if the participant reported that they were "bothersome," a condition that was not specified in the protocol for two of the trials. Serious adverse events were assessed for relationship to the drug by the sponsor, and all adverse events were coded by the sponsor using a glossary that could be updated by the sponsor. The criteria for withdrawal due to adverse events were in one case related to efficacy (high fasting glucose led to withdrawal), which meant that one trial had more withdrawals due to adverse events in the placebo group. Finally, only between 3% and 33% of the total number of investigator-reported adverse events from the trials were reported in the publications because of post hoc filters, though six of seven papers

  15. Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis

    PubMed Central

    Schroll, Jeppe Bennekou; Penninga, Elisabeth I.; Gøtzsche, Peter C.

    2016-01-01

    Background Little is known about how adverse events are summarised and reported in trials, as detailed information is usually considered confidential. We have acquired clinical study reports (CSRs) from the European Medicines Agency through the Freedom of Information Act. The CSRs describe the results of studies conducted as part of the application for marketing authorisation for the slimming pill orlistat. The purpose of this study was to study how adverse events were summarised and reported in study protocols, CSRs, and published papers of orlistat trials. Methods and Findings We received the CSRs from seven randomised placebo controlled orlistat trials (4,225 participants) submitted by Roche. The CSRs consisted of 8,716 pages and included protocols. Two researchers independently extracted data on adverse events from protocols and CSRs. Corresponding published papers were identified on PubMed and adverse event data were extracted from this source as well. All three sources were compared. Individual adverse events from one trial were summed and compared to the totals in the summary report. None of the protocols or CSRs contained instructions for investigators on how to question participants about adverse events. In CSRs, gastrointestinal adverse events were only coded if the participant reported that they were “bothersome,” a condition that was not specified in the protocol for two of the trials. Serious adverse events were assessed for relationship to the drug by the sponsor, and all adverse events were coded by the sponsor using a glossary that could be updated by the sponsor. The criteria for withdrawal due to adverse events were in one case related to efficacy (high fasting glucose led to withdrawal), which meant that one trial had more withdrawals due to adverse events in the placebo group. Finally, only between 3% and 33% of the total number of investigator-reported adverse events from the trials were reported in the publications because of post hoc

  16. Federally Sponsored Multidisciplinary Research Centers: Learning, Evaluation, and Vicious Circles

    ERIC Educational Resources Information Center

    Youtie, Jan; Corley, Elizabeth A.

    2011-01-01

    Despite the increasing investment in multi-year federally funded science and technology centers in universities, there are few studies of how these centers engage in learning and change based on information submitted from various agents in the oversight and evaluation process. One challenge is how to manage and respond to this evaluative…

  17. Federally Sponsored Multidisciplinary Research Centers: Learning, Evaluation, and Vicious Circles

    ERIC Educational Resources Information Center

    Youtie, Jan; Corley, Elizabeth A.

    2011-01-01

    Despite the increasing investment in multi-year federally funded science and technology centers in universities, there are few studies of how these centers engage in learning and change based on information submitted from various agents in the oversight and evaluation process. One challenge is how to manage and respond to this evaluative…

  18. 14 CFR 60.2 - Applicability of sponsor rules to persons who are not sponsors and who are engaged in certain...

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION (CONTINUED) AIRMEN FLIGHT SIMULATION TRAINING DEVICE INITIAL AND CONTINUING QUALIFICATION AND USE § 60.2 Applicability of sponsor...

  19. The uncertainty principle and industry-sponsored research.

    PubMed

    Djulbegovic, B; Lacevic, M; Cantor, A; Fields, K K; Bennett, C L; Adams, J R; Kuderer, N M; Lyman, G H

    2000-08-19

    Reporting of pharmaceutical-industry-sponsored randomised clinical trials often result in biased findings, either due to selective reporting of studies with non-equivalent arms or publication of low-quality papers, wherein unfavourable results are incompletely described. A randomised trial should be conducted only if there is substantial uncertainty about the relative value of one treatment versus another. Studies in which intervention and control are thought to be non-equivalent violates the uncertainty principle. We examined the quality of 136 published randomised trials that focused on one disease category (multiple myeloma) and adherence to the uncertainty principle. To evaluate whether the uncertainty principle was upheld, we compared the number of studies favouring experimental treatments over standard ones. We analysed data according to the source of funding. Trials funded solely or in part by 35 profit-making organisations had a trend toward higher quality scores (mean 2.94 [SD 1.3]; median 3) than randomised trials supported by 95 governmental or other non-profit organisations (2.4 [0.8]; 2; p=0.06). Overall, the uncertainty principle was upheld, with 44% of randomised trials favouring standard treatments and 56% innovative treatments (p=0.17); mean and median preference evaluation scores were 3.7 (1.0) and 4. However, when the analysis was done according to the source of funding, studies funded by non-profit organisations maintained equipoise favouring new therapies over standard ones (47% vs 53%; p=0.608) to a greater extent than randomised trials supported solely or in part by profit-making organisations (74% vs 26%; p=0.004). The reported bias in research sponsored by the pharmaceutical industry may be a consequence of violations of the uncertainty principle. Sponsors of clinical trials should be encouraged to report all results and to choose appropriate comparative controls.

  20. 75 FR 15401 - Information Collection; Online Registration for FSA-sponsored Events and Conferences

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-29

    ... Farm Service Agency Information Collection; Online Registration for FSA-sponsored Events and... associated with online registration for FSA- sponsored events and conferences. The information collection is... and reservations to attend any FSA-sponsored conferences and events. DATES: Comments must be...

  1. 78 FR 16649 - Information Collection; Online Registration for FSA-sponsored Events and Conferences

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-18

    ... Farm Service Agency Information Collection; Online Registration for FSA-sponsored Events and... associated with online registration for FSA- sponsored events and conferences. The information collection is... and reservations to attend any FSA-sponsored conferences and events. DATES: We will consider...

  2. 75 FR 20522 - New Animal Drugs; Change of Sponsor's Name and Address

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-20

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Part 510 New Animal Drugs; Change of Sponsor's Name... Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Minrad, Inc. to Piramal Critical Care, Inc. The sponsor's mailing address will also be changed. DATES:...

  3. 29 CFR 4043.62 - Change in contributing sponsor or controlled group.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 29 Labor 9 2014-07-01 2014-07-01 false Change in contributing sponsor or controlled group. 4043.62... § 4043.62 Change in contributing sponsor or controlled group. (a) Reportable event and information required. Advance notice is required for a change in a plan's contributing sponsor or controlled group,...

  4. 75 FR 66304 - New Animal Drugs; Change of Sponsor; Monensin Blocks

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-10-28

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510 and 520 New Animal Drugs; Change of Sponsor... Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor from Farmland... is not currently listed in the animal drug regulations as a sponsor of an approved application...

  5. 42 CFR 423.553 - Effect of leasing of a PDP sponsor's facilities.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 3 2010-10-01 2010-10-01 false Effect of leasing of a PDP sponsor's facilities... Change of Ownership or Leasing of Facilities During Term of Contract § 423.553 Effect of leasing of a PDP sponsor's facilities. (a) General effect of leasing. If a PDP sponsor leases all or part of its...

  6. 14 CFR 151.51 - Performance of construction work: Sponsor force account.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... force account. 151.51 Section 151.51 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT... Development Projects § 151.51 Performance of construction work: Sponsor force account. (a) Before undertaking any force account construction work, the sponsor (or any public agency acting as agent for the sponsor...

  7. 14 CFR 151.51 - Performance of construction work: Sponsor force account.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... force account. 151.51 Section 151.51 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT... Development Projects § 151.51 Performance of construction work: Sponsor force account. (a) Before undertaking any force account construction work, the sponsor (or any public agency acting as agent for the sponsor...

  8. 14 CFR 151.51 - Performance of construction work: Sponsor force account.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... force account. 151.51 Section 151.51 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT... Development Projects § 151.51 Performance of construction work: Sponsor force account. (a) Before undertaking any force account construction work, the sponsor (or any public agency acting as agent for the sponsor...

  9. 14 CFR 151.51 - Performance of construction work: Sponsor force account.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... force account. 151.51 Section 151.51 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT... Development Projects § 151.51 Performance of construction work: Sponsor force account. (a) Before undertaking any force account construction work, the sponsor (or any public agency acting as agent for the sponsor...

  10. 14 CFR 151.51 - Performance of construction work: Sponsor force account.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... force account. 151.51 Section 151.51 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT... Development Projects § 151.51 Performance of construction work: Sponsor force account. (a) Before undertaking any force account construction work, the sponsor (or any public agency acting as agent for the sponsor...

  11. 7 CFR 226.12 - Administrative payments to sponsoring organizations for day care homes.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 4 2011-01-01 2011-01-01 false Administrative payments to sponsoring organizations... CARE FOOD PROGRAM Payment Provisions § 226.12 Administrative payments to sponsoring organizations for day care homes. (a) General. Sponsoring organizations for day care homes shall receive payments for...

  12. 7 CFR 226.12 - Administrative payments to sponsoring organizations for day care homes.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 4 2010-01-01 2010-01-01 false Administrative payments to sponsoring organizations... CARE FOOD PROGRAM Payment Provisions § 226.12 Administrative payments to sponsoring organizations for day care homes. (a) General. Sponsoring organizations for day care homes shall receive payments for...

  13. 44 CFR 208.34 - Agreements between Sponsoring Agencies and others.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 44 Emergency Management and Assistance 1 2011-10-01 2011-10-01 false Agreements between Sponsoring... SYSTEM Response Cooperative Agreements § 208.34 Agreements between Sponsoring Agencies and others. Sponsoring Agencies are responsible for executing such agreements with Participating Agencies and Affiliated...

  14. 44 CFR 208.34 - Agreements between Sponsoring Agencies and others.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 44 Emergency Management and Assistance 1 2010-10-01 2010-10-01 false Agreements between Sponsoring... SYSTEM Response Cooperative Agreements § 208.34 Agreements between Sponsoring Agencies and others. Sponsoring Agencies are responsible for executing such agreements with Participating Agencies and Affiliated...

  15. 44 CFR 208.9 - Agreements between Sponsoring Agencies and Participating Agencies.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 44 Emergency Management and Assistance 1 2011-10-01 2011-10-01 false Agreements between Sponsoring... RESCUE RESPONSE SYSTEM General § 208.9 Agreements between Sponsoring Agencies and Participating Agencies. Every agreement between a Sponsoring Agency and a Participating Agency regarding the System must include...

  16. 7 CFR 226.13 - Food service payments to sponsoring organizations for day care homes.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 4 2011-01-01 2011-01-01 false Food service payments to sponsoring organizations for... CARE FOOD PROGRAM Payment Provisions § 226.13 Food service payments to sponsoring organizations for day care homes. (a) Payments shall be made only to sponsoring organizations operating under an agreement...

  17. 31 CFR 1030.320 - Reports by housing government sponsored enterprises of suspicious transactions.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 31 Money and Finance:Treasury 3 2014-07-01 2014-07-01 false Reports by housing government... TREASURY RULES FOR HOUSING GOVERNMENT SPONSORED ENTERPRISES Reports Required To Be Made by Housing Government Sponsored Enterprises § 1030.320 Reports by housing government sponsored enterprises of...

  18. Employer-sponsored health insurance and the gender wage gap.

    PubMed

    Cowan, Benjamin; Schwab, Benjamin

    2016-01-01

    During prime working years, women have higher expected healthcare expenses than men. However, employees' insurance rates are not gender-rated in the employer-sponsored health insurance (ESI) market. Thus, women may experience lower wages in equilibrium from employers who offer health insurance to their employees. We show that female employees suffer a larger wage gap relative to men when they hold ESI: our results suggest this accounts for roughly 10% of the overall gender wage gap. For a full-time worker, this pay gap due to ESI is on the order of the expected difference in healthcare expenses between women and men.

  19. Provider-sponsored HMOs: make, buy, or joint venture?

    PubMed

    Clay, S B

    1997-03-01

    Providers can sponsor their own HMOs in one of three ways: by creating their own HMO, by joint venturing with an existing HMO, or by purchasing an existing HMO. When selecting the best option, providers must consider various market conditions. Managed care penetration in the area, potential competitive responses of existing HMOs, market demand, provider reputation, and provider marketing ability will all influence the feasibility of each option. Providers also must examine their own organizational identity, their ability to raise the necessary capital to start an HMO, their managed care expertise and risk contracting experience, and their information systems capabilities.

  20. Ghost- and guest-authored pharmaceutical industry-sponsored studies: abuse of academic integrity, the peer review system, and public trust.

    PubMed

    Flaherty, Dennis K

    2013-01-01

    Industry-sponsored ghost- and guest-authored clinical research publications are a continuing problem in medical journals. These communications are written by unacknowledged medical communication companies and submitted to peer-reviewed journals by academicians who may not have participated in the writing process. These publications, which are used for marketing purposes, usually underestimate the adverse effects and medical risks associated with the products evaluated. Since peer-reviewed data are used to develop health care paradigms, misleading information can have catastrophic effects. A failure to curb ghost and guest authorship will result in an erosion of trust in the peer-review system, academic research, and health care paradigms.

  1. Continuing medical education: ethical collaboration between sponsor and industry.

    PubMed

    Wilson, Frederic S

    2003-07-01

    The quandary is, "How can the very different fiduciary responsibilities of physicians and pharmaceutical companies ethically coexist in a society where its healthcare system is under increasing financial scrutiny?" It is paradoxical that the number of states requiring continuing medical education for medical licensure has increased to 39, in the face of reduced federal funding and the squeeze of managed care. Despite industry's providing more than half of the funding required to sustain the increasing need for continuing medical education, some physicians claim it is inappropriate for continuing medical education sponsors to collaborate with pharmaceutical companies because of their vested interest in selling prescription medications. Is the integrity of the physician-patient relationship at risk? I will show that there are ethical standards in place, for professionals and industry, that are effectively maintaining the continuing medical education system in balance. Eliminating the current opportunities for collaboration between sponsors and commercial supporters would severely compromise the continuing medical education enterprise in the United States, ultimately, a disservice to patients, who expect their physicians to continue their medical education lifelong.

  2. Optical engineering capstone design projects with industry sponsors

    NASA Astrophysics Data System (ADS)

    Bunch, Robert M.; Leisher, Paul O.; Granieri, Sergio C.

    2014-09-01

    Capstone senior design is the culmination of a student's undergraduate engineering education that prepares them for engineering practice. In fact, any engineering degree program that pursues accreditation by the Engineering Accreditation Commission of ABET must contain "a major design experience based on the knowledge and skills acquired in earlier course work and incorporating appropriate engineering standards and multiple realistic constraints." At Rose-Hulman, we offer an interdisciplinary Optical Engineering / Engineering Physics senior design curriculum that meets this requirement. Part of this curriculum is a two-course sequence where students work in teams on a design project leading to a functional prototype. The students begin work on their capstone project during the first week of their senior year. The courses are deliverable-driven and the students are held accountable for regular technical progress through weekly updates with their faculty advisor and mid-term design reviews. We have found that client-sponsored projects offer students an enriched engineering design experience as it ensures consideration of constraints and standards requirements similar to those that they will encounter as working engineers. Further, client-sponsored projects provide teams with an opportunity for regular customer interactions which help shape the product design. The process that we follow in both soliciting and helping to scope appropriate industry-related design projects will be described. In addition, an outline of the capstone course structure as well as methods used to hold teams accountable for technical milestones will be discussed. Illustrative examples of past projects will be provided.

  3. Viewpoint: professional integrity in industry-sponsored clinical trials.

    PubMed

    Miller, Franklin G; Brody, Howard

    2005-10-01

    Evidence-based medicine (EBM) relies on accurate data derived from well-designed, clinically relevant randomized controlled trials (RCTs). Most randomized trials, however, are conducted by industry sponsors aiming at licensing and marketing drugs, which may weaken the usefulness of the findings to EBM. Disturbing evidence has emerged of widespread biases in industry-sponsored trials, including publication bias, selective reporting of findings, and distorted interpretation of results. These practices compromise the professional integrity of physician-investigators who contribute to them. In turn, the well-being of patients participating in RCTs may be jeopardized, and the evidence base upon which EBM is practiced may be corrupted. Regulatory reform alone will be inadequate to resolve these problems; attention must also be paid to physicians' professionalism. The authors recommend a change in the culture of academic medicine whereby physician-investigators who maintain professional integrity are rewarded or recognized. Educational interventions promoting integrity in clinical research may be one part of affecting such change.

  4. Medical Malpractice Reform and Employer-Sponsored Health Insurance Premiums

    PubMed Central

    Morrisey, Michael A; Kilgore, Meredith L; Nelson, Leonard (Jack)

    2008-01-01

    Objective Tort reform may affect health insurance premiums both by reducing medical malpractice premiums and by reducing the extent of defensive medicine. The objective of this study is to estimate the effects of noneconomic damage caps on the premiums for employer-sponsored health insurance. Data Sources/Study Setting Employer premium data and plan/establishment characteristics were obtained from the 1999 through 2004 Kaiser/HRET Employer Health Insurance Surveys. Damage caps were obtained and dated based on state annotated codes, statutes, and judicial decisions. Study Design Fixed effects regression models were run to estimate the effects of the size of inflation-adjusted damage caps on the weighted average single premiums. Data Collection/Extraction Methods State tort reform laws were identified using Westlaw, LEXIS, and statutory compilations. Legislative repeal and amendment of statutes and court decisions resulting in the overturning or repealing state statutes were also identified using LEXIS. Principal Findings Using a variety of empirical specifications, there was no statistically significant evidence that noneconomic damage caps exerted any meaningful influence on the cost of employer-sponsored health insurance. Conclusions The findings suggest that tort reforms have not translated into insurance savings. PMID:18522666

  5. Medical malpractice reform and employer-sponsored health insurance premiums.

    PubMed

    Morrisey, Michael A; Kilgore, Meredith L; Nelson, Leonard Jack

    2008-12-01

    Tort reform may affect health insurance premiums both by reducing medical malpractice premiums and by reducing the extent of defensive medicine. The objective of this study is to estimate the effects of noneconomic damage caps on the premiums for employer-sponsored health insurance. Employer premium data and plan/establishment characteristics were obtained from the 1999 through 2004 Kaiser/HRET Employer Health Insurance Surveys. Damage caps were obtained and dated based on state annotated codes, statutes, and judicial decisions. Fixed effects regression models were run to estimate the effects of the size of inflation-adjusted damage caps on the weighted average single premiums. State tort reform laws were identified using Westlaw, LEXIS, and statutory compilations. Legislative repeal and amendment of statutes and court decisions resulting in the overturning or repealing state statutes were also identified using LEXIS. Using a variety of empirical specifications, there was no statistically significant evidence that noneconomic damage caps exerted any meaningful influence on the cost of employer-sponsored health insurance. The findings suggest that tort reforms have not translated into insurance savings.

  6. Clinical research and industrial sponsoring: avenues towards transparency and credibility.

    PubMed

    Hildebrandt, M; Ludwig, W-D

    2003-12-01

    Clinical research is intended to serve the patient, in the pursuit of a deepened understanding of physiological interactions and their changes in disease, and of potentially beneficial implications for the patient. The impetus to perform clinical research is shaped by various intentions, such as the desire to provide cure or relief, striving for personal and professional success, public attention, financial considerations, or simply scientific curiosity. A similarly wide range of diverging interests must be assumed to impinge on diagnostic and therapeutic decisions in clinical work. How are we to perform clinical research and therapy with the patients' benefit in mind, in view of such a complex motivational status, and how are we to perceive the peculiar interests of those influencing clinical work, including ourselves? In this review, we attempt to elucidate the complex pathways of interaction between physicians and industrial sponsors. Special attention will be paid to the following topics: the pharmaceutical market, public interests, legal and ethical issues, conflicts of interest, and the potential impact of industry-sponsored drug trials on medical information and subsequent therapeutic decisions. We will conclude with recommendations for an acceptable position in the tension between cooperation and corruptibility, a position that grants priority to the patient's needs rather than third party interests. Copyright 2003 S. Karger GmbH, Freiburg

  7. An editor's considerations in publishing industry-sponsored studies.

    PubMed

    Droller, Michael J

    2015-03-01

    The fundamental responsibility of a journal editor is to assure that studies accepted for publication provide rigorous original scientific information and reviews that are considered important to the readership. The fundamental requirements of such reports from an editor's perspective include objectivity and transparency in each of the study design, implementation of investigation methods, acquisition of data, inclusive analysis and interpretation of results, appropriate application of statistical methods, presentation of outcomes in the context of a balanced and comprehensive review of relevant literature, and meaningful conclusions. In proceeding on these presumptions, editors then have the responsibility of obtaining rigorous, objective, and constructive reviews of these reports so that they can make an unbiased decision regarding their disposition. The fundamental objective in this is to enhance the ultimate scientific validity and value of the work if and when it is accepted for publication. Guidelines have been advanced by several organizations to identify how such editorial responsibilities can be fulfilled. These guidelines also pertain to investigators, authors, and sponsors of the studies, which the various reports and reviews describe. The present article reviews these guidelines as they relate to both industry-sponsored and investigator-initiated investigations and as relevant to the variety of reports that a scientific/medical journal such as Urologic Oncology: Seminars and Original Investigations receives for publication.

  8. 41 CFR 301-74.8 - Who may authorize reimbursement of the conference lodging allowance for a Government sponsored...

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ...? The approval authority for the conference lodging allowance is the Government agency sponsoring the conference. The sponsoring agency will determine the appropriate conference lodging allowance, up to 25... a senior agency official at the sponsoring agency. ...

  9. 41 CFR 301-74.8 - Who may authorize reimbursement of the conference lodging allowance for a Government sponsored...

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ...? The approval authority for the conference lodging allowance is the Government agency sponsoring the conference. The sponsoring agency will determine the appropriate conference lodging allowance, up to 25... a senior agency official at the sponsoring agency. ...

  10. An Exploratory Investigation of Important Qualities and Characteristics of Alcoholics Anonymous Sponsors.

    PubMed

    Stevens, Edward B; Jason, Leonard A

    Alcoholics Anonymous recommends members to have sponsors, especially those early in their recovery, yet little research has been done on the qualities of an effective sponsor. 245 adults (117 females, 128 males) currently in substance use disorder recovery participated. 231 of these individuals had experience as a sponsor, sponsee or both (109 had experience as a sponsor). Qualitative results suggest effective sponsors are currently engaged in the program on a personal level, are trustworthy, and are available although a wide variety of attributes were cited. In a choice and ranking exercise, 12- step engagement and qualities of character were also most often ranked highly. No significant differences were found between genders or sponsor/sponsee roles. Implications based on breadth of responses and dominant themes are discussed as well as the need for further research on sponsor/sponsee characteristics, satisfaction, and recovery outcomes.

  11. 31 CFR 1010.711 - Submitting requests.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 31 Money and Finance:Treasury 3 2011-07-01 2011-07-01 false Submitting requests. 1010.711 Section 1010.711 Money and Finance: Treasury Regulations Relating to Money and Finance (Continued) FINANCIAL....711 Submitting requests. (a) Each request for an administrative ruling must be in writing and contain...

  12. 31 CFR 1010.711 - Submitting requests.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 31 Money and Finance:Treasury 3 2013-07-01 2013-07-01 false Submitting requests. 1010.711 Section 1010.711 Money and Finance: Treasury Regulations Relating to Money and Finance (Continued) FINANCIAL....711 Submitting requests. (a) Each request for an administrative ruling must be in writing and contain...

  13. 31 CFR 1010.711 - Submitting requests.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 31 Money and Finance:Treasury 3 2014-07-01 2014-07-01 false Submitting requests. 1010.711 Section 1010.711 Money and Finance: Treasury Regulations Relating to Money and Finance (Continued) FINANCIAL....711 Submitting requests. (a) Each request for an administrative ruling must be in writing and contain...

  14. 31 CFR 1010.711 - Submitting requests.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 31 Money and Finance:Treasury 3 2012-07-01 2012-07-01 false Submitting requests. 1010.711 Section 1010.711 Money and Finance: Treasury Regulations Relating to Money and Finance (Continued) FINANCIAL....711 Submitting requests. (a) Each request for an administrative ruling must be in writing and contain...

  15. Problematic protocols: An overview of medical research protocols not approved by the LUMC medical ethics review committee.

    PubMed

    Tersmette, Derek Gideon; Engberts, Dirk Peter

    2017-01-01

    The Committee for Medical Ethics (CME) of Leiden University Medical Center (LUMC) was established as the first medical ethics reviewing committee (MREC) in the Netherlands. In the period 2000-2010 the CME received 2,162 protocols for review. Some of these protocols were never approved. Until now, there has existed neither an overview of these failed protocols nor an overview of the reasons for their failure. This report draws on data from the digital database, the physical archives, and the minutes of the meetings of the CME. Additional information has been obtained from the Central Committee on Research involving Human Subjects (CCRH) and survey-based research. Protocols were itemized based on characteristic features and their reviewing procedures were analyzed. In total, 1,952 out of 2,162 research protocols submitted during 2000-2010 (90.3%) were approved by the CME; 210 of 2,162 protocols (9.7%) were not approved. Of these 210 protocols, 177 failed due to reasons not related to CME reviewing. In 15 cases CME reviewing led to protocol failure, while another 10 protocols were rejected outright. Eight of the 210 submitted protocols without approval had been conducted prior to submission. In the aforementioned period, little protocol failure occurred. For the most part, protocol failure was caused by problems that are not CME related. This type of failure has several identifiable factors, none of which have anything to do with the ethical reviewing procedure by the CME. A mere 1.2% of protocols failed due to ethical review. Unacceptable burden and risks to the subject and an inadequate methodology are the most common reasons for this CME-related protocol failure.

  16. 21 CFR 822.14 - May I reference information previously submitted instead of submitting it again?

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false May I reference information previously submitted instead of submitting it again? 822.14 Section 822.14 Food and Drugs FOOD AND DRUG ADMINISTRATION..., you may reference information that you have submitted in premarket submissions as well as...

  17. Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials.

    PubMed

    Abrams, Jeffrey S; Mooney, Margaret M; Zwiebel, James A; Korn, Edward L; Friedman, Steven H; Finnigan, Shanda R; Schettino, Patricia R; Denicoff, Andrea M; Kruhm, Martha G; Montello, Mike; Misra, R Rita; Ansher, Sherry S; DiPiazza, Kate J; Souhan, Erin M; Wickerham, D Lawrence; Giantonio, Bruce J; O'Donnell, Robert T; Sullivan, Daniel M; Soto, Nancy I; Fleming, Gini F; Prindiville, Sheila A; Petryshyn, Ray A; Hautala, Judith A; Grad, Oren; Zuckerman, Brian L; Meyer, Ralph M; Yao, James C; Baker, Laurence A; Buckner, Jan C; Hortobagyi, Gabriel N; Doroshow, James H

    2013-07-03

    The National Cancer Institute (NCI) organized the Operational Efficiency Working Group in 2008 to develop recommendations for improving the speed with which NCI-sponsored clinical trials move from the idea stage to a protocol open to patient enrollment. Given the many stakeholders involved, the Operational Efficiency Working Group advised a multifaceted approach to mobilize the entire research community to improve their business processes. New staff positions to monitor progress, protocol-tracking Web sites, and strategically planned conference calls were implemented. NCI staff and clinical teams at Cooperative Groups and Cancer Centers strived to achieve new target timelines but, most important, agreed to abide by absolute deadlines. For phase I-II studies and phase III studies, the target timelines are 7 months and 10 months, whereas the absolute deadlines were set at 18 and 24 months, respectively. Trials not activated by the absolute deadline are automatically disapproved. The initial experience is encouraging and indicates a reduction in development times for phase I-II studies from the historical median of 541 days to a median of 442 days, an 18.3% decrease. The experience with phase III studies to date, although more limited (n = 25), demonstrates a 45.7% decrease in median days. Based upon this progress, the NCI and the investigator community have agreed to reduce the absolute deadlines to 15 and 18 months for phase I-II and III trials, respectively. Emphasis on initiating trials rapidly is likely to help reduce the time it takes for clinical trial results to reach patients in need of new treatments.

  18. Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute–Sponsored Trials

    PubMed Central

    2013-01-01

    Background The National Cancer Institute (NCI) organized the Operational Efficiency Working Group in 2008 to develop recommendations for improving the speed with which NCI-sponsored clinical trials move from the idea stage to a protocol open to patient enrollment. Methods Given the many stakeholders involved, the Operational Efficiency Working Group advised a multifaceted approach to mobilize the entire research community to improve their business processes. New staff positions to monitor progress, protocol-tracking Web sites, and strategically planned conference calls were implemented. NCI staff and clinical teams at Cooperative Groups and Cancer Centers strived to achieve new target timelines but, most important, agreed to abide by absolute deadlines. For phase I–II studies and phase III studies, the target timelines are 7 months and 10 months, whereas the absolute deadlines were set at 18 and 24 months, respectively. Trials not activated by the absolute deadline are automatically disapproved. Results The initial experience is encouraging and indicates a reduction in development times for phase I–II studies from the historical median of 541 days to a median of 442 days, an 18.3% decrease. The experience with phase III studies to date, although more limited (n = 25), demonstrates a 45.7% decrease in median days. Conclusions Based upon this progress, the NCI and the investigator community have agreed to reduce the absolute deadlines to 15 and 18 months for phase I–II and III trials, respectively. Emphasis on initiating trials rapidly is likely to help reduce the time it takes for clinical trial results to reach patients in need of new treatments. PMID:23776198

  19. DOE-sponsored cable aging research at Sandia National Laboratories

    SciTech Connect

    Gillen, K.T.; Clough, R.L.; Celina, M.; Wise, J.; Malone, G.M.

    1995-12-01

    Cables have been identified as critical components requiring detailed technical evaluation for extending the lifetime of Light Water Reactors beyond 40 years. This paper highlights some of the DOE-sponsored cable aging studies currently underway at Sandia. These studies are focused on two important issues: the validity of the often-used Arrhenius thermal aging prediction method and methods for predicting lifetimes in combined thermal-radiation environments. Accelerated thermal aging results are presented for three cable jacket and insulation materials, which indicate that hardening of the outside surface has an Arrhenius temperature dependence and correlates well with reductions in ultimate tensile elongation. This suggests that the indentor approach is a promising NDE technique for cable jacket and unjacketed insulation materials installed in thermally-dominated regions of nuclear power plants.

  20. Assessing the Financial Condition of Provider-Sponsored Health Plans.

    PubMed

    McCue, Michael J

    2015-06-01

    The aim of this study was to assess the performance of health plans sponsored by provider organizations, with respect to plans generating strong positive cash flow relative to plans generating weaker cash flow. A secondary aim was to assess their capital adequacy. The study identified 24 provider-sponsored health plans (PSHPs) with an average positive cash flow margin from 2011 through 2013 at or above the top 75th percentile, defined as "strong cash flow PSHPs:" This group was compared with 72 PSHPs below the 75th percentile, defined as "weak cash flow PSHPs:" Atlantic Information Services Directory of Health Plans was used to identify the PSHPs. Financial ratios were computed from 2013 National Association of Insurance Commissioners Financial Filings. The study conducted a t test mean comparison between strong and weak cash flow PSHPs across an array of financial performance and capital adequacy measures. In 2013, the strong cash flow PSHPs averaged a cash-flow margin ratio of 6.6%. Weak cash flow PSHPs averaged a cash-flow margin of -0.4%. The net worth capital position of both groups was more than 4.5 times authorized capital. The operational analysis shows that strong cash-flow margin PSHPs are managing their medical costs to achieve this position. Although their medical loss ratio increased by almost 300 basis points from 2011 to 2013, it was still statistically significantly lower than the weaker cash flow PSHP group (P<.001). In terms of capital adequacy, both strong and weak cash-flow margin PSHP groups possessed sufficient capital to ensure the viability of these plans.

  1. Protocol Coordinator II | Center for Cancer Research

    Cancer.gov

    •        Provides programmatic and logistical support for the operations of clinical research for Phase I and Phase II clinical trials •        Provides deployment of clinical support services for clinical research  •        Streamlines protocol development timeline •        Provides data and document collection and compilation for regulatory filing with the FDA and other regulatory authorities •        Provides technical review and report preparation •        Provides administrative coordination and general logistical support for regulatory activities •        Ensures the provision of training for investigators and associate staff to reinforce and enhance a GCP culture •        Provides quality assurance and quality control oversight •        Performs regulatory review of clinical protocols, informed consent and other clinical documents  •        Tracks and facilitates a portfolio of protocols through each process step (IRB, RAC, DSMB, Office of Protocol Services) •        Assists clinical investigators in preparing clinical research protocols, including writing and formatting protocol documents and consent forms •        Prepares protocol packages for review and ensures that protocol packages include all the required material and comply with CCR, NCI and NIH policies •        Collaborates with investigators to resolve any protocol/data issues •        Coordinates submission of protocols for scientific and ethical review by the Branch scientific review committees, the NCI Institutional Review Board (IRB) and the clinical trial sponsor or the FDA •        Monitors the review process and maintains detailed, complete and accurate records for each protocol of the approvals at the various stages of the review process, including new protocol submissions, amendments to protocols, and continuing reviews, as well as other submissions such

  2. "Food company sponsors are kind, generous and cool": (Mis)conceptions of junior sports players

    PubMed Central

    2011-01-01

    Background Children's exposure to unhealthy food marketing influences their food knowledge, preferences and consumption. Sport sponsorship by food companies is widespread and industry investment in this marketing is increasing. This study aimed to assess children's awareness of sport sponsors and their brand-related attitudes and purchasing intentions in response to this marketing. Methods Sports clubs known to have food sponsors and representing the most popular sports for Australian children across a range of demographic areas were recruited. Interview-based questionnaires were conducted at clubs with children aged 10-14 years (n = 103) to examine their recall of local sports club and elite sport sponsors, and their attitudes towards sponsors and sponsorship activities. Results Most children (68%) could recall sponsors of their sports club, naming a median of two sponsors, including a median of one food company sponsor each. Almost half (47%) of children could recall any sponsors of their favourite elite sporting team. Children aged 10-11 years were more likely than older children to report that they thought about sponsors when buying something to eat or drink (P < 0.01); that they liked to return the favour to sponsors by buying their products (P < 0.01); and that sponsors were 'cool' (P = 0.02). Most children had received a voucher or certificate from a food or beverage company to reward sport performance (86% and 76%, respectively). Around one-third of children reported liking the company more after receiving these rewards. Conclusions Children's high recall of food and beverage company sport sponsors and their positive attitudes towards these sponsors and their promotions is concerning as this is likely to be linked to children's food preferences and consumption. Limiting children's exposure to this marketing is an important initiative to improve children's nutrition. PMID:21888675

  3. "Food company sponsors are kind, generous and cool": (mis)conceptions of junior sports players.

    PubMed

    Kelly, Bridget; Baur, Louise A; Bauman, Adrian E; King, Lesley; Chapman, Kathy; Smith, Ben J

    2011-09-05

    Children's exposure to unhealthy food marketing influences their food knowledge, preferences and consumption. Sport sponsorship by food companies is widespread and industry investment in this marketing is increasing. This study aimed to assess children's awareness of sport sponsors and their brand-related attitudes and purchasing intentions in response to this marketing. Sports clubs known to have food sponsors and representing the most popular sports for Australian children across a range of demographic areas were recruited. Interview-based questionnaires were conducted at clubs with children aged 10-14 years (n = 103) to examine their recall of local sports club and elite sport sponsors, and their attitudes towards sponsors and sponsorship activities. Most children (68%) could recall sponsors of their sports club, naming a median of two sponsors, including a median of one food company sponsor each. Almost half (47%) of children could recall any sponsors of their favourite elite sporting team. Children aged 10-11 years were more likely than older children to report that they thought about sponsors when buying something to eat or drink (P < 0.01); that they liked to return the favour to sponsors by buying their products (P < 0.01); and that sponsors were 'cool' (P = 0.02). Most children had received a voucher or certificate from a food or beverage company to reward sport performance (86% and 76%, respectively). Around one-third of children reported liking the company more after receiving these rewards. Children's high recall of food and beverage company sport sponsors and their positive attitudes towards these sponsors and their promotions is concerning as this is likely to be linked to children's food preferences and consumption. Limiting children's exposure to this marketing is an important initiative to improve children's nutrition.

  4. 44 CFR 208.9 - Agreements between Sponsoring Agencies and Participating Agencies.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY DISASTER ASSISTANCE NATIONAL URBAN SEARCH AND RESCUE RESPONSE SYSTEM General § 208.9 Agreements between Sponsoring Agencies and Participating Agencies...

  5. 44 CFR 208.9 - Agreements between Sponsoring Agencies and Participating Agencies.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY DISASTER ASSISTANCE NATIONAL URBAN SEARCH AND RESCUE RESPONSE SYSTEM General § 208.9 Agreements between Sponsoring Agencies and Participating Agencies...

  6. 44 CFR 208.9 - Agreements between Sponsoring Agencies and Participating Agencies.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY DISASTER ASSISTANCE NATIONAL URBAN SEARCH AND RESCUE RESPONSE SYSTEM General § 208.9 Agreements between Sponsoring Agencies and Participating Agencies...

  7. 44 CFR 208.9 - Agreements between Sponsoring Agencies and Participating Agencies.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    .... Every agreement between a Sponsoring Agency and a Participating Agency regarding the System must include... EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY DISASTER ASSISTANCE NATIONAL URBAN SEARCH AND...

  8. Preparing, Submitting, and Tracking a Grant Application

    Cancer.gov

    Information compiled by NCI's Epidemiology and Genomics Research Program to help investigators learn more about NIH and NCI information and policies related to writing and submitting new, resubmission, late, and renewal grant applications.

  9. 5 CFR 1205.31 - Submitting appeal.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... REGULATIONS Appeals § 1205.31 Submitting appeal. (a) A partial or complete denial, by the Clerk of the Board... appealed to the Chairman, Merit Systems Protection Board, 1615 M Street, NW., Washington, DC...

  10. 5 CFR 1205.31 - Submitting appeal.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... REGULATIONS Appeals § 1205.31 Submitting appeal. (a) A partial or complete denial, by the Clerk of the Board... appealed to the Chairman, Merit Systems Protection Board, 1615 M Street, NW., Washington, DC...

  11. 5 CFR 1205.31 - Submitting appeal.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... REGULATIONS Appeals § 1205.31 Submitting appeal. (a) A partial or complete denial, by the Clerk of the Board... appealed to the Chairman, Merit Systems Protection Board, 1615 M Street, NW., Washington, DC...

  12. 5 CFR 1205.31 - Submitting appeal.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... REGULATIONS Appeals § 1205.31 Submitting appeal. (a) A partial or complete denial, by the Clerk of the Board... appealed to the Chairman, Merit Systems Protection Board, 1615 M Street, NW., Washington, DC...

  13. RMP*eSubmit Users' Manual

    EPA Pesticide Factsheets

    RMP*eSubmit facilitates secure online Risk Management Plan updates/resubmissions, required at least every 5 years. Reporting requirements have not changed since 2004, but the 2012 version of North American Industry Classification System has been integrated

  14. Tribal Resource Institute in Business, Engineering, and Science (T.R.I.B.E.S.). Part I, TRIBES Energy and Resource Management Simulation. Part II, Creative Writing--Essays submitted by the T.R.I.B.E.S. Students.

    ERIC Educational Resources Information Center

    Veirs, Val; And Others

    The expository and creaive writing of Native American high school students enrolled in a summer program at Colorado College sponsored by TRIBES (Tribal Resource Institute in Business, Engineering, and Science) is featured in this document. Part 1 presents a simulation problem in energy and resource management followed by reports submitted by 28…

  15. Tribal Resource Institute in Business, Engineering, and Science (T.R.I.B.E.S.). Part I, TRIBES Energy and Resource Management Simulation. Part II, Creative Writing--Essays submitted by the T.R.I.B.E.S. Students.

    ERIC Educational Resources Information Center

    Veirs, Val; And Others

    The expository and creaive writing of Native American high school students enrolled in a summer program at Colorado College sponsored by TRIBES (Tribal Resource Institute in Business, Engineering, and Science) is featured in this document. Part 1 presents a simulation problem in energy and resource management followed by reports submitted by 28…

  16. Quantifying and Mitigating Privacy Threats in Wireless Protocols and Services

    DTIC Science & Technology

    2009-07-01

    Quantifying and Mitigating Privacy Threats in Wireless Protocols and Services Jeffrey Anson Pang CMU-CS-09-145 July 2009 School of Computer Science...of Washington Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy. Copyright c© 2009 Jeffrey Anson Pang This

  17. Corporate sponsored education initiatives on board the ISS

    NASA Astrophysics Data System (ADS)

    Durham, Ian T.; Durham, Alyson S.; Pawelczyk, James A.; Brod, Lawrence B.; Durham, Thomas F.

    1999-01-01

    This paper proposes the creation of a corporate sponsored ``Lecture from Space'' program on board the International Space Station (ISS) with funding coming from a host of new technology and marketing spin-offs. This program would meld existing education initiatives in NASA with new corporate marketing techniques. Astronauts in residence on board the ISS would conduct short ten to fifteen minute live presentations and/or conduct interactive discussions carried out by a teacher in the classroom. This concept is similar to a program already carried out during the Neurolab mission on Shuttle flight STS-90. Building on that concept, the interactive simulcasts would be broadcast over the Internet and linked directly to computers and televisions in classrooms worldwide. In addition to the live broadcasts, educational programs and demonstrations can be recorded in space, and marketed and sold for inclusion in television programs, computer software, and other forms of media. Programs can be distributed directly into classrooms as an additional presentation supplement, as well as over the Internet or through cable and broadcast television, similar to the Canadian Discovery Channel's broadcasts of the Neurolab mission. Successful marketing and advertisement can eventually lead to the creation of an entirely new, privately run cottage industry involving the distribution and sale of educationally related material associated with the ISS that would have the potential to become truly global in scope. By targeting areas of expertise and research interest in microgravity, a large curriculum could be developed using space exploration as a unifying theme. Expansion of this concept could enhance objectives already initiated through the International Space University to include elementary and secondary school students. The ultimate goal would be to stimulate interest in space and space related sciences in today's youth through creative educational marketing initiatives while at the

  18. 42 CFR 440.350 - Employer-sponsored insurance health plans.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 4 2011-10-01 2011-10-01 false Employer-sponsored insurance health plans. 440.350 Section 440.350 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN... Benchmark-Equivalent Coverage § 440.350 Employer-sponsored insurance health plans. (a) A State may...

  19. 31 CFR 1030.210 - Anti-money laundering programs for housing government sponsored enterprises.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... housing government sponsored enterprises. 1030.210 Section 1030.210 Money and Finance: Treasury Regulations Relating to Money and Finance (Continued) FINANCIAL CRIMES ENFORCEMENT NETWORK, DEPARTMENT OF THE TREASURY RULES FOR HOUSING GOVERNMENT SPONSORED ENTERPRISES Programs § 1030.210 Anti-money...

  20. A Case Study of Teaching Marketing Research Using Client-Sponsored Projects: Method, Challenges, and Benefits

    ERIC Educational Resources Information Center

    Bove, Liliana L.; Davies, W. Martin

    2009-01-01

    This case study outlines the use of client-sponsored research projects in a quantitative postgraduate marketing research subject conducted in a 12-week semester in a research-intensive Australian university. The case study attempts to address the dearth of recent literature on client-sponsored research projects in the discipline of marketing.…

  1. A Case Study of Teaching Marketing Research Using Client-Sponsored Projects: Method, Challenges, and Benefits

    ERIC Educational Resources Information Center

    Bove, Liliana L.; Davies, W. Martin

    2009-01-01

    This case study outlines the use of client-sponsored research projects in a quantitative postgraduate marketing research subject conducted in a 12-week semester in a research-intensive Australian university. The case study attempts to address the dearth of recent literature on client-sponsored research projects in the discipline of marketing.…

  2. 25 CFR 170.175 - What Indian LTAP-sponsored transportation training and educational opportunities exist?

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 25 Indians 1 2013-04-01 2013-04-01 false What Indian LTAP-sponsored transportation training and... INTERIOR LAND AND WATER INDIAN RESERVATION ROADS PROGRAM Indian Reservation Roads Program Policy and Eligibility Indian Ltap-Sponsored Education and Training Opportunities § 170.175 What Indian...

  3. 25 CFR 170.175 - What Indian LTAP-sponsored transportation training and educational opportunities exist?

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 25 Indians 1 2011-04-01 2011-04-01 false What Indian LTAP-sponsored transportation training and... INTERIOR LAND AND WATER INDIAN RESERVATION ROADS PROGRAM Indian Reservation Roads Program Policy and Eligibility Indian Ltap-Sponsored Education and Training Opportunities § 170.175 What Indian...

  4. 25 CFR 170.175 - What Indian LTAP-sponsored transportation training and educational opportunities exist?

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 25 Indians 1 2012-04-01 2011-04-01 true What Indian LTAP-sponsored transportation training and... INTERIOR LAND AND WATER INDIAN RESERVATION ROADS PROGRAM Indian Reservation Roads Program Policy and Eligibility Indian Ltap-Sponsored Education and Training Opportunities § 170.175 What Indian...

  5. 25 CFR 170.175 - What Indian LTAP-sponsored transportation training and educational opportunities exist?

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 25 Indians 1 2014-04-01 2014-04-01 false What Indian LTAP-sponsored transportation training and... INTERIOR LAND AND WATER INDIAN RESERVATION ROADS PROGRAM Indian Reservation Roads Program Policy and Eligibility Indian Ltap-Sponsored Education and Training Opportunities § 170.175 What Indian...

  6. 25 CFR 170.175 - What Indian LTAP-sponsored transportation training and educational opportunities exist?

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 25 Indians 1 2010-04-01 2010-04-01 false What Indian LTAP-sponsored transportation training and... INTERIOR LAND AND WATER INDIAN RESERVATION ROADS PROGRAM Indian Reservation Roads Program Policy and Eligibility Indian Ltap-Sponsored Education and Training Opportunities § 170.175 What Indian...

  7. 20 CFR 416.1204 - Deeming of resources of the sponsor of an alien.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... alien. 416.1204 Section 416.1204 Employees' Benefits SOCIAL SECURITY ADMINISTRATION SUPPLEMENTAL... of the sponsor of an alien. The resources of an alien who first applies for SSI benefits after September 30, 1980, are deemed to include the resources of the alien's sponsor for 3 years after the alien's...

  8. 45 CFR 2551.24 - What are a sponsor's responsibilities for securing community participation?

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... community participation? 2551.24 Section 2551.24 Public Welfare Regulations Relating to Public Welfare (Continued) CORPORATION FOR NATIONAL AND COMMUNITY SERVICE SENIOR COMPANION PROGRAM Eligibility and Responsibilities of a Sponsor § 2551.24 What are a sponsor's responsibilities for securing community...

  9. 42 CFR 440.350 - Employer-sponsored insurance health plans.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 4 2012-10-01 2012-10-01 false Employer-sponsored insurance health plans. 440.350 Section 440.350 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN... Benchmark-Equivalent Coverage § 440.350 Employer-sponsored insurance health plans. (a) A State may...

  10. 42 CFR 440.350 - Employer-sponsored insurance health plans.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 4 2014-10-01 2014-10-01 false Employer-sponsored insurance health plans. 440.350 Section 440.350 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN... Benchmark-Equivalent Coverage § 440.350 Employer-sponsored insurance health plans. (a) A State may...

  11. Bereavement, Ministerial Attitudes, and the Future of Church-Sponsored Bereavement Support Groups.

    ERIC Educational Resources Information Center

    Sklar, Fred; Huneke, Kathleen D.

    1988-01-01

    Surveyed 72 ministers in the Northern California Conference of the United Church of Christ. Results documented absence of church-sponsored bereavement support groups. Suggests that this absence results from ministers' disinclination, an attitude that appears to arise from bereavement training. Discusses future of church-sponsored bereavement…

  12. 20 CFR 416.1204 - Deeming of resources of the sponsor of an alien.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... alien. 416.1204 Section 416.1204 Employees' Benefits SOCIAL SECURITY ADMINISTRATION SUPPLEMENTAL... of the sponsor of an alien. The resources of an alien who first applies for SSI benefits after September 30, 1980, are deemed to include the resources of the alien's sponsor for 3 years after the...

  13. 14 CFR 152.105 - Sponsors and planning agencies: Airport planning.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 3 2011-01-01 2011-01-01 false Sponsors and planning agencies: Airport... TRANSPORTATION (CONTINUED) AIRPORTS AIRPORT AID PROGRAM Eligibility Requirements and Application Procedures § 152.105 Sponsors and planning agencies: Airport planning. (a) To be eligible to apply for a project...

  14. Curiosity and Commercialization: Faculty Perspectives on Sponsored Research, Academic Science and Research Agendas

    ERIC Educational Resources Information Center

    Perorazio, Thomas E.

    2009-01-01

    Given the need to compete for sponsored research funding, do university faculty believe they retain the freedom to research what is of most interest to them? The higher education literature frequently asserts that faculty research agendas are being subjugated to the demands of sponsors. An alternate perspective, from the science studies…

  15. 21 CFR 500.84 - Conditions for approval of the sponsored compound.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Conditions for approval of the sponsored compound. 500.84 Section 500.84 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN... Used in Food-Producing Animals § 500.84 Conditions for approval of the sponsored compound. (a) On...

  16. 29 CFR 4043.29 - Change in contributing sponsor or controlled group.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... knowledge of the transaction and of the controlled group relationship; and (3) Press releases; Forms 10Q. If... 29 Labor 9 2014-07-01 2014-07-01 false Change in contributing sponsor or controlled group. 4043.29... Events § 4043.29 Change in contributing sponsor or controlled group. (a) Reportable event. A...

  17. 14 CFR 152.105 - Sponsors and planning agencies: Airport planning.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 14 Aeronautics and Space 3 2014-01-01 2014-01-01 false Sponsors and planning agencies: Airport... TRANSPORTATION (CONTINUED) AIRPORTS AIRPORT AID PROGRAM Eligibility Requirements and Application Procedures § 152.105 Sponsors and planning agencies: Airport planning. (a) To be eligible to apply for a project for...

  18. 14 CFR 152.105 - Sponsors and planning agencies: Airport planning.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 14 Aeronautics and Space 3 2013-01-01 2013-01-01 false Sponsors and planning agencies: Airport... TRANSPORTATION (CONTINUED) AIRPORTS AIRPORT AID PROGRAM Eligibility Requirements and Application Procedures § 152.105 Sponsors and planning agencies: Airport planning. (a) To be eligible to apply for a project for...

  19. 14 CFR 152.105 - Sponsors and planning agencies: Airport planning.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 14 Aeronautics and Space 3 2012-01-01 2012-01-01 false Sponsors and planning agencies: Airport... TRANSPORTATION (CONTINUED) AIRPORTS AIRPORT AID PROGRAM Eligibility Requirements and Application Procedures § 152.105 Sponsors and planning agencies: Airport planning. (a) To be eligible to apply for a project for...

  20. 76 FR 2807 - New Animal Drugs; Change of Sponsor; Follicle Stimulating Hormone

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-01-18

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510 and 522 New Animal Drugs; Change of Sponsor... Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for a new animal drug application (NADA) for follicle stimulating hormone from Ausa International...

  1. 75 FR 54016 - New Animal Drugs; Change of Sponsor's Name and Address

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-09-03

    ... Administration 21 CFR Part 510 [Docket No. FDA-2010-N-0002] New Animal Drugs; Change of Sponsor's Name and... Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Alpharma..., Animal drugs, Labeling, Reporting and recordkeeping requirements. 0 Therefore, under the Federal Food...

  2. 76 FR 40612 - New Animal Drugs; Change of Sponsor's Name and Address

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-07-11

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Part 510 New Animal Drugs; Change of Sponsor's Name... Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Alpharma... of Subjects in 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling...

  3. 76 FR 79064 - New Animal Drugs; Change of Sponsor; Zinc Gluconate

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-21

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510 and 522 New Animal Drugs; Change of Sponsor... Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for a new animal drug application (NADA) for zinc gluconate injectable solution from Technology Transfer...

  4. 14 CFR 152.105 - Sponsors and planning agencies: Airport planning.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 14 Aeronautics and Space 3 2010-01-01 2010-01-01 false Sponsors and planning agencies: Airport planning. 152.105 Section 152.105 Aeronautics and Space FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF....105 Sponsors and planning agencies: Airport planning. (a) To be eligible to apply for a project...

  5. 20 CFR 416.1204 - Deeming of resources of the sponsor of an alien.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 20 Employees' Benefits 2 2010-04-01 2010-04-01 false Deeming of resources of the sponsor of an alien. 416.1204 Section 416.1204 Employees' Benefits SOCIAL SECURITY ADMINISTRATION SUPPLEMENTAL SECURITY INCOME FOR THE AGED, BLIND, AND DISABLED Resources and Exclusions § 416.1204 Deeming of resources of the sponsor of an alien. The resources of...

  6. 20 CFR 416.1204 - Deeming of resources of the sponsor of an alien.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 20 Employees' Benefits 2 2013-04-01 2013-04-01 false Deeming of resources of the sponsor of an alien. 416.1204 Section 416.1204 Employees' Benefits SOCIAL SECURITY ADMINISTRATION SUPPLEMENTAL SECURITY INCOME FOR THE AGED, BLIND, AND DISABLED Resources and Exclusions § 416.1204 Deeming of resources of the sponsor of an alien. The resources of...

  7. 75 FR 20523 - New Animal Drugs; Change of Sponsor's Name and Address

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-20

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Part 510 New Animal Drugs; Change of Sponsor's Name and Address AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug... Laboratories (Aust) Pty. Ltd. to Parnell Technologies Pty. Ltd. In addition, the sponsor's mailing address will...

  8. 21 CFR 500.84 - Conditions for approval of the sponsored compound.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Conditions for approval of the sponsored compound. 500.84 Section 500.84 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN... Used in Food-Producing Animals § 500.84 Conditions for approval of the sponsored compound. (a) On...

  9. 48 CFR 970.5235-1 - Federally funded research and development center sponsoring agreement.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... Federally funded research and development center sponsoring agreement. As prescribed in 970.3501-4, the contracting officer shall insert the following clause: Federally Funded Research and Development Center... the operation of a Department of Energy sponsored Federally Funded Research and Development Center...

  10. 20 CFR 416.1204 - Deeming of resources of the sponsor of an alien.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... alien. 416.1204 Section 416.1204 Employees' Benefits SOCIAL SECURITY ADMINISTRATION SUPPLEMENTAL... of the sponsor of an alien. The resources of an alien who first applies for SSI benefits after September 30, 1980, are deemed to include the resources of the alien's sponsor for 3 years after the...

  11. Face to Face: Learning English. LIRS Manual for Sponsors of Refugees.

    ERIC Educational Resources Information Center

    Smalley, Carol

    This manual was designed for refugee sponsors who are teaching English to Southeast Asian refugees. The manual encourages sponsors to research English as a Second Language (ESL) resources in their communities, to teach ESL in a professional and educationally sound manner, and to evaluate their work on a reuular basis. The first section of the…

  12. Institutionalizing Entrepreneurship: A History of Sponsored Research at the University of Michigan

    ERIC Educational Resources Information Center

    DeGraff, Staney

    2006-01-01

    This paper examines the history of sponsored research and industrial relationships at the University of Michigan. For the purposes of this paper, sponsored research is defined as research performed by the university that is funded by an outside constituent. Although this paper covers events from the start of the twentieth century, it concentrates…

  13. The Administration of Sponsored Programs. Handbook for Developing and Managing Research Activities and Other Projects.

    ERIC Educational Resources Information Center

    Beasley, Kenneth L.; And Others

    Designed as a standard reference and training resource for administrators and project managers, this handbook discusses how to plan, organize, and manage sponsored projects in any organizational setting. It provides detailed, how-to-do-it information and many resources for: negotiating grants, awards, and contracts; organizing a sponsored projects…

  14. The Emmanuel Schools Foundation: Sponsoring and Leading Transformation at England's Most Improved Academy

    ERIC Educational Resources Information Center

    Pike, Mark A.

    2009-01-01

    The Emmanuel Schools Foundation (ESF) has so far sponsored four schools in England. Beginning with Emmanuel College in Gateshead in 1990 (which remains a City Technology College) the Foundation sponsors the King's Academy in Middlesbrough, which opened in 2003, and Trinity Academy in Thorne near Doncaster, which opened in 2005. The Foundation's…

  15. Consensus Auditory-Perceptual Evaluation of Voice: Development of a Standardized Clinical Protocol

    ERIC Educational Resources Information Center

    Kempster, Gail B.; Gerratt, Bruce R.; Abbott, Katherine Verdolini; Barkmeier-Kraemer, Julie; Hillman, Robert E.

    2009-01-01

    Purpose: This article presents the development of the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) following a consensus conference on perceptual voice quality measurement sponsored by the American Speech-Language-Hearing Association's Special Interest Division 3, Voice and Voice Disorders. The CAPE-V protocol and recording form were…

  16. Characteristics of NIH- and industry-sponsored head and neck cancer clinical trials.

    PubMed

    Devaiah, Anand; Murchison, Charles

    2016-09-01

    Compare U.S. clinical trials sponsored by the National Institutes of Health (NIH) and industry, especially with regard to trial design, interventions studied, and results reporting rates. U.S. head and neck cancer clinical trials. We used information from ClinicalTrials.gov to compare NIH- and industry-sponsored head and neck cancer clinical trials, specifically analyzing differences in trial design and interventions studied. We examined publication rates and positive results rates using PubMed.gov. About 50% of NIH- and industry-sponsored clinical trials have their results reported in peer-reviewed literature. Industry-sponsored trials had higher rates of positive results than NIH-sponsored trials. NIH- and industry-sponsored clinical trials had similar trial designs, although industry-sponsored trials had significantly lower rates of randomization. Industry trials utilized radiation in 19% of trials and surgery in 2% of trials. NIH trials also had low utilization of both radiation and surgery (27% and 12% of trials, respectively). NIH- and industry-sponsored trials published their results in journals with comparable impact factors. There is significant underreporting of results in U.S. head and neck cancer clinical trials, whether sponsored by NIH or industry. Industry trials have significantly higher rates of positive results, although it is unclear what contributes to this. Both NIH- and industry-sponsored trials underutilize surgery and radiation as treatment modalities, despite the fact that these are standard-of-care therapies for head and neck cancer. We recommend that the NIH and industry report all results from clinical trials and use surgery and radiation as treatment arms in order to arrive at more balanced therapeutic recommendations. N/A. Laryngoscope, 126:E300-E303, 2016. © 2016 The American Laryngological, Rhinological and Otological Society, Inc.

  17. Text of North American Proposal to Amend the Montreal Protocol to Phase-down Production and Consumption of HFCs

    EPA Pesticide Factsheets

    The United States, Canada, and Mexico together submitted a proposal in April 2015 to phase-down production and consumption of hydrofluorocarbons (HFCs) under the Montreal Protocol. This document provides the text of that proposal.

  18. Federally sponsored multidisciplinary research centers: Learning, evaluation, and vicious circles.

    PubMed

    Youtie, Jan; Corley, Elizabeth A

    2011-02-01

    Despite the increasing investment in multi-year federally funded science and technology centers in universities, there are few studies of how these centers engage in learning and change based on information submitted from various agents in the oversight and evaluation process. One challenge is how to manage and respond to this evaluative information, especially when it is conflicting. Although the center can learn and adapt in response to this information, it can also become subject to a vicious circle of continuous restructuring and production of documentation to address various and potentially inconsistent recommendations. In this paper we illustrate the effects of such a dynamic based on our experiences as external evaluators of the $25 million NSF-funded Learning in Informal and Formal Environments (LIFE) Center. The case study presents an analysis of annual reports and strategic planning documents along with other sources of evidence to illustrate the evolution of center organizational approaches in response to evaluations by external review panels, center evaluators, program managers, and other external stakeholders. We conclude with suggestions for how evaluators may help centers ease the cost of learning and reduce the likelihood of a vicious circle. 2010 Elsevier Ltd. All rights reserved.

  19. Nationwide survey on informed consent and ethical review at hospitals conducting post-marketing studies sponsored by pharmaceutical companies.

    PubMed

    Urushihara, Hisashi; Murakami, Yuka; Matsui, Kenji; Tashiro, Shimon

    2017-09-25

      Under the Japanese drug regulatory system, post-marketing studies (PMS) must be in compliance with Good Post-marketing Study Practice (GPSP). The GPSP Ordinance lacks standards for the ethical conduct of PMSs; although only post-marketing clinical trials are subject to Good Clinical Practice.   We conducted a web-based questionnaire survey on the ethical conduct of PMSs in collaboration with the Japanese Society of Hospital Pharmacists and pharmacists belonging to the Society. 1819 hospitals around Japan answered the questionnaire, of which 503 hospitals had conducted company-sponsored PMSs in 2015. 40.2% of the hospitals had obtained informed consent from participating patients in at least one PMS conducted in 2015, the majority of which was in written form. The first and second most frequent reasons for seeking informed consent in PMSs were to meet protocol requirements, followed by the requirement to meet institutional standard operational procedures and the request of the ethical review board of the hospital. Ethical review of PMSs was conducted in 251 hospitals. Despite a lack of standards for informed consent and ethical review in PMSs, a considerable number of study sites employed informed consent and ethical review for PMSs. While company policies and protocols are likely to be major determinants of the ethical conduct of PMSs, the governmental regulatory agency should also play a significant role in implementing a standardized ethical code for the conduct of PMSs.

  20. How to Submit a Risk Management Plan (RMP) to EPA

    EPA Pesticide Factsheets

    RMP*eSubmit software is the only way to submit RMPs. After you have prepared your plan using RMP*eSubmit, you may also re-submit, correct, or withdraw an RMP. Another electronic tool, RMP*Comp, performs the required off-site consequence analysis.

  1. 33 CFR 160.208 - Changes to a submitted NOA.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 2 2011-07-01 2011-07-01 false Changes to a submitted NOA. 160... Conditions, and Certain Dangerous Cargos § 160.208 Changes to a submitted NOA. (a) Unless otherwise specified in this section, when submitted NOA information changes, vessels must submit a notice of...

  2. 33 CFR 160.208 - Changes to a submitted NOA.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 2 2012-07-01 2012-07-01 false Changes to a submitted NOA. 160... Conditions, and Certain Dangerous Cargos § 160.208 Changes to a submitted NOA. (a) Unless otherwise specified in this section, when submitted NOA information changes, vessels must submit a notice of...

  3. 33 CFR 160.208 - Changes to a submitted NOA.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 2 2010-07-01 2010-07-01 false Changes to a submitted NOA. 160... Conditions, and Certain Dangerous Cargos § 160.208 Changes to a submitted NOA. (a) Unless otherwise specified in this section, when submitted NOA information changes, vessels must submit a notice of...

  4. 33 CFR 160.208 - Changes to a submitted NOA.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 2 2014-07-01 2014-07-01 false Changes to a submitted NOA. 160... Conditions, and Certain Dangerous Cargos § 160.208 Changes to a submitted NOA. (a) Unless otherwise specified in this section, when submitted NOA information changes, vessels must submit a notice of...

  5. 33 CFR 160.208 - Changes to a submitted NOA.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 2 2013-07-01 2013-07-01 false Changes to a submitted NOA. 160... Conditions, and Certain Dangerous Cargos § 160.208 Changes to a submitted NOA. (a) Unless otherwise specified in this section, when submitted NOA information changes, vessels must submit a notice of...

  6. Participation willingness in web surveys: exploring effect of sponsoring corporation's and survey provider's reputation.

    PubMed

    Fang, Jiaming; Wen, Chao; Pavur, Robert

    2012-04-01

    Prior research involving response rates in Web-based surveys has not adequately addressed the effect of the reputation of a sponsoring corporation that contracts with a survey provider. This study investigates the effect of two factors, namely, the reputation of a survey's provider and the reputation of a survey's sponsoring corporation, on the willingness of potential respondents to participate in a Web survey. Results of an experimental design with these two factors reveal that the sponsoring corporation's and the survey provider's strong reputations can induce potential respondents to participate in a Web survey. A sponsoring corporation's reputation has a greater effect on the participation willingness of potential respondents of a Web survey than the reputation of the survey provider. A sponsoring corporation with a weak reputation who contracts with a survey provider having a strong reputation results in increased participation willingness from potential respondents if the identity of the sponsoring corporation is disguised in a survey. This study identifies the most effective strategy to increase participation willingness for a Web-based survey by considering both the reputations of the sponsoring corporation and survey provider and whether to reveal their identities.

  7. Participation Willingness in Web Surveys: Exploring Effect of Sponsoring Corporation's and Survey Provider's Reputation

    PubMed Central

    Wen, Chao; Pavur, Robert

    2012-01-01

    Abstract Prior research involving response rates in Web-based surveys has not adequately addressed the effect of the reputation of a sponsoring corporation that contracts with a survey provider. This study investigates the effect of two factors, namely, the reputation of a survey's provider and the reputation of a survey's sponsoring corporation, on the willingness of potential respondents to participate in a Web survey. Results of an experimental design with these two factors reveal that the sponsoring corporation's and the survey provider's strong reputations can induce potential respondents to participate in a Web survey. A sponsoring corporation's reputation has a greater effect on the participation willingness of potential respondents of a Web survey than the reputation of the survey provider. A sponsoring corporation with a weak reputation who contracts with a survey provider having a strong reputation results in increased participation willingness from potential respondents if the identity of the sponsoring corporation is disguised in a survey. This study identifies the most effective strategy to increase participation willingness for a Web-based survey by considering both the reputations of the sponsoring corporation and survey provider and whether to reveal their identities. PMID:22304457

  8. Alternative parallel ring protocols

    NASA Technical Reports Server (NTRS)

    Mukkamala, R.; Foudriat, E. C.; Maly, Kurt J.; Kale, V.

    1990-01-01

    Communication protocols are know to influence the utilization and performance of communication network. The effect of two token ring protocols on a gigabit network with multiple ring structure is investigated. In the first protocol, a mode sends at most one message on receiving a token. In the second protocol, a mode sends all the waiting messages when a token is received. The behavior of these protocols is shown to be highly dependent on the number of rings as well as the load in the network.

  9. 21 CFR 1271.21 - When do I register, submit an HCT/P list, and submit updates?

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 8 2011-04-01 2011-04-01 false When do I register, submit an HCT/P list, and... Listing § 1271.21 When do I register, submit an HCT/P list, and submit updates? (a) You must register and submit a list of every HCT/P that your establishment manufactures within 5 days after...

  10. Marital status, spousal coverage, and the gender gap in employer-sponsored health insurance.

    PubMed

    Buchmueller, T C

    Not only do men who work full time earn more than women, but they are more likely to receive employer-sponsored health benefits. This paper provides evidence on the gender gap in employer-sponsored health insurance. The results indicate that the gap is driven largely by the tendency of married women to decline employer-sponsored insurance in favor of being covered through their husbands. Indeed, among single workers, women are more likely than men to be offered insurance. These findings call into question the conclusion made by previous researchers that employers discriminate against women in the provision of health insurance.

  11. 15 CFR 325.14 - Submitting reports.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 15 Commerce and Foreign Trade 2 2010-01-01 2010-01-01 false Submitting reports. 325.14 Section 325.14 Commerce and Foreign Trade Regulations Relating to Commerce and Foreign Trade (Continued) INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE MISCELLANEOUS REGULATIONS EXPORT TRADE CERTIFICATES...

  12. How to Submit | Center for Cancer Research

    Cancer.gov

    be submitted by a current NIH or FDA fellow. The work does not need to have been done at the NIH/FDA. However, the submitter must be an author on the document and be in compliance with the intended journal's authorship guidelines or general good authorship practices. 

  13. Guidance on submitting quality system information.

    PubMed

    Donawa, Maria E

    2004-03-01

    The Food and Drug Administration's final guidance document on the type of quality system information that should be submitted in some types of premarket submissions was published in February 2003. The final guidance replaces previous draft guidance. This article discusses the final guidance document.

  14. Modeling Transport Layer Protocols

    NASA Astrophysics Data System (ADS)

    Sasnauskas, Raimondas; Weingaertner, Elias

    In a layered communication architecture, transport layer protocols handle the data exchange between processes on different hosts over potentially lossy communication channels. Typically, transport layer protocols are either connection-oriented or are based on the transmission of individual datagrams. Well known transport protocols are the connection-oriented Transmission Control Protocol (TCP) [372] and the User Datagram Protocol (UDP) [370] as well as the Stream Control Transmission Protocol (SCTP) [340] and DCCP, the Datagram Congestion Control Protocol [259]. In this chapter, we focus on the modeling process of the transport layer. While we mostly use TCP and UDP as a base of comparison from this point, we emphasize that the methodologies discussed further on are conferrable to virtually any transport layer in any layered communication architecture.

  15. Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals.

    PubMed

    van Lent, Marlies; Overbeke, John; Out, Henk Jan

    2014-01-01

    Publication bias is generally ascribed to authors and sponsors failing to submit studies with negative results, but may also occur after submission. We evaluated whether submitted manuscripts on randomized controlled trials (RCTs) with drugs are more likely to be accepted if they report positive results. Manuscripts submitted from January 2010 through April 2012 to one general medical journal (BMJ) and seven specialty journals (Annals of the Rheumatic Diseases, British Journal of Ophthalmology, Gut, Heart, Thorax, Diabetologia, and Journal of Hepatology) were included, if at least one study arm assessed the efficacy or safety of a drug and a statistical test was used to evaluate treatment effects. Publication status was retrospectively retrieved from submission systems or provided by journals. Sponsorship and trial results were extracted from manuscripts and classified according to predefined criteria. Main outcome measure was acceptance for publication. Of 15,972 manuscripts submitted, 472 (3.0%) were drug RCTs, of which 98 (20.8%) were published. Among submitted drug RCTs, 287 (60.8%) had positive and 185 (39.2%) negative results. Of these, 60 (20.9%) and 38 (20.5%), respectively, were published. Manuscripts on non-industry trials (n = 213) reported positive results in 138 (64.8%) manuscripts, compared to 71 (47.7%) on industry-supported trials (n = 149), and 78 (70.9%) on industry-sponsored trials (n = 110). Twenty-seven (12.7%) non-industry trials were published, compared to 27 (18.1%) industry-supported and 44 (40.0%) industry-sponsored trials. After adjustment for other trial characteristics, manuscripts reporting positive results were not more likely to be published (OR, 1.00; 95% CI, 0.61 to 1.66). Submission to specialty journals, sample size, multicentre status, journal impact factor, and corresponding authors from Europe or US were significantly associated with publication. For the selected journals, there was no tendency to preferably

  16. Role of Editorial and Peer Review Processes in Publication Bias: Analysis of Drug Trials Submitted to Eight Medical Journals

    PubMed Central

    van Lent, Marlies; Overbeke, John; Out, Henk Jan

    2014-01-01

    Background Publication bias is generally ascribed to authors and sponsors failing to submit studies with negative results, but may also occur after submission. We evaluated whether submitted manuscripts on randomized controlled trials (RCTs) with drugs are more likely to be accepted if they report positive results. Methods Manuscripts submitted from January 2010 through April 2012 to one general medical journal (BMJ) and seven specialty journals (Annals of the Rheumatic Diseases, British Journal of Ophthalmology, Gut, Heart, Thorax, Diabetologia, and Journal of Hepatology) were included, if at least one study arm assessed the efficacy or safety of a drug and a statistical test was used to evaluate treatment effects. Publication status was retrospectively retrieved from submission systems or provided by journals. Sponsorship and trial results were extracted from manuscripts and classified according to predefined criteria. Main outcome measure was acceptance for publication. Results Of 15,972 manuscripts submitted, 472 (3.0%) were drug RCTs, of which 98 (20.8%) were published. Among submitted drug RCTs, 287 (60.8%) had positive and 185 (39.2%) negative results. Of these, 60 (20.9%) and 38 (20.5%), respectively, were published. Manuscripts on non-industry trials (n = 213) reported positive results in 138 (64.8%) manuscripts, compared to 71 (47.7%) on industry-supported trials (n = 149), and 78 (70.9%) on industry-sponsored trials (n = 110). Twenty-seven (12.7%) non-industry trials were published, compared to 27 (18.1%) industry-supported and 44 (40.0%) industry-sponsored trials. After adjustment for other trial characteristics, manuscripts reporting positive results were not more likely to be published (OR, 1.00; 95% CI, 0.61 to 1.66). Submission to specialty journals, sample size, multicentre status, journal impact factor, and corresponding authors from Europe or US were significantly associated with publication. Conclusions For the selected journals

  17. 78 FR 68056 - Information Collection Request Submitted to OMB for Review and Approval; Comment Request; NSPS...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-11-13

    ...The Environmental Protection Agency has submitted an information collection request (ICR), ``NSPS for Stationary Gas Turbines (Renewal)'' (EPA ICR No. 1071.11, OMB Control No. 2060-0028), to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act (44 U.S.C. 3501 et seq). This is a proposed extension of the ICR, which is currently approved through December 31, 2013. Public comments were previously requested via the Federal Register (78 FR 33409) on June 4, 2013, during a 60-day comment period. This notice allows for an additional 30 days for public comments. A fuller description of the ICR is given below, including its estimated burden and cost to the public. An Agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.

  18. 78 FR 44432 - New Animal Drugs; Change of Sponsor; Fentanyl; Iron Injection

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-07-24

    ... Sponsor; Fentanyl; Iron Injection AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY..., NADA 099-667 for IMPOSIL (iron dextran complex) Injection and NADA 110-399 for GLEPTOSIL (gleptoferron...

  19. Strategic considerations for provider sponsored organizations entering the risk-bearing Medicare market.

    PubMed

    Treash, M; Thomson, K

    1997-01-01

    This article considers Michael Porter's five forces of industry competition as it relates to provider sponsored organizations and asks four important questions on marketing differentiation, quality, size of market, and product/service scope.

  20. 22 CFR Appendix A to Part 62 - Certification of Responsible Officers and Sponsors

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ...__. Subscribed and sworn to before me this ______ day of ______, 19__. Notary Public 2. Sponsors. I hereby.../Witness: This ______ day of ______, 19__. Subscribed and sworn to before me this ______ day of ______,...

  1. 22 CFR Appendix A to Part 62 - Certification of Responsible Officers and Sponsors

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ...__. Subscribed and sworn to before me this ______ day of ______, 19__. Notary Public 2. Sponsors. I hereby.../Witness: This ______ day of ______, 19__. Subscribed and sworn to before me this ______ day of ______,...

  2. 45 CFR 2552.24 - What are a sponsor's responsibilities for securing community participation?

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ..., volunteerism and children's issues; (3) Capable of helping the sponsor meet its administrative and program responsibilities including fund-raising, publicity and programming for impact; (4) With interest in and knowledge...

  3. 45 CFR 2553.24 - What are a sponsor's responsibilities for securing community participation?

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... community service and volunteerism; (3) Capable of helping the sponsor meet its administrative and program responsibilities including fund-raising, publicity and programming for impact; (4) With an interest in and...

  4. 21 CFR 312.58 - Inspection of sponsor's records and reports.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... SERVICES (CONTINUED) DRUGS FOR HUMAN USE INVESTIGATIONAL NEW DRUG APPLICATION Responsibilities of Sponsors... new drug is a substance listed in any schedule of the Controlled Substances Act (21 U.S.C. 801; 21...

  5. Industry-Sponsored Dental Health Teaching Aids: Selection Criteria and Program Examples.

    ERIC Educational Resources Information Center

    Travis, Donna L.

    1982-01-01

    Ten questions are provided to facilitate selection and evaluation of materials for a dental health curriculum. Examples of industry-sponsored dental health programs available free or at minimal cost are given. (JN)

  6. 45 CFR 2553.107 - What must a sponsor do if it cannot meet its performance measures?

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 45 Public Welfare 4 2011-10-01 2011-10-01 false What must a sponsor do if it cannot meet its... Performance Measurement § 2553.107 What must a sponsor do if it cannot meet its performance measures? Whenever a sponsor finds it is not on track to meet its performance measures, it must develop a plan to get...

  7. Try D.E. and See (Students That Is). A Handbook for Training Station Sponsors. Educated Students Make Productive Adults.

    ERIC Educational Resources Information Center

    Charney, Alan

    This handbook was developed to provide information on distributive education (D.E.) to business managers who, as training sponsors, provide job experiences for D.E. high school students. The content, including several illustrations, focuses on what D.E. is and how it operates; what is needed from the training sponsor; what the training sponsor can…

  8. 42 CFR 423.2010 - When CMS, the IRE, or Part D plan sponsors may participate in an ALJ hearing.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 3 2014-10-01 2014-10-01 false When CMS, the IRE, or Part D plan sponsors may... CMS, the IRE, or Part D plan sponsors may participate in an ALJ hearing. (a) An ALJ may request, but may not require, CMS, the IRE, and/or the Part D plan sponsor to participate in any proceedings...

  9. 42 CFR 423.2010 - When CMS, the IRE, or Part D plan sponsors may participate in an ALJ hearing.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 3 2012-10-01 2012-10-01 false When CMS, the IRE, or Part D plan sponsors may... CMS, the IRE, or Part D plan sponsors may participate in an ALJ hearing. (a) An ALJ may request, but may not require, CMS, the IRE, and/or the Part D plan sponsor to participate in any proceedings...

  10. 42 CFR 423.2010 - When CMS, the IRE, or Part D plan sponsors may participate in an ALJ hearing.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 3 2013-10-01 2013-10-01 false When CMS, the IRE, or Part D plan sponsors may... CMS, the IRE, or Part D plan sponsors may participate in an ALJ hearing. (a) An ALJ may request, but may not require, CMS, the IRE, and/or the Part D plan sponsor to participate in any proceedings...

  11. Sponsor-Imposed Publication Restrictions Disclosed on ClinicalTrials.gov.

    PubMed

    Stretton, Serina; Lew, Rebecca A; Ely, Julie A; Snape, Mark J; Carey, Luke C; Haley, Cassandra; Woolley, Mark J; Woolley, Karen L

    2016-01-01

    We investigated whether sponsor-imposed publication restrictions for ClinicalTrials.gov trials were reasonable, based on consistency with Good Publication Practice 2 (GPP2). ClinicalTrials.gov trial record data were electronically imported (October 7, 2012) and screened for eligibility (phase 2-4, interventional, recruitment closed, results available, first received for registration after November 10, 2009, any sponsor type, investigators not sponsor employees). Two authors categorized restrictions information as consistent or not consistent with GPP2, resolving discrepancies by consensus. Of the eligible trials (388/484, n = 81,768 participants), 80.7% (313/388) had restrictions disclosed, and 92.5% (311/388) were industry-sponsored. Significantly more trials had restrictions that were consistent with GPP2 than not (74.1% [232/313], n = 55,280 participants vs. 25.9% [81/313], n = 19,677 participants; P < .001). Reasons for inconsistency were insufficient, unclear, or ambiguous information (48.1%, 39/81), sponsor-required approval for publication (35.8%, 29/81), sponsor-required text changes (8.6%, 7/81), and outright bans (7.4%, 6/81). Follow-up of trials with insufficient information and a contact email (response rate, 46.9% [15/32]) revealed 2 additional bans. A total of 776 participants had consented to trials that had publication bans. Many, but not all, sponsor-imposed publication restrictions disclosed on ClinicalTrials.gov may be considered reasonable. Sponsors should ensure restrictions are appropriately disclosed. Volunteers should be alerted to any restrictions before consenting to participate in a clinical trial.

  12. Enhancing family advocacy networks: an analysis of the roles of sponsoring organizations.

    PubMed

    Briggs, H E; Koroloff, N M

    1995-08-01

    Family participation in shaping system reforms in children's mental health has increased over the past ten years. In 1990 the National Institute of Mental Health funded the development and enhancement of 15 statewide advocacy organizations that were to be controlled and staffed by families of children who have serious emotional disorders. These family advocacy organizations had three major goals: to establish support networks, to advocate for service system reforms, and to develop statewide family advocacy networks. Seven family advocacy networks worked with sponsoring organizations because they needed assistance and/or could not receive funding directly. State and local chapters of the National Alliance for the Mentally Ill and the National Mental Health Association served in this capacity. Because there were no guidelines to educate sponsoring organizations about their interorganizational roles and responsibilities, staff of some sponsoring organizations used approaches that were supportive and effective, while staff in other organizations used methods that were counterproductive. The information and recommendations discussed in this paper are based on evaluation data and observations of the relationships between seven sponsoring organizations and family advocacy groups over a three-year period. This paper proposes a conceptual framework that includes: (1) a clear definition of the sponsoring organization's roles, and (2) an analysis of the advantages, limitations, and critical issues for the sponsoring organization.

  13. Composing Interfering Abstract Protocols

    DTIC Science & Technology

    2016-04-01

    when composing abstract protocols. To evaluate the expres- siveness of our protocol framework for ensuring safe shared memory interference, we show how...progress and preservation theorems that show the ab- sence of unsafe interference in correctly typed programs. Our design ensures memory safety and data...system by discussing how our core shared memory protocol framework is capable of expressing safe, typeful message-passing idioms. Next, we briefly

  14. How a submitted manuscript is processed.

    PubMed

    Peh, W C G; Ng, K H

    2009-09-01

    Processing of a submitted manuscript is a complex and time-consuming process. Authors should be aware of items in the editorial office checklist. The journal editors and peer reviewers are an essential part of the manuscript processing system. Copy editors serve as a link between authors and the printer/publisher, and aim to adapt the accepted manuscript to the journal house style and to improve readability of the article.

  15. How to submit your revalidation application.

    PubMed

    Middleton, Lyn; Llewellyn, Denise

    2016-08-03

    Rationale and key points This is the final in a series of eight articles providing information about the Nursing and Midwifery Council revalidation process. This article focuses on submitting a revalidation application to the NMC. » Nurses and midwives must demonstrate that they have: completed 450 hours of practice, or 900 hours if revalidating as both a nurse and midwife; undertaken 35 hours of continuing professional development, 20 hours of which must be participatory; recorded five examples of feedback on their practice; written five reflective accounts; had a reflective discussion with an NMC registrant; and sought confirmation that they have met these requirements. » Nurses and midwives who fail to submit their revalidation application by the stated date will put the renewal of their registration at risk. Reflective activity 'How to' revalidate articles can help to update your practice and provide information about the revalidation process, including how you can submit your revalidation application. Reflect on and write a short account of: 1. The professional accountability associated with declaring that you have met the revalidation requirements. 2. How you could use this article to educate your colleagues. Subscribers can upload their reflective accounts at: rcni.com/portfolio .

  16. Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials

    PubMed Central

    Atal, Ignacio; Trinquart, Ludovic; Porcher, Raphaël; Ravaud, Philippe

    2015-01-01

    Background Mapping the international landscape of clinical trials may inform global health research governance, but no large-scale data are available. Industry or non-industry sponsorship may have a major influence in this mapping. We aimed to map the global landscape of industry- and non-industry–sponsored clinical trials and its evolution over time. Methods We analyzed clinical trials initiated between 2006 and 2013 and registered in the WHO International Clinical Trials Registry Platform (ICTRP). We mapped single-country and international trials by World Bank's income groups and by sponsorship (industry- vs. non- industry), including its evolution over time from 2006 to 2012. We identified clusters of countries that collaborated significantly more than expected in industry- and non-industry–sponsored international trials. Results 119,679 clinical trials conducted in 177 countries were analysed. The median number of trials per million inhabitants in high-income countries was 100 times that in low-income countries (116.0 vs. 1.1). Industry sponsors were involved in three times more trials per million inhabitants than non-industry sponsors in high-income countries (75.0 vs. 24.5) and in ten times fewer trials in low- income countries (0.08 vs. 1.08). Among industry- and non-industry–sponsored trials, 30.3% and 3.2% were international, respectively. In the industry-sponsored network of collaboration, Eastern European and South American countries collaborated more than expected; in the non-industry–sponsored network, collaboration among Scandinavian countries was overrepresented. Industry-sponsored international trials became more inter-continental with time between 2006 and 2012 (from 54.8% to 67.3%) as compared with non-industry–sponsored trials (from 42.4% to 37.2%). Conclusions Based on trials registered in the WHO ICTRP we documented a substantial gap between the globalization of industry- and non-industry–sponsored clinical research. Only 3% of

  17. Differential Globalization of Industry- and Non-Industry-Sponsored Clinical Trials.

    PubMed

    Atal, Ignacio; Trinquart, Ludovic; Porcher, Raphaël; Ravaud, Philippe

    2015-01-01

    Mapping the international landscape of clinical trials may inform global health research governance, but no large-scale data are available. Industry or non-industry sponsorship may have a major influence in this mapping. We aimed to map the global landscape of industry- and non-industry-sponsored clinical trials and its evolution over time. We analyzed clinical trials initiated between 2006 and 2013 and registered in the WHO International Clinical Trials Registry Platform (ICTRP). We mapped single-country and international trials by World Bank's income groups and by sponsorship (industry- vs. non- industry), including its evolution over time from 2006 to 2012. We identified clusters of countries that collaborated significantly more than expected in industry- and non-industry-sponsored international trials. 119,679 clinical trials conducted in 177 countries were analysed. The median number of trials per million inhabitants in high-income countries was 100 times that in low-income countries (116.0 vs. 1.1). Industry sponsors were involved in three times more trials per million inhabitants than non-industry sponsors in high-income countries (75.0 vs. 24.5) and in ten times fewer trials in low- income countries (0.08 vs. 1.08). Among industry- and non-industry-sponsored trials, 30.3% and 3.2% were international, respectively. In the industry-sponsored network of collaboration, Eastern European and South American countries collaborated more than expected; in the non-industry-sponsored network, collaboration among Scandinavian countries was overrepresented. Industry-sponsored international trials became more inter-continental with time between 2006 and 2012 (from 54.8% to 67.3%) as compared with non-industry-sponsored trials (from 42.4% to 37.2%). Based on trials registered in the WHO ICTRP we documented a substantial gap between the globalization of industry- and non-industry-sponsored clinical research. Only 3% of academic trials but 30% of industry trials are

  18. 49 CFR 194.101 - Operators required to submit plans.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... operator of an onshore pipeline facility shall prepare and submit a response plan to PHMSA as provided in... substantial harm. Operators of substantial harm pipeline facilities must prepare and submit plans to PHMSA...

  19. 49 CFR 194.101 - Operators required to submit plans.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... operator of an onshore pipeline facility shall prepare and submit a response plan to PHMSA as provided in... substantial harm. Operators of substantial harm pipeline facilities must prepare and submit plans to PHMSA...

  20. A Checklist for Submitting Your Risk Management Plan (RMP)

    EPA Pesticide Factsheets

    Important information about 2014 submissions and a checklist to consider in preparing and resubmitting a 5-year update, as required by 40 CFR part 68. Use the RMP*eSubmit software application, which replaced RMP*Submit.

  1. National Sample Assessment Protocols

    ERIC Educational Resources Information Center

    Ministerial Council on Education, Employment, Training and Youth Affairs (NJ1), 2012

    2012-01-01

    These protocols represent a working guide for planning and implementing national sample assessments in connection with the national Key Performance Measures (KPMs). The protocols are intended for agencies involved in planning or conducting national sample assessments and personnel responsible for administering associated tenders or contracts,…

  2. Montreal protocol: Business opportunites

    SciTech Connect

    1998-12-31

    The Montreal Protocol on Substances that Deplete the Ozone Layer was signed by 24 countries in 1987, establishing measures for controlling the production and consumption of ozone-depleting substances. This publication begins with some background information on ozone depletion and the history of the Protocol. It then describes aspects of the Protocol`s Multilateral Fund, created to assist developing countries to meet Protocol deadlines: Its administration, structure, and how projects are initiated. Names, addresses, and phone/fax numbers of Fund contacts are provided. Canadian projects under the Fund are then reviewed and opportunities for Canadian environmental companies are noted. Finally, information sheets are presented which summarize Fund-related Canadian bilateral projects undertaken to date.

  3. Reliable broadcast protocols

    NASA Technical Reports Server (NTRS)

    Joseph, T. A.; Birman, Kenneth P.

    1989-01-01

    A number of broadcast protocols that are reliable subject to a variety of ordering and delivery guarantees are considered. Developing applications that are distributed over a number of sites and/or must tolerate the failures of some of them becomes a considerably simpler task when such protocols are available for communication. Without such protocols the kinds of distributed applications that can reasonably be built will have a very limited scope. As the trend towards distribution and decentralization continues, it will not be surprising if reliable broadcast protocols have the same role in distributed operating systems of the future that message passing mechanisms have in the operating systems of today. On the other hand, the problems of engineering such a system remain large. For example, deciding which protocol is the most appropriate to use in a certain situation or how to balance the latency-communication-storage costs is not an easy question.

  4. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

    PubMed

    Moher, David; Shamseer, Larissa; Clarke, Mike; Ghersi, Davina; Liberati, Alessandro; Petticrew, Mark; Shekelle, Paul; Stewart, Lesley A

    2015-01-01

    Systematic reviews should build on a protocol that describes the rationale, hypothesis, and planned methods of the review; few reviews report whether a protocol exists. Detailed, well-described protocols can facilitate the understanding and appraisal of the review methods, as well as the detection of modifications to methods and selective reporting in completed reviews. We describe the development of a reporting guideline, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015). PRISMA-P consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review. Funders and those commissioning reviews might consider mandating the use of the checklist to facilitate the submission of relevant protocol information in funding applications. Similarly, peer reviewers and editors can use the guidance to gauge the completeness and transparency of a systematic review protocol submitted for publication in a journal or other medium.

  5. Using research to establish protocols for practice: a statewide study of acute care agencies.

    PubMed

    Morin, K H; Bucher, L; Plowfield, L; Hayes, E; Mahoney, P; Armiger, L

    1999-03-01

    The purpose of the study was to examine research utilization practices relative to developing and revising practice protocols in acute care agencies in Delaware. Nurse leaders in 13 acute care agencies identified resource nurses most familiar with the development and revision of agency protocols. Thirty-two resource nurses from 11 agencies, representing critical care, emergency, general medical, general surgical, obstetric, and psychiatric nursing, were interviewed. Interviews were tape-recorded and transcribed. Examples of research-based protocols, defined as those supported by research citations, were obtained. The authors found that the majority of protocols submitted, although referenced, were not research-based. Most institutions used textbooks and standards to support nursing practice protocols. The authors concluded that nurses who are responsible for developing and revising agency protocols were not familiar with the use of research findings to guide the development or revision of protocols and were unsure what constituted the "use of research."

  6. The GLOBE Contrail Protocol: Initial Analysis of Results

    NASA Technical Reports Server (NTRS)

    Chambers, Lin; Duda, David

    2004-01-01

    The GLOBE contrail protocol was launched in March 2003 to obtain surface observer reports of contrail occurrence to complement satellite and model studies underway at NASA Langley, among others. During the first year, more than 30,000 ground observations of contrails were submitted to GLOBE. An initial analysis comparing the GLOBE observations to weather prediction model results for relative humidity at flight altitudes is in progress. This paper reports on the findings to date from this effort.

  7. 48 CFR 32.1109 - EFT information submitted by offerors.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 48 Federal Acquisition Regulations System 1 2011-10-01 2011-10-01 false EFT information submitted... REGULATION GENERAL CONTRACTING REQUIREMENTS CONTRACT FINANCING Electronic Funds Transfer 32.1109 EFT information submitted by offerors. If offerors are required to submit EFT information prior to award, the...

  8. 48 CFR 32.1109 - EFT information submitted by offerors.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false EFT information submitted... REGULATION GENERAL CONTRACTING REQUIREMENTS CONTRACT FINANCING Electronic Funds Transfer 32.1109 EFT information submitted by offerors. If offerors are required to submit EFT information prior to award, the...

  9. 10 CFR 905.12 - How must IRPs be submitted?

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... one of the following options: (1) Customers may submit IRPs individually. (2) MBAs may submit IRPs for... an MBA must specify the responsibilities and participation levels of individual members and the MBA. Any member of an MBA may submit an individual IRP to Western instead of being included in an MBA IRP...

  10. 13 CFR 120.830 - Reports a CDC must submit.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 13 Business Credit and Assistance 1 2011-01-01 2011-01-01 false Reports a CDC must submit. 120.830... Company Loan Program (504) Requirements for Cdc Certification and Operation § 120.830 Reports a CDC must submit. A CDC must submit the following reports to SBA: (a) An annual report within one...

  11. 13 CFR 120.830 - Reports a CDC must submit.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 13 Business Credit and Assistance 1 2013-01-01 2013-01-01 false Reports a CDC must submit. 120.830... Company Loan Program (504) Requirements for Cdc Certification and Operation § 120.830 Reports a CDC must submit. A CDC must submit the following reports to SBA: (a) An annual report within one...

  12. 13 CFR 120.830 - Reports a CDC must submit.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 13 Business Credit and Assistance 1 2014-01-01 2014-01-01 false Reports a CDC must submit. 120.830... Company Loan Program (504) Requirements for Cdc Certification and Operation § 120.830 Reports a CDC must submit. A CDC must submit the following reports to SBA: (a) An annual report within one...

  13. 10 CFR 905.13 - When must IRPs be submitted?

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 10 Energy 4 2010-01-01 2010-01-01 false When must IRPs be submitted? 905.13 Section 905.13 Energy DEPARTMENT OF ENERGY ENERGY PLANNING AND MANAGEMENT PROGRAM Integrated Resource Planning § 905.13 When must IRPs be submitted? (a) Submitting the initial IRP. Except as provided in paragraph (c) of this...

  14. 48 CFR 32.1109 - EFT information submitted by offerors.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 48 Federal Acquisition Regulations System 1 2013-10-01 2013-10-01 false EFT information submitted... REGULATION GENERAL CONTRACTING REQUIREMENTS CONTRACT FINANCING Electronic Funds Transfer 32.1109 EFT information submitted by offerors. If offerors are required to submit EFT information prior to award,...

  15. 48 CFR 32.1109 - EFT information submitted by offerors.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 48 Federal Acquisition Regulations System 1 2012-10-01 2012-10-01 false EFT information submitted... REGULATION GENERAL CONTRACTING REQUIREMENTS CONTRACT FINANCING Electronic Funds Transfer 32.1109 EFT information submitted by offerors. If offerors are required to submit EFT information prior to award,...

  16. 48 CFR 32.1109 - EFT information submitted by offerors.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 48 Federal Acquisition Regulations System 1 2014-10-01 2014-10-01 false EFT information submitted... REGULATION GENERAL CONTRACTING REQUIREMENTS CONTRACT FINANCING Electronic Funds Transfer 32.1109 EFT information submitted by offerors. If offerors are required to submit EFT information prior to award,...

  17. 10 CFR 905.12 - How must IRPs be submitted?

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 10 Energy 4 2013-01-01 2013-01-01 false How must IRPs be submitted? 905.12 Section 905.12 Energy DEPARTMENT OF ENERGY ENERGY PLANNING AND MANAGEMENT PROGRAM Integrated Resource Planning § 905.12 How must IRPs be submitted? (a) Number of IRPs submitted. Except as provided in paragraph (c) of this...

  18. 10 CFR 905.12 - How must IRPs be submitted?

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 10 Energy 4 2012-01-01 2012-01-01 false How must IRPs be submitted? 905.12 Section 905.12 Energy DEPARTMENT OF ENERGY ENERGY PLANNING AND MANAGEMENT PROGRAM Integrated Resource Planning § 905.12 How must IRPs be submitted? (a) Number of IRPs submitted. Except as provided in paragraph (c) of this...

  19. 10 CFR 905.12 - How must IRPs be submitted?

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 10 Energy 4 2014-01-01 2014-01-01 false How must IRPs be submitted? 905.12 Section 905.12 Energy DEPARTMENT OF ENERGY ENERGY PLANNING AND MANAGEMENT PROGRAM Integrated Resource Planning § 905.12 How must IRPs be submitted? (a) Number of IRPs submitted. Except as provided in paragraph (c) of this...

  20. 10 CFR 905.12 - How must IRPs be submitted?

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 10 Energy 4 2011-01-01 2011-01-01 false How must IRPs be submitted? 905.12 Section 905.12 Energy DEPARTMENT OF ENERGY ENERGY PLANNING AND MANAGEMENT PROGRAM Integrated Resource Planning § 905.12 How must IRPs be submitted? (a) Number of IRPs submitted. Except as provided in paragraph (c) of this...

  1. 33 CFR 160.210 - Methods for submitting an NOA.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 2 2013-07-01 2013-07-01 false Methods for submitting an NOA... Conditions, and Certain Dangerous Cargos § 160.210 Methods for submitting an NOA. (a) Submission to the..., vessels must submit NOA information required by § 160.206 (entries 1 through 9 in Table 160.206) to...

  2. 33 CFR 160.212 - When to submit an NOA.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 2 2012-07-01 2012-07-01 false When to submit an NOA. 160.212... Conditions, and Certain Dangerous Cargos § 160.212 When to submit an NOA. (a) Submission of NOA. (1) Except... and operating solely between ports or places in the continental United States, must submit an...

  3. 33 CFR 160.212 - When to submit an NOA.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 2 2013-07-01 2013-07-01 false When to submit an NOA. 160.212... Conditions, and Certain Dangerous Cargos § 160.212 When to submit an NOA. (a) Submission of NOA. (1) Except... and operating solely between ports or places in the continental United States, must submit an...

  4. 33 CFR 160.210 - Methods for submitting an NOA.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 2 2012-07-01 2012-07-01 false Methods for submitting an NOA... Conditions, and Certain Dangerous Cargos § 160.210 Methods for submitting an NOA. (a) Submission to the..., vessels must submit NOA information required by § 160.206 (entries 1 through 9 in Table 160.206) to...

  5. 33 CFR 160.210 - Methods for submitting an NOA.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 2 2011-07-01 2011-07-01 false Methods for submitting an NOA... Conditions, and Certain Dangerous Cargos § 160.210 Methods for submitting an NOA. (a) Submission to the..., vessels must submit NOA information required by § 160.206 (entries 1 through 9 in Table 160.206) to...

  6. 33 CFR 160.210 - Methods for submitting an NOA.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 2 2014-07-01 2014-07-01 false Methods for submitting an NOA... Conditions, and Certain Dangerous Cargos § 160.210 Methods for submitting an NOA. (a) Submission to the..., vessels must submit NOA information required by § 160.206 (entries 1 through 9 in Table 160.206) to...

  7. 33 CFR 160.210 - Methods for submitting an NOA.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 2 2010-07-01 2010-07-01 false Methods for submitting an NOA... Conditions, and Certain Dangerous Cargos § 160.210 Methods for submitting an NOA. (a) Submission to the..., vessels must submit NOA information required by § 160.206 (entries 1 through 9 in Table 160.206) to...

  8. Characteristics of project management at institutions sponsoring National Library of Medicine MedlinePlus Go Local.

    PubMed

    Olney, Cynthia A; Backus, Joyce E B; Klein, Lori J

    2010-01-01

    Through interviews with the National Library of Medicine's MedlinePlus Go Local collaborators, an evaluation team sought to identify process characteristics that are critical for long-term sustainability of Go Local projects and to describe the impact that Go Local projects have on sponsoring institutions. Go Local project coordinators (n = 44) at 31 sponsor institutions participated in semi-structured interviews about their experiences developing and maintaining Go Local sites. Interviews were summarized, checked for accuracy by the participating librarians, and analyzed using a general inductive methodology. Institutional factors that support Go Local projects were identified through the interviews, as well as strategies for staffing and partnerships with external organizations. Positive outcomes for sponsoring institutions also were identified. The findings may influence the National Library of Medicine team's decisions about improvements to its Go Local system and the support it provides to sponsoring institutions. The findings may benefit current sponsoring institutions as well as those considering or planning a Go Local project.

  9. Characteristics of project management at institutions sponsoring National Library of Medicine MedlinePlus Go Local*

    PubMed Central

    Olney, Cynthia A.; Backus, Joyce E. B.; Klein, Lori J.

    2010-01-01

    Objectives: Through interviews with the National Library of Medicine's MedlinePlus Go Local collaborators, an evaluation team sought to identify process characteristics that are critical for long-term sustainability of Go Local projects and to describe the impact that Go Local projects have on sponsoring institutions. Methods: Go Local project coordinators (n = 44) at 31 sponsor institutions participated in semi-structured interviews about their experiences developing and maintaining Go Local sites. Interviews were summarized, checked for accuracy by the participating librarians, and analyzed using a general inductive methodology. Results: Institutional factors that support Go Local projects were identified through the interviews, as well as strategies for staffing and partnerships with external organizations. Positive outcomes for sponsoring institutions also were identified. Conclusions: The findings may influence the National Library of Medicine team's decisions about improvements to its Go Local system and the support it provides to sponsoring institutions. The findings may benefit current sponsoring institutions as well as those considering or planning a Go Local project. PMID:20098657

  10. Sponsorship, ambushing, and counter-strategy: effects upon memory for sponsor and event.

    PubMed

    Humphreys, Michael S; Cornwell, T Bettina; McAlister, Anna R; Kelly, Sarah J; Quinn, Emerald A; Murray, Krista L

    2010-03-01

    Corporate sponsorship of sports, causes, and the arts has become a mainstream communications tool worldwide. The unique marketing opportunities associated with major events also attract nonsponsoring companies seeking to form associations with the event (ambushing). There are strategies available to brands and events which have been ambushed; however, there is only limited information about the effects of those strategies on attainment of sponsorship objectives. In Experiment 1, university staff and students participated by studying paragraphs linking a sponsor to a novel event. Relative to each sponsor-event pair, they then studied one of three different messages about a competitor. Results find a message which linked the competitor and the event increased competitor recall given the event as a cue and event recall given the competitor as a cue. These effects were moderated if there was information about the competitor not being the sponsor. In Experiment 2 ambushing and counter-ambushing information was presented over 2 days. Both types of messages increased competitor recall given the event as a cue and event recall given the competitor as a cue. In addition, "not sponsor" information was not always used even when it should have been recallable. The results can be explained if participants are using three cues: a specific cue such as a brand name, a contextual cue, and a category cue, such as the concept of an event. Findings suggest to sponsoring firms and event properties that counter-ambushing communications may have the unintended effect of strengthening an ambusher-event relationship in memory.

  11. 42 CFR 423.520 - Prompt payment by Part D sponsors.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... paragraph (b) of this section, submitted by network pharmacies (other than mail-order and long-term care pharmacies) within— (i) 14 days after the date on which the claim is received, as defined in paragraph (a)(2... not provide notice to the submitting network pharmacy of any deficiency in the claim within— (i)...

  12. 21 CFR 1271.21 - When do I register, submit an HCT/P list, and submit updates?

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... submit updates? 1271.21 Section 1271.21 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH... Listing § 1271.21 When do I register, submit an HCT/P list, and submit updates? (a) You must register and... update your establishment registration annually in December, except as required by § 1271.26. You...

  13. Reliable multicast protocol specifications protocol operations

    NASA Technical Reports Server (NTRS)

    Callahan, John R.; Montgomery, Todd; Whetten, Brian

    1995-01-01

    This appendix contains the complete state tables for Reliable Multicast Protocol (RMP) Normal Operation, Multi-RPC Extensions, Membership Change Extensions, and Reformation Extensions. First the event types are presented. Afterwards, each RMP operation state, normal and extended, is presented individually and its events shown. Events in the RMP specification are one of several things: (1) arriving packets, (2) expired alarms, (3) user events, (4) exceptional conditions.

  14. Creating an effective and efficient publicly sponsored health care delivery system.

    PubMed

    Zweifler, John; Prado, Kris; Metchnikoff, Chris

    2011-02-01

    An effective and efficient publicly sponsored health care delivery system can increase access to care, improve health care outcomes, and reduce spending. A publicly sponsored health care delivery system can be created by integrating services that are already federally subsidized: community health centers (CHCs), public and safety-net hospitals, and residency training programs. The Patient Protection and Affordable Care Act includes measures that support primary care generally and CHCs in particular. A publicly sponsored health care delivery system combining primary care based in CHCs with safety-net hospitals and the specialists that serve them could also benefit from incentives in the Patient Protection and Affordable Care Act for the creation of accountable care organizations, and reimbursement based on quality and cost control.

  15. Protocols — EDRN Public Portal

    Cancer.gov

    EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.

  16. Enhanced evaluation data initiates a collaborative out-of-school time food sponsors work group.

    PubMed

    Rifkin, Robin; Williams, Lauren A; Grode, Gabrielle M; Roberts-Johnson, Wendy-Anne

    2015-01-01

    Philadelphia's Healthy Kids, Healthy Communities Out-of-School Time (OST) Initiative led by the Health Promotion Council developed 10 Healthy Living Guidelines for Out-of-School Time Programs to support a healthy environment for Philadelphia youth in 200 OST programs. Health Promotion Council participated in an enhanced cross-site evaluation with the national Robert Wood Johnson Foundation evaluator during the final year of funding to learn more about food and nutrition in the OST setting, and to share data and engage the OST food providers. A plate waste study measured the quantity and nutrition composition of meals served to youth compared to food not eaten. Staff interviews measured program adherence to the Healthy Living Guidelines, along with other facets of the food environment in 7 Philadelphia OST programs. Online surveys were sent to OST programs. Food providers (sponsors) were interviewed using Appreciative Inquiry methodology to gain insight into systems, goals, and common interests. Aggregated plate waste data from 7 observations showed an average of 42% of the food uneaten after meal/snack consumption, and high sodium content of the meals. Twenty-nine staff at OST programs completed the online survey, and 3 food sponsors were interviewed. Recommendations to improve the food included increasing variety, offering more salads, fruits and vegetables, and culturally appropriate foods. Food sponsor interviews showed a variety of meal production, distribution, service and training systems, and an interest in working together. The food sponsors met to review the data and prioritized common goals. They continue to work together to improve systems and meals for food service. A food sponsors work group formed and continues as a result of sharing enhanced cross-site data about food in OST settings. Food sponsors continue to work together to improve systems and nutritional offerings for Philadelphia OST programs.

  17. Student experimenter and sponsor display SE83-9 'Chix in Space' incubator

    NASA Technical Reports Server (NTRS)

    1988-01-01

    Student experimenter John C. Vellinger (left) explains components of an incubator for his Student Experiment (SE) 83-9 Chicken Embryo Development in Space or 'Chix in Space' to be carried onboard STS-29 Discovery, Orbiter Vehicle (OV) 103. Mark S. Deusser, representing the sponsoring organization, holds up the incubator for inspection by STS-29 crewmembers who will monitor in-space operation of the experiment. Mission Specialist (MS) Robert C. Springer is partially visible in the lower right foreground. The student's sponsor is Kentucky Fried Chicken (KFC).

  18. The frequency of company-sponsored alcohol brand-related sites on Facebook™-2012.

    PubMed

    Nhean, Siphannay; Nyborn, Justin; Hinchey, Danielle; Valerio, Heather; Kinzel, Kathryn; Siegel, Michael; Jernigan, David H

    2014-06-01

    This research provides an estimate of the frequency of company-sponsored alcohol brand-related sites on Facebook™. We conducted a systematic overview of the extent of alcohol brand-related sites on Facebook™ in 2012. We conducted a 2012 Facebook™ search for sites specifically related to 898 alcohol brands across 16 different alcoholic beverage types. Descriptive statistics were produced using Microsoft SQL Server. We identified 1,017 company-sponsored alcohol-brand related sites on Facebook™. Our study advances previous literature by providing a systematic overview of the extent of alcohol brand sites on Facebook™.

  19. Your Boss, Players, and Sponsor: The Three Witches of War Gaming

    DTIC Science & Technology

    2014-01-01

    unclassified c. THIS PAGE unclassified Standard Form 298 (Rev. 8-98) Prescribed by ANSI Std Z39-18 3 2 Nava l Wa r C o l l e g e r e v I e W...place by performing good objectives analysis with the sponsor and by keeping his or her chain of command informed 3 4 Nava l Wa r C o l l e g e r e...results to influence the sponsor’s audiences. 3 6 Nava l Wa r C o l l e g e r e v I e W • second, senior sponsors, who necessarily delegate most day

  20. Student experimenter and sponsor display SE83-9 "Chix in Space" incubator

    NASA Image and Video Library

    1988-08-13

    S88-44514 (13 Aug 1988) --- Student experimenter John C. Vellinger, left, explains components of an incubator used in his experiment to be carried onboard the Discovery for NASA's STS-29 mission next year. Mark S. Deusser, representing the sponsoring organization, holds up the incubator for inspection by members of the STS-29 crew who will monitor in-space operation of the experiment, titled "Chicken Embryo Development in Space." Astronaut Robert C. Springer is partially visible in lower right foreground. The student's sponsor is Kentucky Fried Chicken.

  1. Drug company-sponsored patient assistance programs: a viable safety net?

    PubMed

    Choudhry, Niteesh K; Lee, Joy L; Agnew-Blais, Jessica; Corcoran, Colleen; Shrank, William H

    2009-01-01

    Drug company-sponsored patient assistance programs (PAPs) provide access to brand-name medications at little or no cost and have been advocated as a safety net for inadequately insured patients. Yet little is known about these programs. We surveyed drug company-sponsored PAPs and found much variability in their structures and application processes. Most cover one or two drugs. Only 4 percent disclosed how many patients they had directly helped, and half would not disclose their income eligibility criteria. A better understanding of PAPs might clarify their role in improving access to medications, the adequacy of existing public programs, and their impact on cost-effective medication use.

  2. [Sponsoring of research by the industry is not good for science].

    PubMed

    Vermeulen, M

    2006-08-12

    The pharmaceutical industry is not basically interested in knowledge about diseases and their treatment--its main interest is selling drugs. Hence, its research may even be aimed at shifting the border between health and disease in order to produce more indications for which drugs can be prescribed. In contrast, non-industry sponsored research can be aimed at solving medical problems that really matter and problems for which other forms of treatment are indicated than medication. Therefore, industry-sponsored research is bad for medical science.

  3. Quantum deniable authentication protocol

    NASA Astrophysics Data System (ADS)

    Shi, Wei-Min; Zhou, Yi-Hua; Yang, Yu-Guang

    2014-07-01

    The proposed quantum identity authentication schemes only involved authentication between two communicators, but communications with deniability capability are often desired in electronic applications such as online negotiation and electronic voting. In this paper, we proposed a quantum deniable authentication protocol. According to the property of unitary transformation and quantum one-way function, this protocol can provide that only the specified receiver can identify the true source of a given message and the specified receiver cannot prove the source of the message to a third party by a transcript simulation algorithm. Moreover, the quantum key distribution and quantum encryption algorithm guarantee the unconditional security of this scheme. Security analysis results show that this protocol satisfies the basic security requirements of deniable authentication protocol such as completeness and deniability and can withstand the forgery attack, impersonation attack, inter-resend attack.

  4. Internet Protocol Transition Workbook

    DTIC Science & Technology

    1982-03-01

    i~yif.al Pi.y~iiy wi -! b , ..aye meaning. U [Page il March 1982 Internet Protocol Transition Workbook CONTACTS ARPANET MANAGEMENT. POLICY, AND SERVICE...C) September 1981 Internet Protocol Example 2: In this example, we show fi -st a moderate size internet datagram (452 data octets), then two...00111100. fI Note that the assumed maximum segment lifetime is two minutes. Here we explicitly ask that a segment be destroyed if it cannot be delivered by

  5. Recording and submitting specimen history data

    USGS Publications Warehouse

    Franson, J. Christian

    1987-01-01

    Webster defines history as "a chronological record of significant events." In wildlife disease investigations, determining the history or background of a problem is the first significant step in establishing a diagnosis. You can greatly assist the diagnostic process by providing a thorough history with specimens yo submit. This information is also of value in understanding the natural history of disease outbreaks, and is difficult if not impossible to obtain after the event has occurred. Detailed field observations during the course of a die-off and investigation of significant events preceding it also provide valuable information on which to base corrective actions. Remember, the most helpful information is that which obtained at the time of the event by a sensitive and aware observer.

  6. Cohort study of trials submitted to ethics committee identified discrepant reporting of outcomes in publications.

    PubMed

    Redmond, Shelagh; von Elm, Erik; Blümle, Anette; Gengler, Malou; Gsponer, Thomas; Egger, Matthias

    2013-12-01

    To identify factors associated with discrepant outcome reporting in randomized drug trials. Cohort study of protocols submitted to a Swiss ethics committee 1988-1998: 227 protocols and amendments were compared with 333 matching articles published during 1990-2008. Discrepant reporting was defined as addition, omission, or reclassification of outcomes. Overall, 870 of 2,966 unique outcomes were reported discrepantly (29.3%). Among protocol-defined primary outcomes, 6.9% were not reported (19 of 274), whereas 10.4% of reported outcomes (30 of 288) were not defined in the protocol. Corresponding percentages for secondary outcomes were 19.0% (284 of 1,495) and 14.1% (334 of 2,375). Discrepant reporting was more likely if P values were <0.05 compared with P ≥ 0.05 [adjusted odds ratio (aOR): 1.38; 95% confidence interval (CI): 1.07, 1.78], more likely for efficacy compared with harm outcomes (aOR: 2.99; 95% CI: 2.08, 4.30) and more likely for composite than for single outcomes (aOR: 1.48; 95% CI: 1.00, 2.20). Cardiology (aOR: 2.34; 95% CI: 1.44, 3.79) and infectious diseases (aOR: 1.77; 95% CI: 1.01, 3.13) had more discrepancies compared with all specialties combined. Discrepant reporting was associated with statistical significance of results, type of outcome, and specialty area. Trial protocols should be made freely available, and the publications should describe and justify any changes made to protocol-defined outcomes. Copyright © 2013 Elsevier Inc. All rights reserved.

  7. Motivations of Government-Sponsored Kurdish Students for Pursuing Postgraduate Studies Abroad; An Exploratory Study

    ERIC Educational Resources Information Center

    Ahmad, Ahmad Bayiz; Hassan, Hemin Ali; Al-Ahmedi, Mustafa Wshyar Abdulla

    2017-01-01

    This study examines the motivations of government-sponsored Kurdish students to study abroad and the reasons for choosing a particular country as their destination choice. Based on data we collected through an online survey and follow-up interviews, we compare demographic differences to explore the diversity among this cohort. The findings of the…

  8. 8 CFR 204.1 - General information about immediate relative and family-sponsored petitions.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 8 Aliens and Nationality 1 2010-01-01 2010-01-01 false General information about immediate relative and family-sponsored petitions. 204.1 Section 204.1 Aliens and Nationality DEPARTMENT OF HOMELAND... for an alien's classification as an immediate relative under section 201(b) of the Act or as a...

  9. Student Self-Assessment of Non-Sponsored Learning; A CAEL Special Project. Final Report.

    ERIC Educational Resources Information Center

    Vermont Community Colleges, Montpelier.

    Within broad guidelines provided by the Community College of Vermont (CCV), associate degree students write their own individualized, competence-based contracts. Development of the contract includes both assessment of prior learning, and planning for sponsored learning: These are integrated through a "degree development sequence" which includes a…

  10. Report on Autism Conference Sponsored by NEC*TAS (Hartford, Connecticut, February 1996).

    ERIC Educational Resources Information Center

    Ziegler, Martha

    1996-01-01

    This issue of the "Early Childhood Bulletin" is a summary of information that was presented at a 1996 conference on autism sponsored by the National Early Childhood Technical Assistance System (NECTAS). Participants included Part H and Part B, Section 619 Program coordinators, individual program providers, and Interagency Coordinating…

  11. Marketing Executive MBA Programs: A Comparison of Student and Sponsoring Organization Decision Considerations.

    ERIC Educational Resources Information Center

    Carrel, Ann E.; Schoenbachler, Denise D.

    2001-01-01

    Surveyed students and supporting organizations about their decision considerations regarding enrolling in and supporting an executive master of business administration (EMBA) program. The findings from this studyprovide direction for EMBA directors in strengthening recruiting efforts toward both students and organization sponsors. (EV)

  12. 21 CFR 58.217 - Suspension or termination of a testing facility by a sponsor.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 1 2012-04-01 2012-04-01 false Suspension or termination of a testing facility by a sponsor. 58.217 Section 58.217 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY...

  13. 21 CFR 58.217 - Suspension or termination of a testing facility by a sponsor.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 1 2010-04-01 2010-04-01 false Suspension or termination of a testing facility by a sponsor. 58.217 Section 58.217 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY...

  14. 21 CFR 58.217 - Suspension or termination of a testing facility by a sponsor.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 1 2011-04-01 2011-04-01 false Suspension or termination of a testing facility by a sponsor. 58.217 Section 58.217 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY...

  15. 21 CFR 58.217 - Suspension or termination of a testing facility by a sponsor.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 1 2014-04-01 2014-04-01 false Suspension or termination of a testing facility by a sponsor. 58.217 Section 58.217 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY...

  16. 21 CFR 58.217 - Suspension or termination of a testing facility by a sponsor.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 1 2013-04-01 2013-04-01 false Suspension or termination of a testing facility by a sponsor. 58.217 Section 58.217 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY...

  17. A Cost-Containment Incentive for a University Research Contract with a Commercial Sponsor.

    ERIC Educational Resources Information Center

    Gedney, Matt

    1994-01-01

    A recent mechanical engineering research contract between the Georgia Institute of Technology and an international industrial manufacturer contains a clause providing an incentive for cost containment. The measure helps bridge the gap between the expectations of an industrial sponsor and the needs of the university. (Author/MSE)

  18. 22 CFR Appendix C to Part 62 - Update of Information on Exchange-Visitor Program Sponsor

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Update of Information on Exchange-Visitor Program Sponsor C Appendix C to Part 62 Foreign Relations DEPARTMENT OF STATE PUBLIC DIPLOMACY AND EXCHANGES EXCHANGE VISITOR PROGRAM Pt. 62, App. C Appendix C to Part 62—Update of Information on Exchange...

  19. 22 CFR 62.63 - Responsibilities of the sponsor upon termination or revocation.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Responsibilities of the sponsor upon termination or revocation. 62.63 Section 62.63 Foreign Relations DEPARTMENT OF STATE PUBLIC DIPLOMACY AND EXCHANGES EXCHANGE VISITOR PROGRAM Termination and Revocation of Programs § 62.63 Responsibilities of the...

  20. 22 CFR 62.63 - Responsibilities of the sponsor upon termination or revocation.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 22 Foreign Relations 1 2011-04-01 2011-04-01 false Responsibilities of the sponsor upon termination or revocation. 62.63 Section 62.63 Foreign Relations DEPARTMENT OF STATE PUBLIC DIPLOMACY AND EXCHANGES EXCHANGE VISITOR PROGRAM Termination and Revocation of Programs § 62.63 Responsibilities of...

  1. 77 FR 20987 - Oral Dosage Form New Animal Drugs; Change of Sponsor; Lincomycin Hydrochloride Soluble Powder...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-04-09

    ... HUMAN SERVICES Food and Drug Administration 21 CFR Part 520 Oral Dosage Form New Animal Drugs; Change of Sponsor; Lincomycin Hydrochloride Soluble Powder; Penicillin G Potassium in Drinking Water; Tetracycline Powder AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; technical amendment. SUMMARY: The...

  2. 76 FR 49649 - Oral Dosage Form New Animal Drugs; Change of Sponsor; Chlortetracycline; Sulfamethazine

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-11

    ... / Thursday, August 11, 2011 / Rules and Regulations#0;#0; ] DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 520 Oral Dosage Form New Animal Drugs; Change of Sponsor... for five new animal drug applications (NADAs) from Fort Dodge Animal Health, Division of...

  3. 42 CFR 440.350 - Employer-sponsored insurance health plans.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 4 2010-10-01 2010-10-01 false Employer-sponsored insurance health plans. 440.350 Section 440.350 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL ASSISTANCE PROGRAMS SERVICES: GENERAL PROVISIONS Benchmark Benefit and Benchmark-Equivalent Coverage § 440.350...

  4. 45 CFR 149.600 - Sponsor's duty to report data inaccuracies.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 45 Public Welfare 1 2010-10-01 2010-10-01 false Sponsor's duty to report data inaccuracies. 149.600 Section 149.600 Public Welfare DEPARTMENT OF HEALTH AND HUMAN SERVICES REQUIREMENTS RELATING TO HEALTH CARE ACCESS REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM Disclosure of Data...

  5. Citrus Research Board-sponsored review of the University of California Riverside citrus breeding

    USDA-ARS?s Scientific Manuscript database

    In October 2015 the Citrus Research Board (CRB) assembled a panel of experts to review the Citrus Research Board-sponsored Citrus Research and Genetics Programs at University of California Riverside (UCR). The panel consisted of: Gennaro Fazio, USDA/ARS, Geneva, NY; Maria Angeles Forner-Giner, Insti...

  6. 26 CFR 46.4376-1 - Fee on sponsors of self-insured health plans.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 26 Internal Revenue 16 2013-04-01 2013-04-01 false Fee on sponsors of self-insured health plans..., except that for the 2014 plan year Employer B determines the number of lives covered that are not covered... this section)). (ii) On January 10, 2014, Employer B Self-Insured Health Plan provides self-only...

  7. 45 CFR 2553.25 - What are a sponsor's administrative responsibilities?

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... operate the project successfully. (b) Provide levels of staffing and resources appropriate to accomplish the purposes of the project and carry out its project management responsibilities. (c) Employ a full... staff positions in the sponsor organization and/or project service area. (f) Establish risk...

  8. 45 CFR 2553.25 - What are a sponsor's administrative responsibilities?

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... operate the project successfully. (b) Provide levels of staffing and resources appropriate to accomplish the purposes of the project and carry out its project management responsibilities. (c) Employ a full... staff positions in the sponsor organization and/or project service area. (f) Establish risk...

  9. 45 CFR 2553.25 - What are a sponsor's administrative responsibilities?

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... operate the project successfully. (b) Provide levels of staffing and resources appropriate to accomplish the purposes of the project and carry out its project management responsibilities. (c) Employ a full... staff positions in the sponsor organization and/or project service area. (f) Establish risk...

  10. 45 CFR 2551.25 - What are a sponsor's administrative responsibilities?

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... project and carry out its project management responsibilities. (c) Employ a full-time project director to... the sponsor organization and/or project service area. (f) Establish risk management policies and... responsibility for securing maximum and continuing community financial and in-kind support to operate the...

  11. 45 CFR 2551.25 - What are a sponsor's administrative responsibilities?

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... project and carry out its project management responsibilities. (c) Employ a full-time project director to... the sponsor organization and/or project service area. (f) Establish risk management policies and... responsibility for securing maximum and continuing community financial and in-kind support to operate the...

  12. 45 CFR 2551.25 - What are a sponsor's administrative responsibilities?

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... project and carry out its project management responsibilities. (c) Employ a full-time project director to... the sponsor organization and/or project service area. (f) Establish risk management policies and... responsibility for securing maximum and continuing community financial and in-kind support to operate the...

  13. Teaching Ethical Copyright Behavior: Assessing the Effects of a University-Sponsored Computing Ethics Program

    ERIC Educational Resources Information Center

    Siemens, Jennifer Christie; Kopp, Steven W.

    2006-01-01

    Universities have become sensitized to the potential for students' illegal downloading of copyrighted materials. Education has been advocated as one way to curb downloading of copyrighted digital content. This study investigates the effectiveness of a university-sponsored computing ethics education program. The program positively influenced…

  14. 78 FR 19713 - Possible Role of Independent Third Parties in Industry-Sponsored Tobacco Product Research...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-02

    ... design and conduct of research, the oversight of specific studies, and the distribution of sponsor funds... premarket tobacco product applications and other submissions to FDA, as well as research designed to... product research could be subject to third-party governance? For example, should both the design and...

  15. 29 CFR 4043.29 - Change in contributing sponsor or controlled group.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ...., the binding contract), because as a result of the transaction, Company Q (and any other member of its... and Company R enter into the binding contract, the change in the contributing sponsor has not yet...” includes, but is not limited to, a legally binding agreement, whether or not written, to transfer...

  16. 21 CFR 516.22 - Permanent-resident U.S. agent for foreign sponsor.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES Designation of a Minor Use or Minor Species New Animal Drug § 516.22 Permanent-resident U.S. agent..., decisions, requirements, and other communications may be made on behalf of the sponsor. Notifications...

  17. 21 CFR 516.22 - Permanent-resident U.S. agent for foreign sponsor.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES Designation of a Minor Use or Minor Species New Animal Drug § 516.22 Permanent-resident U.S. agent..., decisions, requirements, and other communications may be made on behalf of the sponsor. Notifications...

  18. 21 CFR 516.22 - Permanent-resident U.S. agent for foreign sponsor.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES Designation of a Minor Use or Minor Species New Animal Drug § 516.22 Permanent-resident U.S. agent..., decisions, requirements, and other communications may be made on behalf of the sponsor. Notifications...

  19. 21 CFR 516.22 - Permanent-resident U.S. agent for foreign sponsor.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... SERVICES (CONTINUED) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES Designation of a Minor Use or Minor Species New Animal Drug § 516.22 Permanent-resident U.S. agent..., decisions, requirements, and other communications may be made on behalf of the sponsor. Notifications...

  20. 42 CFR 403.806 - Sponsor requirements for eligibility for endorsement.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... comparison Web site, as described in paragraph (i)(4)(v) of this section. (6) Obtain rebates, discounts, or... description of the endorsed discount drug card program. (2) An endorsed sponsor must include on a Web site the following: (i) Information regarding when the Web site was last updated; and (ii) A disclaimer that the...

  1. The Relationship between Emotional Intelligence and Leadership Effectiveness among Sponsored Research Administrators

    ERIC Educational Resources Information Center

    Jones, Ventez Derrell

    2012-01-01

    The purpose of this study was to examine the relationship of emotional intelligence, as perceived by senior level university sponsored research administration professionals and their perceived leadership effectiveness, as measured by the Bar-On Emotional Quotient Inventory and the Kouzes and Posner Leadership Practices Inventory (LPI) for Self.…

  2. Marketing Capstone Models "The Apprentice" Television Show with Client-Sponsored Projects

    ERIC Educational Resources Information Center

    Strauss, Judy

    2011-01-01

    Marketing faculty use cases, simulations, and client-sponsored projects to achieve learning objectives in the marketing capstone class. This class typically aims to integrate and apply previously learned material and to transition students into their careers. Drawing on the professional school, creative problem solving and constructivist learning…

  3. 42 CFR 403.822 - Reimbursement of transitional assistance and associated sponsor requirements.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... allowed balance provided by CMS to the sponsor. (d) Payment transactions will be audited by the Secretary or his agent. (e) Federal funding in excess of the amount of the balance included in CMS's system is... Account the amounts certified by CMS as necessary to make payments for transitional assistance as...

  4. Rights-Based Education for South Asian Sponsored Wives in International Arranged Marriages

    ERIC Educational Resources Information Center

    Merali, Noorfarah

    2008-01-01

    The Family Class Category of Canada's Immigration Policy exists with the key objective of family unification. Among Canada's second largest immigrant group, the South Asians, the cultural practice of arranged marriage is applied across international borders, leading to spousal sponsorship. Existing research on South Asian sponsored wives suggests…

  5. 44 CFR 208.34 - Agreements between Sponsoring Agencies and others.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 44 Emergency Management and Assistance 1 2012-10-01 2011-10-01 true Agreements between Sponsoring Agencies and others. 208.34 Section 208.34 Emergency Management and Assistance FEDERAL EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY DISASTER ASSISTANCE NATIONAL URBAN SEARCH AND RESCUE RESPONSE...

  6. 44 CFR 208.34 - Agreements between Sponsoring Agencies and others.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 44 Emergency Management and Assistance 1 2013-10-01 2013-10-01 false Agreements between Sponsoring Agencies and others. 208.34 Section 208.34 Emergency Management and Assistance FEDERAL EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY DISASTER ASSISTANCE NATIONAL URBAN SEARCH AND RESCUE RESPONSE...

  7. 44 CFR 208.34 - Agreements between Sponsoring Agencies and others.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 44 Emergency Management and Assistance 1 2014-10-01 2014-10-01 false Agreements between Sponsoring Agencies and others. 208.34 Section 208.34 Emergency Management and Assistance FEDERAL EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY DISASTER ASSISTANCE NATIONAL URBAN SEARCH AND RESCUE RESPONSE...

  8. An Economic Approach to Setting Contribution Limits in Qualified State-Sponsored Tuition Savings Plans.

    ERIC Educational Resources Information Center

    Ma, Jennifer; Warshawsky, Mark J.; Ameriks, John; Blohm, Julia A.

    This study used an expected utility framework with a mean-lower partial moment specification for investor utility to determine the asset allocation and the allowable contribution limits for qualified state-sponsored tuition savings plans. Given the assumptions about state policymakers' perceptions of investor utility, the study determined the…

  9. Directory of Indochinese Health Education Materials for Southeast Asian Refugees, Refugee Sponsors and Refugee Health Providers.

    ERIC Educational Resources Information Center

    Minnesota State Dept. of Health, St. Paul. Refugee Education Resource Center.

    This is a directory of (print) health education materials for Indochinese refugees, refugee sponsors, and refugee health providers. Materials listed for refugees cover dental health, diseases, family planning, infant and child health, maternal care and pregnancy, legal systems, nutrition, patient instruction, and education. The directory also…

  10. Support from Chief Executives to Sponsored Programs Administration at Baccalaureate Universities in the United States

    ERIC Educational Resources Information Center

    Hamilton, Zoya

    2012-01-01

    This research study examined support to sponsored programs administrators (SPAs, or research administrators) at baccalaureate universities from their chief executives. Support to SPAs strengthens the shared purpose of the university, enabling SPAs to serve as effective organizational representatives in business transactions pertaining to grants…

  11. Financial administration of work for nonfederal sponsors, DOE Field Office (AL), Albuquerque, New Mexico

    SciTech Connect

    Not Available

    1991-09-30

    The Department of Energy (DOE) Field Office, Albuquerque (AL) is responsible for managing and controlling nonfederally sponsored work done by Los Alamos National Laboratory (LANL). The audit objective was to determine whether the funding of, and accounting for, work done under a 1984 funds-in agreement and work for others in Fiscal Year (FY) 1989 complied with laws, regulations, and policies.

  12. Teaching Ethical Copyright Behavior: Assessing the Effects of a University-Sponsored Computing Ethics Program

    ERIC Educational Resources Information Center

    Siemens, Jennifer Christie; Kopp, Steven W.

    2006-01-01

    Universities have become sensitized to the potential for students' illegal downloading of copyrighted materials. Education has been advocated as one way to curb downloading of copyrighted digital content. This study investigates the effectiveness of a university-sponsored computing ethics education program. The program positively influenced…

  13. 7 CFR 226.13 - Food service payments to sponsoring organizations for day care homes.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... day care homes. 226.13 Section 226.13 Agriculture Regulations of the Department of Agriculture... CARE FOOD PROGRAM Payment Provisions § 226.13 Food service payments to sponsoring organizations for day... children and eligible enrolled children of day care home providers, at approved day care homes. (b)...

  14. 7 CFR 226.13 - Food service payments to sponsoring organizations for day care homes.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... day care homes. 226.13 Section 226.13 Agriculture Regulations of the Department of Agriculture... CARE FOOD PROGRAM Payment Provisions § 226.13 Food service payments to sponsoring organizations for day... children and eligible enrolled children of day care home providers, at approved day care homes. (b)...

  15. 7 CFR 226.12 - Administrative payments to sponsoring organizations for day care homes.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... for day care homes. 226.12 Section 226.12 Agriculture Regulations of the Department of Agriculture... day care homes. (a) General. Sponsoring organizations for day care homes shall receive payments for... organization's: (i) Initial 50 day care homes by 42 dollars; (ii) Next 150 day care homes by 32 dollars;...

  16. The "Ripple Effect" of a University Sponsored Death and Dying Symposium.

    ERIC Educational Resources Information Center

    Cook, Alicia S.; And Others

    1985-01-01

    Conducted a follow-up study of a three-week, university sponsored death and dying symposium to measure attitudes of nonattendees. The findings showed a declining taboo regarding death education and a "ripple effect" in which individuals are affected by a death education program even though they do not attend it. (JAC)

  17. A Guide for Setting Up a Church-Sponsored Nursery School.

    ERIC Educational Resources Information Center

    Hostrawser, Sara

    This document provides a guide for setting up a church-sponsored nursery school. Chapter One outlines the verbal-cognitive model of preschool education which emphasizes interaction between teacher and child. Perceptual, motor, cognitive, social, emotional, and language objectives are indicated. Chapter Two covers aspects of school management such…

  18. Industry-Sponsored Credentials. In Brief: Fast Facts for Policy and Practice.

    ERIC Educational Resources Information Center

    Wonacott, Michael E.

    A study investigated the influence of information technology (IT) industry-sponsored credentials commonly called IT certifications (ITCs) from both organizational and individual perspectives. Findings indicated that there was increasing acceptance, prevalence, and benefits of ITCs in business and industry. Both executives and employees reported…

  19. 21 CFR 312.58 - Inspection of sponsor's records and reports.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 5 2013-04-01 2013-04-01 false Inspection of sponsor's records and reports. 312.58 Section 312.58 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN... shall upon request from any properly authorized officer or employee of the Food and Drug Administration...

  20. 47 CFR 68.602 - Sponsor of the Administrative Council for Terminal Attachments.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... Terminal Attachments. 68.602 Section 68.602 Telecommunication FEDERAL COMMUNICATIONS COMMISSION (CONTINUED... Administrative Council for Terminal Attachments § 68.602 Sponsor of the Administrative Council for Terminal Attachments. (a) The Telecommunications Industry Association (TIA) and the Alliance for...